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SUMMARY
Considerable evidence has accumulated in recent
years which suggests that endogenous prostaglandins,
particularly of the E-series, might modulate the release
of noradrenaline from peripheral adrenergic nerve endings.
Exogenous PGE has been shown to reduce the amount of
noradrenaline released from several tissues during
adrenergic nerve stimulation. In addition, adrenergic
nerve stimulation has been shown to release or increase
the release of prostaglandins from several tissues.
The rabbit kidney synthesises large amounts of
prostaglandin (mainly PGE2 and and renal nerve
stimulation has been shown to increase the output of
prostaglandins into renal venous blood. Prostaglandins
are known to influence total renal blood flow and its
distribution and it is thought that their endogenous
production might contribute to renal autoregulation.
The experiments in this thesis were conducted with
a view to finding out whether prostaglandins produce their
effects on renal blood flow by acting presynaptically to
alter vascular tone or by a postsynaptic action.
In Section 1, experiments on rabbits in vivo showed,
using two different methods of analysis, that noradrenaline,
like renal nerve stimulation, increased prostaglandin
release from the kidney. It seems likely that the source
of the prostaglandin was the postjunctional effector cell
rather than the adrenergic nerve ending itself.
In Section 2, experiments were performed on rabbit
kidneys in situ and in vitro to investigate the effects
of prostaglandins a2> e2 and F2rt on vascular responsiveness
to injected noradrenaline and to noradrenaline released
during renal nerve stimulation. PGA2 and PGF^ both
potentiated vascular responses to noradrenaline and to renal
nerve stimulation similarly. It was concluded that their
action was primarily at a postjunctional site. PGE2
inhibited vascular responses to renal nerve stimulation but
did not inhibit responses to noradrenaline in parallel,
suggesting that it might possess a prejunctional component
of action.
In Section 3> the prejunctional action of each
prostaglandin on noradrenaline release during RNS was investi¬
gated in the rabbit kidney, in vitro. All three prosta¬
glandins inhibited noradrenaline overflow from the kidney
during renal nerve stimulation but PGE2 was ten times more
potent than PGA2 or PGF^.
In Section 4, the role of endogenous prostaglandins
in the control of adrenergic transmitter release was
investigated in vitro, using the isolated, perfused rabbit
kidney. An attempt was made to reduce prostaglandin
synthesis with indoraethacin and to increase synthesis with
arachidonate. Infusion of indomethacin increased whilst
arachidonate infusion reduced the overflow of noradrenaline
during renal nerve stimulation.
Prostaglandins released from the kidney during renal
nerve stimulation appear to come from postsynaptic sites.
The action of PGE^ on renal vascular responses to nerve
stimulation is, in part, attributable to an action on
adrenergic neurotransmission. The evidence which is
presented is compatible with the hypothesis that PGE2
which is released during renal nerve stimulation may, under
physiological conditions, reduce the output of noradrenaline




In 1965 Lee, Covino, Taxman and Smith described the
isolation of three vasodilator lipids from rabbit renal
medulla, one of which was tentatively identified as prosta¬
glandin F (PGF). The second was believed to be PGE and the
third, which was inactive on non-vascular smooth muscle, was
named "medullin" (Lee et al., 1965). Medullin was subse¬
quently identified as PGA2 (Lee, Gougoutas, Takman, Daniels,
Grostic, Pike, Hinman and Muirhead, 1966). Prostaglandins
of the A series, tinlike those of the E and F series, are not
readily metabolised on passage through the lungs (Horton and
Jones, 1969; McGiff, Terragno, Strand, Lee, Lonigro and Ng,
1969). This property,in addition to its ability to lower
blood pressure by decreasing total peripheral resistance,
appears to fit PGA2 for the role of a circulating antihyper¬
tensive hormone. Furthermore, PGA2 showed no effect on
cardiac contractility or heart rate (Lee et al., 1965).
PGEZ shared with PGA2 the ability to decrease peripheral
vascular resistance and also had similar effects on the
renal system (for a comparison of their effects, see Table a).
However, its substantial degradation on circulation through
the lungs would seem to rule out a role for PGE2 as a
circulating hormone. Thus PGA2 seems better fitted to the
role of a circulating antihypertensive agent. The existence
of such a natural hormone was soon challenged, however, when
evidence appeared in the literature that PGA was readily
formed from PGE by acid treatment, a procedure which was
involved during extraction procedures (Strong, Boucher,
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Table a: A comparison of the cardiovascular effects of
PGA and PGE administered intravenously to the



















Renal medullary blood flow














PGE was given i.v. in large amounts allowing part to escape
degradation by the lung and act systemically. When given
in equimolar amounts at which PGA has an intravenous effect
(< lcr^M), PGE is devoid of systemic circulating actions as
a result of its metabolism by the lung.
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Nowaczynski and Genest, 1966). It was suggested that PGA
might not be naturally-occurring as first thought but
rather an extraction artefact. This possibility was
further documented by Daniels, Hinman, Leach and Muirhead
(1967) who found, by mass spectrometric analysis, that
PGE2 was the principal vasodilator lipid of the rabbit renal
medulla. Recent development of more sophisticated and
sensitive analytical techniques using isotope dilution
overwhelmingly supports the proposition that PGA isolated
from the kidney derives solely from dehydration of PGE.
Frolich, Sweetman, Carr and Oates (1975) have shown using
the deuterium carrier method (cf. Section 1) that all PGA2
recovered either prior to or following incubation of rabbit
renal medullary tissue could be accounted for by in vitro
.0 ^
dehydration of PGE2. Larsson and iinggard (1976) have
similarly demonstrated, by use of deuterium and radioactively-
labelled prostaglandin internal standards, that the small
amount of PGA2 found in their study of rabbit renal cortex
and medulla could be accounted for by conversion from PGE2.
These last authors have shown by the same method that
the renal cortex produces approximately equal amounts of
PGE2 and PGF2r and that the renal medulla produces approxi¬
mately 50% more PGE2 than PGF^» The functional significance
of PGF2ry in the kidney is not clear. It produces vasocon¬
striction in rabbit and rat kidneys (Malik and McGiff, 1975)
but in doses comparable to those at which PGE2 is active,
PGF2r( does not affect total renal blood flow or its distri¬
bution in the dog kidney (McGiff, Terragno, Malik and
Lonigro, 1972a; Chang, Splawinski, Oates and Nies, 1975).
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The probable artefactual nature of PGA2 and the
general lack of potency of PGF2^ in kidney &hed doubt
on the possible functions of these prostaglandins as intra-
renal hormones. The rapid degradability of PGE2 on passage
through the lung detracts from its suitability as a circu¬
lating hormone. It does, however, possess fivefold the
vasodilator-diuretic potency of PGA2 in the renal bed
(Lonigro, Terragno, Malik and McGiff, 1973a)and is, as
indicated previously, the major prostaglandin synthesised
by the kidney. Thus, if any of the prostaglandins has a
role in autoregulation of renal blood flow and in diuresis,
PGE2 seems to be the most likely candidate. There is
considerable evidence which indicates that PGE2 is a local
intrarenal hormone (Terragno, Strand, Pacholczyk and McGiff,
1973; Vane and McGiff, 1975).
Prostaglandin biosynthesis and metabolism by the kidney
All prostaglandins have as their basic structure a
20-carbon skeleton which has been named prostanoic acid.
They are named semi-systematically with reference to this
formula (Nugteren, van Dorp, Bergstr'dm and Hamberg, 1966).
The complexity of their chemical names, however, has led
to the adoption of trivial names. Prostaglandins have been
divided into groups according to their cyclopentane ring
structure, which is denoted by a letter (see Fig. a). The
prostaglandins synthesised by the kidney constitute mainly
the 2-series, PGE2 and PGF2fT. The subscript number refers
to the number of double bonds occurring in the two side-
chains and a or 0 to the position of the alcohol groups in





PGF, either both below the ring («) or 9-OH above and 11-OH
below the ring (g). The substrate for the synthesis of
these two prostaglandins is the polyenoic fatty acid,
arachidonic acid (BergstrSm, Danielsson and Samuelsson, 1964;
«
van Dorp, Beerthius, Nugteren and Vonkeman, 1964). A
scheme of synthesis is represented in Fig. b. Two inter¬
mediate endoperoxide compounds have been isolated during
enzymatic conversion of arachidonic acid into PGE2 and
PGF2a- They were isolated and named simultaneously by
Nugteren and Hazelhof (1973) who called them 15-hydroperoxy-
PGR2 and PGR2 and by Hamberg and Samuelsson (1973)» who
called them PGG2 and PGH2 respectively. PGG2/15-hydroperoxy-
PGR2 possesses a hydroperoxy (-00H) group at C15 whilst
PGH2/PGR2 possesses a hydroxyl group at C^ (see Fig. b).
The prostaglandin endoperoxides have been reported to be
more active than the classical prostaglandins in some
biological systems e.g. blood platelet aggregation (Hamberg,
Hedqvist, Strandberg, Svensson and Samuelsson, 1975)• A
role for these substances in the kidney, if any, is as yet
undiscovered. The endoperoxides can undergo isomerisation
to form PGE2 or PGB2, or reduction to form PGF2^. Another
important pathway leads to the formation of major metabolites
known as PHD and HHT (Hamberg and Samuelsson, 1974; Hamberg,
Svensson and Samuelsson, 1974). It was recently discovered
that the intermediate compound between PGG2 and PHD is also
highly active biologically. It has been named thromboxane A2
as a result of its production by platelets (Hamberg, Svensson
and Samuelsson, 1975). This compound is highly labile,















having a half-life of about thirty seconds at 37°C (in
aqueous solution). It is now known to be the unstable
factor which induces irreversible platelet aggregation
when platelets are incubated with either arachidonic acid
or PGG2* There is further evidence which indicates that
thromboxane Az is also the major component of the rabbit
aorta contracting substance (RCS) released from sensitised
guinea pig lung during antigen-challenge (Piper and Vane,
1969). PHD belongs to the same group of substances as
thromboxane A£ and has been renamed thromboxane B2. Thus
the thromboxanes constitute a new group of important mediators
of the actions of polyenoic fatty acids transformed via the
cyclo-oxygenase pathway. Thromboxane production by the
kidney has not been investigated as yet and cannot be assumed
to occur. Endoperoxide formation, on the other hand, is
essential to the production of the renal prostaglandins,
PGE2 and PGF'2 .
The sites of synthesis and metabolism of prostaglandins
in the rabbit kidney can be clearly differentiated. Synthetic
capacity appears to increase about tenfold from the renal
cortex to the renal medulla, reaching a maximum in the inner
medulla or papillary region (Larsson and Xnggard, 1973a).
Rabbit renal medulla contains one of the most active prosta¬
glandin synthetase enzymes ... known (Christ and van
Dorp, 1972). The cortical synthesis of prostaglandins,
although only 10% of that in the medulla, is nevertheless
significant in view of the very high synthetic capacity of
the medulla. As much as 44 Mg PG/g medullary tissue has been
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shown to be synthesised (Knggard, Bohman, Griffin, Larsson
and Maunsbach, 1972). Recent results suggest that the sub¬
cellular location of prostaglandin synthetase is in the
endoplasmic reticulum of the medullary cells (Bohman and
Larsson, 1975).
Prostaglandins are metabolised in the kidney by
conversion of the 15-hydroxyl group to a ketone and then
reduction of the 1>-14 double bond (Knggard and Larsson, 1971).
The enzymes responsible for these transfigurations are 15-
13
hydroxy prostaglandin dehydrogenase and prostaglandin-a -
reductase respectively (!4nggard, Larsson and Samuelsson,
1971). In contrast to the distribition of the prostaglandin
synthetic enzyme system in the kidney, prostaglandin dehydro¬
genase occurs most prevalently in the renal cortex, activity
in this region being about ten times higher than that found
in the outer medulla and papilla (Larsson and Xnggard, 1973a).
As a result of the high metabolic capacity of the cortex,
prostaglandin production in this region remained undetected
in earlier studies (Crowshaw and Szlyk, 1970; Crowshaw, 1971).
The subcellular localisation of dehydrogenase was found to be
the non-particulate fraction of both cortex and outer medulla
with no demonstrable activity in the papillary region
(Anggard et al., 1971).
The implications of the regionalisation of renal
prostaglandin production and degradation are discussed with
relation to renal blood flow in the General Discussion at
the end of this thesis.
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Release of prostaglandins by the kidney
Prostaglandins are released from the kidney in
response to a variety of stimuli, all of which involve
haemodynamic changes within the organ. Some examples are
listed in Table b. Prostaglandin release following vaso¬
constriction in some of these studies was associated with
a recovery or "escape" from vasoconstriction. Prostaglandins
have also been implicated as mediators of natriuresis (see
Lee, 1972) although these is some disagreement as to whether
their effect in promoting salt excretion is the result of
haemodynamic changes or of a direct action on renal tubules
(Vander, 1968; McGiff et al.. 1972a; Gross and Bartter,
1973; Tannenbaum, Splawinski, Oates and Nies, 1975; Slick,
Aguilera, Zambraski, Di Bona and Kaloyanides, 1975). The
present study is primarily concerned with interactions between
prostaglandins and the renal adrenergic system. The major
discussion will be confined to aspects of these interactions
relating to haemodynamic changes in the kidney.
Renal innervation and vascular anatomy
The renal nerves are mainly adrenergic with fibres
originating from the inferior mesenteric ganglion. They
form a plexus around the renal artery and pass, in association
with it, into the kidney. Adrenergic innervation is
associated only with the blood vessels and supplies the main
interlobar arteries and the preglomerular arterioles of
rabbit, rat and dog kidneys (Nilsson, 1965; McKenna and
Angelakos, 1968). In a series of experiments on dog, guinea
11
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pig, rat, hamster and mouse kidneys, Dolezel (1966) also
demonstrated adrenergic innervation of the large veins. The
overall distribution of renal innervation suggests that it
may have an integral role in the control of renal blood flow.
The large interlobar arteries arising from the main
renal artery supply glomeruli in both the outer and inner
(juxtamedullary) cortex. Each outer cortical glomerulus
consists of an afferent arteriole, a glomerular tuft and an
efferent arteriole, with no evidence of a connection between
the arterioles other than via the glomerulus. The efferent
arteriole empties into a network of cortical capillaries of
small calibre. The juxtamedullary arteriole-glomerular
units of the human and rabbit kidney have been shown to
differ from those in the outer cortex (Ljungqvist, 1964).
They consist of afferent and efferent arterioles which form
continuous vessels and from which glomerular capillaries are
given off as side-branches. The efferent part of the
continuous vessel empties ultimately into straight vessels
of large calibre, known as the vasa recta, which penetrate
the medulla (Trueta, Barclay, Daniel, Franklin and Prichard,
1947; Ljungqvist, 1964). In normal kidneys, all blood
circulating through the organ passes through the glomeruli
and the medulla receives only the blood supply which enters
it through the juxtamedullary glomeruli (not more than 25%
of total renal blood flow). During intense cortical vaso¬
constriction, blood is diverted from the cortex to the
medulla and filtration is reduced or eliminated. The juxta-
medullary vessels are responsible for the by-pass of blood,
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the calibre of these vessels controlling the magnitude of
the extra-glomerular flow.
Nervous control of renal blood flow
During renal nerve stimulation (RNS), blood is "short-
circuited" from the cortex to the medulla via the juxta-
medullary shunt described above. Pomeranz, Birtch and
Barger (1968) have demonstrated that RNS at 10 impulses/
second (10 Hz), which may not alter total renal blood flow,
decreases perfusion of the outer cortical capillaries and
increases that of the outer medulla. At higher frequencies
of stimulation (30-32 Hz), vasoconstriction has been shown to
occur in both the outer and juxtamedullary cortex, producing
cessation of blood flow through this region, whilst blood in
the medulla remains static. A significant shunting of
blood flow from cortex to medulla was not observed in these
experiments (Block, Wakim and Mann, 1952). The stimulation
frequency employed by these authors was, however, far in
excess of physiological impulse frequency in renal nerves.
In the cat it has been demonstrated that, even when baro-
receptor inhibition is completely abolished, the impulse
traffic in renal afferent nerves rarely exceeds about
4 Hz (Kendrick, Oberg and Wennergren, 1972). Redistri¬
bution of renal blood flow has been demonstrated at higher
stimulation frequency, however, using the radioactive micro¬
sphere technique. Slick et al. (1975) found that the dis¬
tribution of renal blood flow to the outer cortex was dimini¬
shed after RNS at 20 Hz. In summary, RNS alters the
distribution as well as the total amount of blood flowing to
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the various regions of the kidney. The functional aspects
of nervous control of renal blood flow are considered in
the General Discussion at the end of this thesis.
Prostaglandins and the adrenergic nervous system
The first interaction between prostaglandins and
catecholamines was that noted by Euler in 1939. He found
that intravenous injection of prostaglandin extract
attenuated pressor responses to adrenaline in the rabbit (von
Euler, 1939). In 1963, following purification and identifi¬
cation of prostaglandins, this observation was confirmed using
pure PGE-j_ (Holmes, Horton and Main, 1963). Furthermore,
these authors demonstrated that pressor responses to vaso¬
pressin, angiotension and noradrenaline were similarly
attenuated by PGE-^. These early observations were succeeded
by a large number of studies by other workers in the field
who investigated the interactions of prostaglandins with
adrenergic stimuli in a variety of vascular and non-vascular
smooth muscle preparations (for reviews, see Horton, 1969,
1972, 1973; Hedqvist, 1970a; Weeks, 1972; Brody and
Kadowitz, 1974; Kadowitz, Joiner and Hyman, 1975). It was
not until 1969, however, that the effect of prostaglandin on
adrenergic transmitter release was investigated (Hedqvist,
1969a, 19b9b; Hedqvist'and Brundin, 1969). These authors
demonstrated that close-arterial infusion of PGE^ into the
isolated cat spleen reduced overflow of noradrenaline (NA) in
response to splenic nerve stimulation in four out of ten
experiments. When PGE2 was infused in the same concentrations,
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however, NA overflow consistently fell, often to less than
50% of the preceding control. Phenoxybenzamine, which lias
been shown to inhibit the release of prostaglandins from
some tissues (see Section 1), when infused into the spleen,
resulted in a sevenfold increase in NA overflow in response
to nerve stimulation (Hedqvist, 1969b, 1969c). Simultaneous
infusion of PGEg strongly counteracted this effect. Hedqvist
suggested, therefore, that PGE might be locally mobilised on
sympathetic nerve stimulation to act as a negative feedback
inhibitor of further NA release from adrenergic nerves. He
then proceeded to investigate this concept further in cat
spleen, rabbit heart and guinea pig vas deferens (Hedqvist,
1970a). In 1971 Swedin, a colleague of Hedqvist, made an
important observation which contributed to the idea that
endogenous prostaglandin might regulate adrenergic transmitter
release. He found that repeated nerve stimulation or field
stimulation of the guinea pig vas deferens depressed the
initial rapid phase "twitch" of the organ and he made the
following observations:
1) inhibition was immediately abolished upon washing the organ
2) inhibition was greater in a small-volume organ bath than
in a larger one
3) an inhibitory factor could be transferred from one bath to
influence another organ
4) this substance probably acted prejunctionally since tests
with exogenous NA revealed unaltered responses.
These observations led the author to the conclusion
that inhibition was induced by some substance released together
16
with the transmitter upon nerve stimulation. That this
inhibitory substance was prostaglandin-like was suggested
by the following results:
1) the inhibitory agent influenced both phases of contraction
(slow and fast) of the vas deferens, as did PGE-^ and PGE2-
2) incubation of the tissue with the prostaglandin synthesis
inhibitor, eicosatetraynoic acid (ETA) abolished inhibition.
The identification of the substance as PGE2-like was
established by thin layer chromatography.
This piece of work (Swedin, 1971 ) establishes an
important link between the effects of exogenous prostaglandins
and those of endogenous prostaglandins on adrenergic neuro¬
transmission. These observations in conjunction with those
of Hedqvist led, inevitably, to the implication that prosta¬
glandins might owe at least part of their potent action on
smooth muscle to an ability to alter sympathetic tone. The
discovery of drugs which block the synthesis of prostaglandins
(for references, see Section 4) permitted further investigation
of the role of endogenous prostaglandin in sympathetic neuro¬
transmission. Such drugs, e.g. indomethacin, have been
shown to reduce blood flow in several vascular beds by inducing
vasoconstriction (see Vane and McGiff, 1975). It is tempting
to speculate, therefore, that these drugs act by reducing the
prostaglandin braking mechanism on adrenergic transmitter
release, thereby increasing vascular sympathetic tone.
The following aspects of the research described on
adrenergic/prostaglandin/renal interactions provided the
stimulus for the work presented in this thesis:
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(1) RNS increases the output of endogenous prostaglandins
from the kidney.
(2) Exogenous prostaglandins can modify adrenergic
transmitter release from adrenergic nerve endings.
The e:xperiments described in Sections 1-4 were
designed to answer the following questions:
(i) Are prostaglandins released presynaptically from
adrenergic nerve endings or postsynaptically from vascular
smooth muscle in the kidney?
(ii) Do prostaglandins influence renal vascular responsive¬
ness to both RNS and circulating NA?
(iii) Do prostaglandins owe all or part of their action on
renal vasculature to an effect on vascular sympathetic tone,
by virtue of their ability to alter adrenergic transmitter
release?
(iv) Is endogenous prostaglandin involved in the control of
sympathetic transmitter release in the kidney and hence renal
vascular tone?
The species chosen for study was the rabbit, as a
considerable proportion of research into prostaglandin bio¬




The effects of noradrenaline on prostaglandin output from
the rabbit kidney, in vivo and in vitro
The release of prostaglandins from the kidney in
response to renal nerve stimulation (RNS) or noradrenaline
(NA) is a matter of some dispute. In the dog, it has
been demonstrated by Dunham and Zimmerman (1970) that RNS
causes the release of a prostaglandin-like material
(resembling PGE2) into the renal venous blood and by
Terashima, Anderson, Jubiz, Tsagaris and Kuida (1974) that
NA causes an increased output of PGE into renal venous
blood. In contrast, McGiff and colleagues have shown a
differential effect of these two stimuli, where NA causes
an increase in prostaglandin output, but RNS does not
(McGiff, Crowshaw, Terragno and Lonigro, 1970a; McGiff,
Crowshaw, Terragno, Malik and Lonigro, 1972). The methods
used for measurement of prostaglandins in all of the fore-
mentioned experiments did not include absolute chemical
identification. Davis and Norton (1972) have provided
evidence (using combined gas chromatography - mass spectro¬
metry for absolute identification) that RNS increases the
output of prostaglandins in renal venous blood, of rabbits.
As an extension of their work, this section describes a
series of experiments on the effect of noradrenaline on
output of prostaglandins from the rabbit kidney in vivo.
It is of particular interest to know whether NA, as
well as RNS, is capable of releasing prostaglandins from
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the kidney since this may, indirectly, indicate the site
of origin of released prostaglandins. They may be
released either from adrenergic nerve endings, i.e. pre-
junctionally, from the post-synaptic effector cell, or
from both of these sites. If only HITS is capable of
releasing prostaglandins, one might expect the source to be
prejunctional. If, however, both PINS and NA release
prostaglandins, it is likely, although not certain, that
the release is from a postjunctional site. Various lines
of evidence relating to site of release and its implications
are discussed at the end of this section.
A small group of experiments which were carried out
at a later date on the Isolated kidney, is included in this
section. These experiments were conducted to test the
viability of the in vitro preparation. They describe the
output of prostaglandins in the perfusate under resting
conditions and during RNS. For details of the isolated
kidney experimental design, the reader is referred to
Section 2#
Section 1 describes the utilisation of various
techniques for the estimation of prostaglandins. Some
of these techniques were developed in the laboratory
during the course of the present experiments. The
advantages and/or disadvantages of each method are discussed





Male New Zealand white rabbits were injected intra¬
venously with 25% urethane, 7 ml/kg, which produced a good
depth of anaesthesia with little reflex muscle activity,
thus facilitating dissection procedures.
Two or three donor rabbits (litter-mates to the
experimental animal if possible) provided replacement blood
for each experimental animal. The donor animals were
anaesthetised as above and were given an intravenous
injection of heparin, 1 i.u./g. Blood was collected into
polythene tubes via a cannula inserted into the abdominal
aorta.
In the experimental rabbit, the trachea, right
external jugular vein and right femoral vein were cannulated.
In addition, a fine catheter was Inserted into the right
femoral artery, and pushed up into the abdominal aorta until
its tip lay just rostral to the renal arteries. Blood
pressure was monitored from the left carotid artery using
a Statham pressure transducer (P23 DC) connected either to
a Grass polygraph or to a Devices recorder. The abdomen
was opened along its midline and the renal artery and. vein
were cleared. Ties were placed round the vein. The
abdomen was then closed and kept moist with warm 0.9?6 saline.
The animal was left for about 15 min until capillary bleeding
resulting from surgery had lessened or stopped. Heparin
(1 i.u/g.) was then injected intravenously via the femoral
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vein and the left renal vein was cannulated. The left
vein was chosen since ix is considerably longer than the
right, in the rabbit. The blood supply to the kidney was
never cut off for more than 2-3 rain during carmulation of
the vein. The renal venous cannula was connected to a Y-
piece, one arm of which was attached to the external jugular
venous cannula and the other arm connected to a side-arm
of polythene tubing which allowed for the collection of
renal venous blood samples. After cannulation of the renal
vein, the side-arm was clamped off and the blood was
directed from the kidney to the external jugular vein.
Heparinised donor blood (10 ml) was then slowly infused
via the femoral vein by a Watson-Marlow pump, to compensate
for the exteriorised circuit blood. The abdomen was closed
off and the animal was maintained at 37°C by use of a
heating mat.
All venous cannulas were filled with 0.9% saline
containing 50 i.u./ml heparin and arterial cannulae with
saline containing 300 i.u./ml heparin.
A period of 30 min was allowed for the animal to re¬
gain homeostasis before collecting blood samples. The
experimental arrangement is represented diagrammatically
in Fig. la.
(b) Blood sample collection
Renal venous blood samples were collected by clamping
off the external jugular cannula and hence redirecting the
blood through the collection side-arm. Measuring cylinders
Figure la: Experimental rabbit dissection.
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containing 0.1 pCi of each tritiated PGA^, PGE2 and PGF2r,
were used for collection of samples to be analysed by bio-
assay and combined gas chromatography/mass spectrometry.
As indicated in the results sub-section, these samples were
collected over periods of 2 to 5 min and ranged in volume
from 20 to 50 ml. In later experiments, where the blood
samples were assayed for prostaglandin content using radio¬
immunoassay, collection of small blood samples, each 3 ml,
was possible; no radioactive prostaglandins were added to
these samples. Exact time intervals between consecutive
samples are indicated for each individual experiment in the
results sub-section.
The effect of noradrenaline on output of prostaglandins
from the kidney was tested by intra-arterial infusion of the
drug (Levophed,Winth.) via the femoral arterial cannula, which
ended just above the renal artery. It was assumed that a
proportion of the noradrenaline would be washed into the
renal artery by this means. The dose range investigated
was 50-1000 ng/kg/min and Infusion times were approximately
10 min in duration. Renal venous blood was sampled prior
to, during and subsequent to noradrenaline infusion.
2. Assay Procedures
(a) Assay of prostaglandins by bioassay and combined gas-
liquid chroroatography/mass spectrometry
Plasma Extraction Procedures
Prostaglandin extraction techniques were based on
those described by Bergstrbm and Samuelsson (1963) and
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Horton and Main (1967). The procedures are outlined in
Figs, lb and lc. The latter figure describes an additional
extraction step used to further purify fractions containing
F prostaglandins following thin layer chromatographic
separation. PGF is the most polar of the prostaglandins
measured and thus remained close to the origin of the
chromatographic plate. This region retained many of the
pigments of the biological sample with the result that
the F-fraction tended to be highly coloured. Further puri¬
fication involved extraction into phosphate buffer, pH 8.
Blood samples, collected as described in Experimental
Procedures and containing tritium labelled PGA-, , PGE2 and
PGFp^, were centrifuged at 2,500 rpm for 10 min at 4°C.
Plasma was removed using Pasteur pipettes and the cells
were washed with 0,9% ice-cold saline (a volume equivalent
to that of the original blood sample) and centrifuged once
more as described. The supernatant was removed and bulked
with the plasma. After measuring the volume, the diluted
plasma was acidified to pH 4.5 with 10% acetic acid. The
acidified fluid was then partitioned twice with two times
an equal volume of redistilled ethyl acetate, the organic
phases were pooled and the pH of the aqueous phase was
checked. The organic phase was washed with about 1/10 vol
H20, the water discarded and the ethyl acetate evaporated
to dryness in a pear-shaped flask under reduced pressure.
The residue was desiccated under vacuum to remove any
remaining acetic acid. It was then dissolved in 30 ml 67%
ethanol and shaken in a separating funnel with 20 ml heavy
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Fig. lb; Extraction of -prostaglandins from renal
venous plasma samples
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Fig. Ic: Phosphate buffer extraction of PGF samples
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petroleum spirit (B.Pt. 60-80). The petroleum spirit
phases were discarded, the pear-shaped flask rinsed with a
further 15 ml 67% ethanol and the total ethanolic material
partitioned with 20 ml petroleum spirit. The petroleum
phase was discarded once more and the ethanolic phase
evaporated to dryness and desiccated. The residue was
stored at -15°C prior to thin layer chromatographic purifi¬
cation and separation of the extract (see Fig. lb).
Phosphate Buffer Extraction of PGF Samples
following thin layer chromatography, extracts con¬
taining PGF were further purified to remove pigmentation
so that they would be suitable for nass-spectrometric
analysis. The methanolic extract obtained from the
chromatography plate was evaporated to dryness and the
residue dissolved in 15 ml phosphate buffer, pi-I 8.0. The
buffer was partitioned twice with 15 ml ethyl acetate and
this last phase discarded. The buffer phase was taken to
pH 4.0 using about 1 drop of concentrated acetic acid and
re-extracted twice with 15 ml ethyl acetate. In this
instance, the aqueous phase was discarded and the ethyl
acetate bulked for washing with ca. 5 ml P^O to remove acetic
acid. The ethyl acetate was then evaporated to dryness
and desiccated, after which the residue v.ras suitable for
bioassay and for mass spectrometry (see Fig. lc).
Silica Gel Thin Layer Chromatography
A detailed account of thin layer chromatographic
separation of prostaglandins is described by Horton and
Main (1967).
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Thin layer plates were prepared freshly for each
experiment as follows: grooved glass plates, 5 x 20 cm, were
coated with a 0.5 mm thick layer of silica gel G (Merck),
45 g silica to 88 ml water. They were then dried and
activated by heating at 100°C for 1 hour. The prepared
plates were stored in a desiccator until required.
Plasma extracts (containing tritiated marker prosta¬
glandins as foreraentioned) were dissolved in 0.2 ml methanol
and applied as a narrow band to the plates using an Agla
micrometer syringe. The flasks were rinsed with a further
2 x 0.1 ml methanol and these washings applied to the band
of extract. Following evaporation of the methanol in a
stream of cool air, the plates were developed in the AI
solvent system described by Green and bamuelsson (1964),
which contains toluene:dioxan:acetic acid in a ratio of
20:20:1 respectively. The solvent was allowed to move
about threequarters (15 cm), of the way up the plates where¬
upon the plates were dried in a stream of cool air and
scanned with a Panax Radio TLC plate scanner (time constant
10 sec; range 3 cps; paper speed 1 cm/min) to check that
the tritiated prostaglandins (and hence endogenous prosta¬
glandins) had traversed from the origin. The area of
silica between the origin and the first radioactive peak on
each plate was scraped off and retained in a centrifuge
tube. This procedure reraoved much of the pigment which
tended to be associated with the origin and prevented its
passage further up the plate on subsequent solvent runs.
The plates were then re-run twice in HDII solvent
(Davis, 1971), containing toluene:dioxan:acetic acid in a
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50:30:1 ratio respectively. This solvent promoted
further separation of PGE and PGF with little further move¬
ment of PGA. After thorough drying, the plates were
scanned once more and the silica marked off into five
zones, according to its radioactive content (see Fig. Id).
Each zone was scraped into a centrifuge tube and the silica
in each (including the tube containing silica from the
origin, removed prior to development in the second solvent
system) was washed with 5 ml methanol. The mixture was
vortexed and the silica centrifuged down at 1,000 rpm for
about 5 min. The methanolic supernatant was removed into
a clean centrifuge tube and the silica remaining washed
with a further 5 ml methanol. The mixing and centrifugation
procedures were repeated and the methanol supernatant removed
and bulked with that in the clean tube. This 10 ml
methanol was recentrifuged to remove any remaining traces
of silica and the supernatant methanol transferred to a pear-
shaped flask for evaporation to dryness. Residues from
zones 2, 3 and 4 were dissolved in 10 ml methanol and those
from the origin, 1 and 5 in 2 ml methanol. Aliquots of
2.0 ml were removed for radioactive counting in 10 ml of a
toluene-scintillant fluid containing: toluene, 2.5 I; 2,
5, diphenyloxazole (PPO), 10.65 g; 1» 4-di-(2-(4-methyl-5-
phenyloxazolyl)-benzene), 0.275 g. Counting efficiencies
for samples in methanol averaged about 45°-a.
Recovery of tritiated prostaglandins could now be
calculated by dividing the total number of disintegrations
per minute (dpm) in each particular zone by the total number
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Figure Id: Thin-layer radiochromatographic scan of
an extracted plasma sample containing standard tritiated
prostaglandins, PGE21 and following develop¬
ment of the plate in AI and HDII solvent systems.
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of dpm of appropriate tritiated prostaglandin added e.g.
Total dpm in zone 2 x 100%- Fraotions obtained
Total dpm -5H-PGF2^ added
from the origin and zones 1 and 5 were discarded at this
stage provided that their radioactive content was less
than about 10$ of tritiated PGF (origin and zone 1) or
tritiated PGA (zone 5) added. In general the content of
these zones was considerably less than 10$.
The remaining methanolic fractions from zones 2, 3 and
4 were split into a 40$ aliquot for bioassay and a 60$
aliquot for combined GLC/MS. All aliquots were evaporated
to dryness, desiccated and stored at -15°C.
Biological Assay
Since biological assay was carried out in parallel
with combined GLC/MS, assay of each prostaglandin type was
confined to one appropriate system.
(a) The rat fundal strip
This preparation was first described by Vane (1957)
as suitable for bioassay of 5-hydroxytryptamine. It is,
however, also extremely sensitive to prostaglandins of the
E and F series. The muscle was cut twice longitudinally
to form a zig-zag strip and was then suspended in a 5 ml
organ bath containing Tyrode's solution, at 37°C, gassed
vigorously with oxygen. PGE and PGF fractions were
dissolved in 1 ml distilled water for assay on this pre¬
paration. Stocks solution of standard PGE, and PGF2ft
containing 100 ng/ml were prepared. Doses of 5-10 ng were
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injected giving a final bath concentration of 1-2 ng/ml.
A three minute dose cycle with a drug contact time of
45-60 seconds was used for PGE2 standards and samples. A
slightly longer dose cycle of 5 rain with 60-90 second
drug contact time wras used for PGF2fT, as it produced mar¬
ginally slower contractile responses. Contractions
elicited by doses of samples were compared quantitatively
and qualitatively with those elicited by standard
p rostaglandin.
(b) Kitten blood pressure assay
As a result of their particularly high sensitivity to
the vasodepressor activity of PGA (Horton and Jones, 1969),
kittens weighing 1-2 kg, of either sex, were used for assay
of fractions containing PGA. The animals were anaesthetised
with 40 mg/kg sodium pentobarbitone (Nembutal, Abbott)
injected intra-peritoneally and a subsequent maintenance
dose of a 6 mg/inl solution was infused intravenously as
required. Carotid blood pressure was recorded on a Grass
polygraph. Standard solutions of PGA2 containing 200 and
400 ng/ml were prepared in saline. According to the
sensitivity of the preparation, bolus injections (via the
femoral vein) of 20-100 ng were used for bracket assay of
unknown samples. The 40^ aliquots of PGA fractions retained
for bioassay were dissolved in 0.4 ml 0.9^ saline for bolus
injection and were washed in with 0.2 ml saline. A ten
minute dose cycle was used for comparison of standard and
sample vasodepressor activity.
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Combined Gas-Liquid Chromatography/Mass Spectrometry
The gas chromatographic behaviour of prostaglandins is
summarised by Ramwell et al. (1968). In order to prevent
breakdown of prostaglandins on the GC column, their hydroxyl
and ketonic substituents require to be protected by forming
stable derivatives and their acid grouping must be esterified.
This is effected by (i) methylation of the C : 1 acid group
with diazomethane (ii) silylation of the hydroxy and
ketonic groups with bis(trimethylsilyl)-trifluoroacetamide
(BSTFA) or formation of trifluoroacetate groupings with
trifluoroacetic anhydride (TFA).
Fractions remaining after bioassay of PGE, PGF and
PGA were pooled with the 60% residues reserved specifically
for GLC/MS and taken to dryness. PGE and PGA fractions
were converted to the more stable PGB prior to derivatisation
to protect them from breakdown on the GC column. This
involved treatment with 1 ml 0.1 N potassium hydroxide at
room temperature for 1 hour. The PGE samples dehydrate to
the corresponding PGA compound under these conditions and
PGA isomerises into the more stable PGB conformation. When
the reaction was supposed to have gone to completion, the
samples were diluted with 15 ml distilled water and the
acidity was adjusted to pH 5.0 with conc. acetic acid.
They were then partitioned with 2 x 30 ml redistilled ethyl
acetate. The ethyl acetate phases were pooled, washed with
water, evaporated to dryness and desiccated. The residues
of these samples were dissolved in 0.5 ml methanol and trans¬
ferred to clean Eppindorf micro-tubes. The original flasks
were rinsed with further 2 x 0.25 ml methanol and the
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washings added to the appropriate Eppindorf tube. The
solvent was vaporised off with a fine Jet of air and the
tubes then desiccated. PGF residues were similarly
dissolved in methanol and each sample was divided equally
between two Eppindorf tubes for dual derivative formation.
Derivatisation of PGB and PGF
(i) Methylation (Me)
All samples were methylated by addition of fresh
diazomethane solution, 0.5 ml, to each Eppindorf tube. The
tubes were vortexed and left for 30 min at room temperature,
at which stage methylation is complete. The solvent (ether)
was vaporised and the samples desiccated.
(ii)a Trimethylsilyl derivatisation of PGB and PGF (Me/TMS)
13 Ml of BSTFA (Sigma Chemicals) was added to each
sample and the tubes were left at room temperature overnight.
(Rapid silylation may be induced by incubation at 60°C for
15 rain). 10 pi of each sample in BSTFA was injected onto
the gas chromatographic column.
(ii)b Trifluoroacetate derivatisation of PGF (Me/TFA)
Trifluoroacetic anhydride (TFA, Koch-light Labs.)
was added by Pasteur pipette (about 0.5 ml) to the duplicate
methylated PGF samples. The Eppindorf tubes were closed
and left at room temperature for 2 hours. The TFA was then
removed by evaporation under water vacuum in a desiccator.
Samples were redissolved in 13 pi hexane for injection
(10 pi) onto the GC column.
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Preparation of Authentic Prostaglandin Derivatives
The Me/TMS derivatives of PGB2 and PG^rt (1 MS of each)
were prepared in 25 pi BSTFA. Similarly, 1 pg of Me/TFA
PGF2rr was prepared in 25 pi hexane.
Standards were injected on to the GC column in 5 or
10 pi aliquots and retention times noted for comparison
with the unknown samples.
GC/MS Analysis
Analysis was performed using an LKB 9000 gas chromato-
graph-mass spectrometer. The column (3.0 m x 1.5 mm i.d.)
was packed with 3% OVI on a Supelcoport pretreated with
dimethylchlorosilane. The column temperature was 190-200°C
and the flow rate of the carrier gas, helium, was 30 ml/min.
Authentic prostaglandin derivatives were injected on
to the column as described and a mass spectrum of each
standard was taken at the peak of its chromatogram. Extract
derivatives were then injected on to the column and mass
spectra were taken at retention times corresponding to those
obtained with authentic prostaglandin derivatives (see
Results, Figs, lj, Ik and 1a).
(b) A Critical Appraisal of Bioassay of Prostaglandins by
the Blood Superfusion Technique in Rabbits
Introduction
Prior to the development of radioimmunoassay and
multiple ion detection mass spectrometry in the laboratory,
the techniques available for prostaglandin assay involved
principally those extensive procedures of extraction,
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purification, bioassay and combined GLC/MS previously
described in this section. Thus the complete purification
and identification of prostaglandins in a series of blood
samples took several weeks. In the hope of obviating the
need for such lengthy procedures, which inevitably reduce
productivity, it was decided to investigate the use of the
superfusion bioassay technique first described by Gaddum
(1953). This technique has recently been developed by
Vane (1969) for the assay of a number of blood-bome
substances. Blood (or perfusion fluid) is passed over
the surfaces of a series of smooth muscle preparations
which have been selected for their sensitivity to the endo¬
genous substance(s) being measured. The presence of
substances is recognised by appropriate contractions or
relaxations of the tissues and quantitation involves a
comparison of these effects with those produced by standard
solutions of the substance in question. In addition to
tissue selectivity, additional specificity may be attained
by the use of specific blocking drugs to eliminate effects
produced by other endogenous substances. The advantage of
this technique is that it affords on-the-spot monitoring of
endogenous substances. Blood samples may be collected as
appropriate for more refined analysis and. absolute identifi¬
cation. It was the intention in present experiments to
utilise this method as a means of discovering which doses
of noradrenaline, if any, were effective in stimulating
release of prostaglandins from the rabbit kidney. Control
blood samples could be collected as usual and test samples
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when there was an indication of altered biological activity.
Methods
The tissues selected for their sensitivity to
prostaglandins were the rat fundal strip and the chick
rectum. The specificity of these tissues was increased
by soaking them in appropriate antagonist solutions in
Tyrode for about an hour prior to setting them up.
Adrenaline relaxes both tissues whilst noradrenaline relaxes
the rat stomach with little effect on the chick rectum. In
addition, 5-hydroxytryptamine (5-HT) contracts the rat
stomach, having little effect on the chick rectum. Prosta¬
glandins contract both tissues. It was decided, therefore,
to soak the tissues in a mixture of the 5-HT antagonist,
—7
bromlysergicdiethylamide (5 x 10 M) and the e-blocker,
propranolol (5 x 10~^M). Vane (1969) provides a compre¬
hensive list of other hormones which do not affect these
tissues at normal blood concentrations. The list includes
angiotensins I and II, vasopressin, bradykinin, ATP,
corticoids, gastrin, histamine, kallikrein, oxytocin,
renin and SRS-A.
Subsequent to antagonist treatment, the preparations
were set up in series with the fundus (tension 2 g) above
the rectum (tension 5 g). They were cascaded initially
with Tyrode's solution at 37°C, gassed with 02. A flow
rate of 2.4 ml/min was used. The tissues contracted to a
5 ng/ml standard solution of PGE2 in Tyrode, responses being
recorded isometrically from Statham (P23 EC) pressure
transducer onto a Devices recorder.
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Eight experimental rabbits weighing 2.0 to 2.5 kg
were set up in a manner similar to that described under
"Experimental Procedures" and, following dissection, were
injected intravenously with heparin (1 i.u./g body vrt.).
When the isolated tissues had stabilised in Tyrode's
solution, the latter was replaced by renal venous blood
from the experimental animal, similarly cascading at a
rate of 2.4 ml/min over the tissues (Fig. le). Blood from
a donor rabbit (usually a litter-mate to lessen the risk of
incompatibility) was infused into the experimental animal
at the onset of cascade to replace the blood in the circuit.
The renal venous outflow in excess of that used to cascade
the tissues was returned to the animal via its external
jugular vein. It could also be collected through a side-
arm for further analysis. Blood from the assay tissues was
collected in a heated polythene reservoir maintained at -38°C,
and was returned to the animal via the external jugular vein
at the same rate (using a dual-flow Watson-Marlow pump) as
that blood being removed for cascade.
A fine cannula (P50) was inserted into the right
femoral artery and pushed up into the abdominal aorta such
that its tip lay just rostral to the left renal artery.
After equilibration of the isolated tissues in renal venous
blood, noradrenaline, NA (250 ng/kg/min) was infused through
the aortic cannula. In two experiments, carried out in
collaboration with Br. H.A. Davis, antidiuretic hormone (ADH)
was infused in place of noradrenaline in doses ranging from
100 p units to 20 m units/kg/min.




In two experiments, NA was infused into the
abdominal aorta at a rate of 250 ng/kg/min. This rather
high dose was chosen as a result of the apparently
negligible effect of 100 ng/kg/min on renal prostaglandin
output in a previous experiment where blood samples were
collected for bioassay/GLC/MS analyses. A dose of
250 ng/kg/min has also been employed in the dog using the
superfusion assay technique to measure prostaglandins
(McGiff et al., 1972). When NA was infused into the rabbits
as above, an increase in systemic blood pressure was
observed, followed by an eventual large decrease in renal
blood flow. The decrease in blood flow was sufficiently
great to render the cascade system inoperable, thus
defeating its purpose. The tissues were switched temporarily
to a cascade of arterial blood from an emergency reservoir
(obtained from a donor animal) so that a further infusion
of a lower dose of NA might be attempted. Renal blood flow
did not return to the pre-infusion level and the condition
of the animals gradually deteriorated until they were hypo¬
tensive and soon died.
A further four experimental rabbits were set up to
test the effect of lower doses of NA on renal blood flow
and prostaglandin output. All four animals died soon after
being set up with their renal venous blood superfusing the
isolated tissues. Death in each case occurred prior to
infusion of noradrenaline.
In the two experiments in which ADH was used, a rise
in systemic blood pressure was observed when doses from
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6 mu/kg/min were infused intra-aortically. Changes in the
tone of the isolated preparations were observed, as
indicated below.
Changes in blood pressure and tissue tone observed
during infusion of AIH
Dose of ADH B.P. Rectal Fundic
per kg min"1 Sys/Dias Tone Tone
100 pu No change No change No change
200 » it »! 1! 11 it it
Exp. 1 400 " II II It II ti it
800 » II II II II it ii
1.6 mu II II II II n ii
3.2 » II II Rise it ii
6.0 " 68/33 to 72/39 Fall Fall then rise
6 mu 62/29 to 65/36 Rise Slight fall
Exp. 2 20 » 65/33 to 80/60 Rise Fall then rise
10 » 80/47 to 94/68 Rise Fall then rise
In Experiment 1, the responses of the isolated tissues
during ATH were inconsistent, making interpretation of the
tone changes in terms of prostaglandin concentration impossible.
Following infusion of ABH at 6 mu/kg/min, the systemic blood
pressure rose initially but then fell until the animal was
severely hypotensive and died.
In Experiment 2, the responses of the isolated tissues
during infusion of higher doses of ADH, 6-20 mu/kg/min, were
consistent and do indicate that prostaglandin concentration
in the renal venous blood had probably increased. The
condition of this animal did not deteriorate so rapidly.
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Conclusion
Despite the precautionary measures taken to
supplement the experimental animals' blood loss and
to maintain oxygenation and warming of the blood
returning to the animals from cascade, it was generally
found that rabbits could not withstand the conditions
of the cascade experiment for long periods of time.
Infusion of noradrenaline and ADH, which may have
resulted in increased prostaglandin concentrations in
the renal venous blood, may, in part, have been
responsible for the severe hypotensive states which
followed when the blood from cascade was returned to
the animals. However, in four out of eight experiments,
the animals died prior to any drug infusion. It is
possible that active substances (probably prostaglandins)
were released from the isolated tissues themselves and
were then infused into the animal in the blood from
cascade. On reflection, it would have been preferable
to soak the isolated tissues in indomethacin to block
endogenous prostaglandin synthesis, as well as in the
selected antagonists.
The survival rate of the animals would almost
certainly have been improved if the blood from cascade
had not been re-infused. This would undoubtedly have
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led to problems, however, In blood-transfusing the
animal with compatible blood for a sufficient period of
time. In addition, it would require a large number
of donor rabbits.
In conclusion, the blood superfusion technique,
although successfully used by others in dogs, proved
unsuccessful in present rabbit experiments. The
renal outflow from the dog kidney is sufficiently large,
even during marked vasoconstriction, to permit continued
superfusion of isolated tissues (McGlff et al.. 1972).
This is evidently not so in the rabbit. Neither does
the rabbit respond well to re-infusion of cascade blood.
In view of these difficulties, attempts to
measure prostaglandin output in blood from the rabbit
kidney using the cascade method were abandoned.
(c) Radioimmunoassay
The development over the past few years of a radio¬
immunoassay for prostaglandins has permitted an increase of
about one hundred fold in sensitivity of detection of these
substances. Whereas bioassay is capable of detecting
amounts of prostaglandin in the nanogram range, radioimmuno¬
assay is capable of detecting tens of picograms. The success
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in raising antibodies to H}F2r! and PGB2 in the Edinburgh
laboratory led to the development of sensitive assays for
these prostaglandins. A combination of sensitivity,
specificity and facility for assay of large numbers of
samples constituted good reason for adaptation and use of
radioimmunoassay in preference to the traditional bioassay
for measurement of prostaglandin levels in renal venous
samples.
The method is dependent upon the immunogenic properties
of the substance being measured. The prostaglandins, which
are of relatively low molecular weight and are not in them¬
selves immunogenic, must be conjugated to a macromolecule
such as bovine serum albumin. Antisera raised in this way
contain a mixed population of antibodies but only those
which are directed towards the prostaglandin (which is the
hapten) will be involved in reactions with the free hapten.
The reaction of these antibodies may be followed by using a
radioactively-labelled hapten (tritiated prostaglandin).
At the concentration of antigen used in such assays, the
antibody-antigen complex (Ab-Ag complex) remains in solution.
Thus, in order to follow the reaction of the labelled
antigen with the antibody, it is necessary to separate Ab-
bound labelled antigen from free labelled antigen. In the
present system this was effected by precipitation of the
bound antigen using a second antibody which was raised to
the y-globulin of the original antibody, in another species,
the donkey. The second antibody will be referred to as
donkey anti-rabbit serum. This method is known as the double
antibody method and it relies upon the finding that the
45
antigenic site(s) of an antibody are separate from its
antibody sites. An antibody molecule may form a complex
with its antigen and then itself be complexed to a second
antibody. In radioimmunoassay, however, the primary Ab-.g
complex is too dilute to be precipitated and requires the
presence of non-immune serum belonging to the same species
as the first antibody (referred to later as normal rabbit
serum). If this is added and is then followed by the second
antibody, a sizeable lattice can be built up and the whole,
including labelled antigen bound to the first antibody, is
precipitated. The percentage bound is determined by
measuring the radioactivity present in the supernatant after
centrifugation and subtracting this from the initial amount
of labelled antigen added. (Precipitation is generally
complete after 16 hours at 4°C and this was found to be the
case in the present system.) As the amount of cold antigen
in the medium increases, the greater is its competition with
the labelled antigen for binding sites on the antibody.
Hence, the percentage of bound labelled antigen decreases.
Reductions of less than 10% below the binding of zero
standards (containing all reagents except cold prostaglandin)
are not accepted as accurate, however, as this part of the
dose/response curve is inherently imprecise. Factors which
may affect the specificity of the assay include tracer homo¬
geneity and background medium interference e.g. from plasma
or from solvent residues resulting from extraction of samples.
These effects may be additive and will be rexatively most
significant where the concentration of the antigen approaches
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the detection limit of the system.
For further information on radioimmunoassay, the
reader is referred to the excellent account by Hunter
(1973). A detailed description of all procedures employed
in this section is presented by Dighe, Emslie, Henderson,
Bimon and Rutherford (1975).
Methods
(a) Development of antisera
In the Edinburgh laboratory, antisera to PGB2 and to
PGF2a were raised in rabbits. This was effected by
immunising the rabbits with appropriate prostaglandin-bovine
serum albumin conjugates. Of the various antisera obtained,
those exhibiting a combination of high specificity (i.e. low
cross-reactivity with prostaglandins other than that to
which they were raised) and high "titre" (i.e. high PG-binding
capacity per unit volume) were selected for routine assay
of prostaglandins. The "titre" of an antiserum was obtained
by constructing a dilution curve of % binding of tracer-PG
by antiserum VS. dilution of antiserum. The "titre" was
read as that dilution which bound 60% of the tracer-PG in
the absence of non-radioactive standard prostaglandins.
This value was chosen since from about 70% binding downwards
to about 50%, a straight line is obtained when the abscissa
is plotted logarithmically.
Antisera titres
The antisera utilised for rabbit renal venous plasma
estimations of PGF2fY and PGB2 had the following titres:
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PGF2a antiserum 1 in 11,200 dilution to bind 150 pg
3xi-PGF2fl (35.6 ng/pCi)
PGB2 antiserum 1 in 24,800 dilution to bind 20 pg
3H-PGB£ (2.5 ng/pCi)
Specificity of Antisera
Table la lists the percentage cross-reactivity of
PGF2^ antiserum (using two differing tracer specific
activities) and PGB2 antiserum with other prostaglandins.
The values indicate a high cross-reactivity of the antisera
with the corresponding 1-series prostaglandins, PGF-,^ and
PGB-^, but otherwise show these antisera to be reasonably
specific.
(b) Reagents used in radioimmunoassay
A diluent of the following composition was used for
diluting all reagents used in the assay: 0.05 M tris-
hydrochloride buffer (pH 8), sodium azide (0.1 g/1) and
gelatine (1 g/1).
Tritiated prostaglandin F2„ (35.6 ng/pCi; New England
Nuclear Company), and 3H-PGB2 (2.5 ng/pCi; Amersham) were
dissolved in diluent to give the following concentrations:
Tracer Concentration Amount per 50 pi
3H-PGF2^ 35.6 ng/pCi 3 ng/ml 150 pg
3H-PGB2 2.5 ng/pCi 0.4 ng/ml 20 pg
PG-antisera were diluted with diluent so that when
50 pi was added to the reaction tube (in which the reaction
volume was 1.2 mis) the final dilution of the antiserum was
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Table la
Cross-reactivity of antisera (%)
PG tested Antisera + titres for given tracer-PG
PGF?^ 1 in 11,200
150 pg 3H-PGF2a
(35.6 ng/pCi)

























equal to its "titre". The second antibody, donkey anti-
rabbit serum (EARS) (Wellcome Reagents, Ltd) was used as
a 3:7 dilution in diluent. Normal rabbit serum (NRS),
obtained from non-immunised donors, was used as a 1:53
dilution in diluent. (The methods for determining the
concentration of NRS and EARS required for radioimmuno¬
assay have been described by Hunter (1973)).
A scintillation fluid with the following composition
was used for radioactive counting: naphthalene 75 g; PPO
7 g; EMPOPOP 0.6 g; 2-ethoxyethanol, 600 ml; toluene 1
litre. A volume of 13 ml scintillant absorbed 0.6 ml of
an aqueous solution, counting efficiency being approximately
3Qo.
(c) Preparation of standard curves
Standard curves were set up for each antiserum covering
various ranges of cold standard prostaglandin concentration
(see Table lb and Fig. If). A standard curve was included
as a control in every radioimmunoassay of unknown samples.
Each curve consisted of duplicate tubes containing a range
of prostaglandin concentrations contained in a volume of
1 ml diluent. In addition, zero standards (to check binding
capacity of the antiserum), blanks (to check for non-specific
binding of tracer to any of the other reagents) and counting
standards (to check number of counts added in 50 pi of tracer)
were set up in quadruplicate (Table lc), each tube containing
1 ml diluent in place of standard prostaglandin solution.
Tracer solution (50 pi) was added to each tube and the
solutions were mixed and equilibrated for about 10 min.
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Table lb





















curve 1 ml — 50 Ml 50 Ml 50 Ml 50 Ml
Blanks - 1 ml 50 pi - 50 Ml 50 Ml
Zero
standards mm 1 ml 50 Ml 50 Ml 50 Ml 50 Ml
Counting




Figure If: Standard curves obtained by radioimmunoassay
of standard prostaglandins B2 and F2a. The means of four
blank samples are represented for each curve. Dots
represent duplicate binding values obtained for each
prostaglandin amount.' The abscissa is plotted on a
logarithmic scale.
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50 pi diluted antiserum (as described in (b)) was then
added to all tubes excepting blanks and counting standards
and, after mixing, the samples were incubated at room
temperature (18-20°C) for one hour. After incubation, NRS
(50 pi) was added, followed, after mixing, by PARS (50 pi)
to all tubes excepting counting standards. The tubes were
mixed once more before incubating for 16 hours at 4°C.
After incubation, the samples were centrifuged at 4°C,
1200 g for 45 minutes. 0.6 ml aliquots of supernatant
were removed from each tube and added to counting vials
containing 13 ml scintillant. The vials were monitored for
radioactivity in a Nuclear Chicago liquid scintillation
counter, using the external channels/ratio method and
counting each vial for 4 or 10 min.
(d) Preparation of -plasma samples for radioimmunoassay
As in experiments employing bioassay and mass spectro¬
metry, it was desirable to measure PGE2, PGF2rT and A, C or
B-like prostaglandins in rabbit renal venous plasma. The
only antibodies available were those to PGB2 and PGF2 .
Consequently, PGE and PGA or PGC had to be converted to PGB
for assay. A series of control experiments was carried out
to study the effects of plasma extraction and of chemical
conversion procedures on radioimmunoassay.
Conversion of PGE to PGB
PGE was converted to PGB by dehydration treatment
with methanolic KOH. This treatment also resulted in
conversion of PGA and PGC to PGB, but since there was also
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a separate assay of these prostaglandins following incubation,
their concentration only required to be subtracted from the
total ?GB2 assayed, thus leaving the PGB2 which resulted
from PGE2 dehydration.
A series of control experiments was carried out to
determine optimum conditions for the conversion of plasma
PGE2 to PGB2. Rabbit aortic blood was used as a background
medium for conversion of standard PGE2 solutions to PGB2 as
it contains very little, if any, endogenous prostaglandin.
Two procedures of dehydration were attempted at varying
temperature, time and KOH concentration. (Fig. lg):
(i) Incubation of plasma with 1 ml methanolic KOIi, followed
by acidification and extraction into ethyl acetate. Ethyl
acetate evaporated under reduced pressure, the residue
desiccated and made up in diluent for radioimmunoassay.
(ii) Acidification and extraction of plasma into ethyl
acetate, followed by reduced pressure evaporation and
desiccation of the ethyl acetate residue. Incubation of
residue with 1 ml methanolic KOH, addition of 15 ml water
and reacidification of sample. Re-extraction with ethyl
acetate, vacuum evaporation and desiccation and addition of
diluent for radioimmunoassay. The results are summarised
in Table Id.
It was concluded that the best conditions of those
investigated for conversion of PGE2 to PGB2 were incubation
of plasma with 1 ml IN KOH in methanol at 45°C for one hour.
These conditions were subsequently employed for renal venous
sample analyses.
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Figure Ig: rehydration and extraction procedures for
the radioimmunoassay of PQE^ as PG3o
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Conversion of PGA or PGC to PGB
Rabbit plasma is known to contain an enzyme, prosta¬
glandin isornerase, which rapidly isoraerises PGA to PGC.
The latter is very unstable and converts quickly to the more
stable isomer, PGB (Jones, 1970, 1972). It was assumed,
therefore, that any PGA or PGC-like compounds released into
renal venous blood would be rapidly converted to PGB prior
to assay. To ensure complete isomerisation, however, renal
venous plasma was reheated to 3S°C for two hours to reactivate
the isomerase. (This procedure was carried out using
standard PGA2 in Aortic blood by Dr. H.A. Davis, results in
press).
Following incubation, the renal venous plasma was
acidified and extracted into ethyl acetate (as described for
PGE2), the ethyl acetate was evaporated under reduced
pressure and the residue vacuum-desiccated. The residue
was taken up in diluent for radioimmunoassay.
Extraction of PGF2^ from plasma
A series of control extractions was performed with
aortic blood as a background medium for assay of standard
PGF2^ solution. PGF2rf was added to blood to obtain con¬
centrations of 1 and 10 ng per ml blood. The plasma was
removed, acidified and extracted with ethyl acetate. The
residue remaining after evaporation was dissolved in diluent
for radioimmunoassay (cf. procedure with that for PGE and
PGB).
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The mean results are summarised in the table below:
Table Ie
Control radioimmunoassay of • Figures in brackets
indicate number of experiments.
Background
medium










Saline 10 ng 10.5
9.7
It was concluded that the standard prostaglandin extraction
procedure did not interfere with the radioimmunoassay of
PGF2^ and, therefore, might be used for measurement of PGF2a
in renal venous samples.
(d) Multiple Ion Detection Mass Spectrometry
A multiple ion detection (MID) system using a Finnigan
3000P quadruple mass spectrometer was developed for the
sensitive quantitative assay of prostaglandins E2 and F2a'
either separately or in parallel (Hensby and Naylor, 1974).
This procedure offers three major advantages over radio¬
immunoassay:
(1) Mass spectrometry provides absolute identification.
(2) PGE may be assayed without conversion to PGB.
(3) PGE and PGF may be assayed in parallel.
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The method is Dased on the reversed isotope dilution
technique described by Samuelsson, Hamberg and Sweeiey
(1970). A known amount (in this case, 1 pg) of the
corresponding deuterium isotope (d^) is added to the unknown
sample of prostaglandin and the two, when derivatised, co-
chromatograph. The excess of the deuterated derivative
acts as a carrier for the sample prostaglandin both through
the column and the separator. This method has the added
advantage of quantitation using the deuterated prosta¬
glandin as an internal standard. By comparing the intensity
of the chromatographic peaks obtained from the deuterated
prostaglandin and the sample prostaglandin, a peak ratio
may be calculated. A calibration curve is obtained by
plotting the ratio of protium (dg) to deuterium (d^) peak
heights over a range of protium amounts (in this case,
1-100 ng), deuterium being kept constant (l ug).
Preparation of calibration curves
For each set of samples analysed by MID, it was
necessary to construct a calibration curve (Fig. lh).
Each standard contained a mixture of PGE2, PGF^, d^ PGE2
and d^ PGF2ft. A plot of peak ratios (protium/deuterium)
versus amount of protium produced a straight line between
0 ng and 100 ng protium (and up to 1000 ng protium;
Hensby, personal communication). Hence, by calculating the
peak ratio in an unknown sample, it is possible to read off
the protium content from the calibration curve.
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Figure lh: Calibration curves for assay of PGE2
and PGF~ by multiple ion detection. Ordinate = ratio
d

















Control analyses of "mock" biological samples
The samples analysed by MID consisted of Dextran-
Tyrode -perfusate obtained from the isolated kidney
preparation. It was necessary to carry out control
extraction and mass spectrometric procedures on standard
solutions of prostaglandins in Dextran-Tyrode solution to
check that this medium did not interfere with prostaglandin
extraction and analysis. A small amount of tracer prosta¬
glandin was mixed with cold prostaglandin to enable esti¬
mation of recoveries following extraction procedures. Two
standard tracer/cold prostaglandin mixtures were made up,
one containing 10 pg cold PGE-? + 2 pCi %-PGE2 in 1 ml H20,
and the other containing 10 pg cold PGFp^ 2 pCi %-PGFp^ in
1 ml HpO. 4 x 10 pi of each mixture was sampled into 10 ml
toluene scintillant for monitoring of its radioactivity.
Each standard tracer/cold prostaglandin mixture was mixed
with Dextran-Tyrode solution as follows:
(100 ul tracer/cold mixture —>10 ml Dextran-Tyrode
solution) x 3*
The six solutions were then adjusted to pH 4.5 with 109£
acetic acid and extracted as usual with 2x2 vols re¬
distilled ethyl acetate. The aqueous phase was discarded
whilst the ethyl acetate phases were pooled and washed with
1/10 vol H90 to remove acetic acid. The ethyl acetate was
then evaporated to dryness under reduced pressure and the
residues desiccated. Residues were dissolved in 1 ml
methanol and 4 x 10 pi of each residue was sampled into
scintillant for radioactive counting as before. The recovery
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of labelled prostaglandin could be determined by comparing
radioactive counts obtained pre- and post-extraction. The
mean recovery of PGE2 (from the three tracer/cold mixtures)
was 96.3$ and that for PGF^ was 105.4$. It was concluded
that Dextran-Tyrode solution did not interfere with the
extraction of prostaglandins using ethyl acetate. It was
decided, however, to check that the radioactivity measured
following extraction did, in fact, represent intact prosta¬
glandin. This involved the absolute analysis of the
residues by combined GC/MS. The methanolic extracts were
transferred to Ejppindorf micro-tubes and evaporated almost
to dryness in preparation for derivatisation (see Section 1).
A residual amount of methanol was retained to catalyse the
methylation of samples with diazomethane. Following
methylation of acid groups of botn PGE2 and PGF2^ samples,
PGE samples were oximated (to protect the 9-keto group) by
treatment with about 100 pi of methyl methoxime (in pyridine)
and incubation at 60°C for 1.5-2 nours. The pyridine was
removed by vacuum desiccation. Methyl esters of PGF^ 331(1
methyl methoxime derivatives of PGE2 were then silinated
with 50 pi BSTFA (60°C for 15 min.).
10 pi aliquots were injected on to the GC column and
mass spectra were taken at appropriate retention times.
Positive identification of PGE2 and PGF2^ was obtained with
major peaks occurring at m/e values of 295 (M-(199 + 45))
for PGE2 and 423 (M-(90 +71)) for PGF2a)•
From these results it could be inferred that Dextran-
Tyrode did not affect either the stability of prostaglandins
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or their chromatographic and mass spectrometric behaviour.
The possibility remained that other substances released
from the kidney into the perfusate might affect analyses
of prostaglandins.
Preparation of biological samples
The levels of prostaglandin (if any) in Dextran-Tyrode
perfusate from the isolated kidney preparation had not
previously been measured. It is desirable to measure peak
ratios in triplicate during MID analysis. It was suspected,
however, that the prostaglandin contained in a one minute
perfusate fraction (10 ml), particularly under resting
conditions, might not contain sufficient prostaglandin for
multiple injection. Samples were therefore grouped into
types according to the timing of their collection relative
to RNS:
Pre-stimulation or resting sample - Minute 1 - Sample R
Stimulation sample - Minute 2 - Sample S
First post-stimulation sample - Minute 3 - Sample PS
Second " " " - Minute 4 - Sample P2S
Third " " " - Minute 5 - Sample P^S
Four resting samples obtained from one experiment and
correspondingly four of each other "type" of sample were
pooled for prostaglandin analysis. Each group of samples
will henceforth be referred to in the singular. The volume
of each sample was measured, always being approximately 40 ml
(4 x 10 ml/min). Deuterated (d^) PGE2 (l ug) and PGF2of
(1 pg) were added to each sample prior to extraction. These
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known amounts of d4, as in standard calibration samples,
acted as internal reference standards.
Extraction and derivatisation of calibration standards and
biological samples
The following procedures were carried out on all
samples (calibration and biological). Samples were
acidified to pH 4.5 with 10% acetic acid and were extracted
with redistilled ethyl acetate as described for the "mock"
analyses. The residues obtained after evaporation were
desiccated and re-dissolved in methanol for transfer into
Eppindorf tubes. Ethylation was carried out as previously
described for methylation, replacing diazomethane with
diazoethane (slightly more active). This was followed
by oximation of all samples (to protect the 9-keto group
of PGE) by incubation with about 100 pi of pentyloxime (in
pyridine), at bO°C for 1.5-2 hours. The pyridine was
removed by vacuum desiccation and samples were silanated
with BSTFA, 25 pi to each biological sample and 50 pi to
each calibration sample. After incubation for 15 min at
6QUC, samples -were supposed to contain the ethyl/TMS
derivatives of PGF^ (Mol. Wt. 598) and d4 PGF^ (Mol. Wt.
602) and the ethyl pentyloxime/'IMS derivatives of PGE2
(Mol. Wt. 596) and d4 PGE2 (Mol. Wt. 600) (see Fig. li).
Multiple Ion Detection
The Finnigan 3000D mass spectrometer was capable at
the time of analysis of monitoring four ions in parallel.
Figure 11: (1) Ethyl trimethylsilyl PGF,,^.
(2) Ethyl pentyloxime trimethylsilyl PGE2
(1) PGF20( M.Wt. 598
(2) PGE2 M.Wt. 596
0 Si (CH3)3 OSi (CH3)3
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It was necessary, therefore, to tune the machine in such a
way that it focus"ed on one peak for derivatives of each cf
d^ PGE2, d^ PGF2a» PGE2 and PGF2fl. Major ion peaks are
produced at m/e values of 437 and 441 for PGF2^ and d^ PGF£^
derivatives respectively, and at m/e values of 309 and 313
for PGE2 and d^ PGE2 respectively. It is obviously pre¬
ferable to focus on more than one m/e peak for each
» *
derivative to ensure absolute identification>but ip a parallel
estimation such as this it was impossible to do so. The
$ ■ * '
presence of a deuterated standard, however, makes it highly
* *
probable that a substance which co-chromatographs with the
*
* 2
deuterium and produces a major ion peak fbur mass units down,
is a,*prostaglandin of the same character.
*«
-3 pi aliquots of calibration standards and biological
r
», • # f r
samples itt'SSTFA. were injected on to the column. The
4 * ' * *
columji-ir^Temp. 230°C) was packed with 3% -QV1 and the pressure
of the carrier gas, helium, was 14 psi. Prostaglandin
•.* V ..













Experiment 1: The effect of clamping the renal artery and
vein, as required for renal vein cannulation, on spontaneous
output of prostaglandin into renal venous blood.
The purpose of this experiment was to investigate the
effect of the clamping procedure necessary for cannulation
of the renal vein on the output of prostaglandins from the
kidney. Renal ischaemia has been shown to cause release
of prostaglandin-like substances in canine renal venous
blood (McGiff, Crowshaw, Terragno, Lonigro, Strand,
Williamson, Lee and Ng, 1970). Consequently, it was of
considerable importance to determine whether essential
dissection procedures could influence spontaneous prosta¬
glandin output and, if so, whether the influence was
immediate or delayed. Any such influence would clearly
affect the credibility of control sampling shortly after
completion of dissection.
Methods
One experimental rabbit (2.3 kg) and two donor
rabbits (for blood) were anaesthetised with 25?^ urethane,
7 ml/kg. A detailed description of the dissection and
method of blood collection is given in "General Methods"
of this section. Cannulation of the renal vein, which
demanded clamping of the renal vein followed by clamping
of the renal artery, took 2.25 minutes. This time interval
was employed for subsequent clampings throughout the
experiment. The first sample was collected 3.5 min after
completion of the cannulation procedure and was designated
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post-clamp 1. After a 30 min period with no clamping inter¬
vention, a "control" sample was collected. Fifteen
minutes later, a second clamping procedure was effected and
a third sample corresponding to Sample 1, and hence desig¬
nated post-clamp 2, was collected. Sample 4 was collected
30 min later as another "control" and the final clamping
procedure was elicited 15 min later with collection of
Sample 5 or post-clamp 3, and a final "control", sample 6.
Prostaglandin content of renal venous blood was
analysed by bioassay and combined GLC/MS (see General Methods
of 4this section).
Results
The results are shown in Table If. Conclusive
identification of PGE2 and in most samples was
obtained by combined GLC/MS. Examples of mass spectra are
shewn in Figs, lj, lk and 14. The amounts of prosta¬
glandins in the first pair of samples (post-clamp 1 and
control) though high were closely similar. After the
second clamping, renal blood flow was smaller and the output
of prostaglandins, especially of PGE^, was also less.
During the collection of sample 3 the systemic arterial
pressure fell, possibly due to incompatibility of the donated
blood. Blood flow had improved by the time that the control
sample (sample No.4 ) was collected but the prostaglandin
levels were now a little lower. The third post-clamping
sample (sample No.5) contained similar levels of prosta¬
glandin to the preceding control, but the levels in the final
>
control sample (sample No.6) were less.
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Figure l.i: Mass spectrometric identification of
PGF2a (Me/TMS derivative) in a standard sample
(upper spectrum) and in a biological sample (lower
spectrum). Peak intensities were measured relative
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Figure lk: Mass spectrometric identification of
PGF2a (Me/TFA derivative) in a standard sample (upper
spectrum) and in a biological sample (lower spectrum).
Peak intensities were measured relative to the major
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Figure 11: Mass spectrometric identification of
PGB2 (Me/TMS derivative) in a standard sample (upper
spectrum) and in a biological sample (lower spectrum).
Peak intensities were measured relative to the major
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On the basis of the first pair of samples, it
appears that the amount of prostaglandins released from
the rabbit kidney is similar whether the collection is
preceded by clamping or not. The results of the subsequent
clampings are obscured by the decline in prostaglandin out¬
put which may reflect a deterioration in the condition of
the animal, as suggested by the reduced blood flow and fall
in systemic arterial pressure from sample 3 onwards.
In conclusion, rabbit renal venous blood contains high
amounts of PCrE2 and PGFgr? a small amount of a PGA, C or
B-like prostaglandin, confirming the results of Eavis and
Horton (1972). It seems probable that the operative pro¬
cedures in general rather than the clamping procedures caused
the large initial output of prostaglandins, since output of
prostaglandins fell during the first post-operative hour and
then remained relatively constant. The next experiment was
designed, therefore, to examine the spontaneous output of
prostaglandins over several hours following dissection
procedures.
Experiment 2: The spontaneous output of prostaglandins from
the rabbit kidney over several hours, keeping body temperature
and blood pressure variation to a minimum
Methods
The experimental rabbit was set up as for Experiment 1
and donor blood was collected from two rabbits. Table lg
indicates the timing of sample collection and the systemic
arterial pressure recorded during collection. Prostaglandin
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content was measured by bioassay and samples were subjected
to combined GLC/MS.
Results
Amounts of prostaglandin assayed in renal venous
blood are indicated in Table lg. A gradual increase in
prostaglandin output was observed, reaching a maximum in
the third and fourth samples. From sample 5 onwards, the
output remained relatively stable. The systemic arterial
pressure followed an inverse pattern, gradually falling
from the time of collection of sample 1 until collection of
sample 4. From sample 5 onwards, blood pressure also
remained relatively constant. It is interesting to note
that maximal output of PGF2rr occurred in sample 3> whilst
maximal output of PGE2 was seen in sample 4. This high
output of PGE2 in sample 4 may have resulted from the large
fall in arterial blood pressure during collection of this
sample, although renal blood flow decreased only slightly.
It seems probable that the increases in prostaglandin
output observed in this experiment are explicable in terms
of the gradual decrease in systemic blood pressure, leading
in turn to a decrease in renal perfusion pressure. The
reason for the apparent time displacement of the output
curves for PGE2 and PGF2rf is somewhat obscure. It is, never¬
theless, an Interesting phenomenon which lends support to the
idea that the output of each prostaglandin is specifically
controlled.
Since the prostaglandin levels in the samples collected
were considerably lower in this experiment than in Experiment 1,
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mass spectrometric analysis was performed on each PGF
fraction (Me/TMS derivatives), on pooled PGE fractions
from samples 1-4 and 5-8 (Me/TMS derivatives) and finally
on pooled PGA fractions from samples 1-4 and 5-8 (Me/TMS
derivatives). There was no confirmed identification of
any of the prostaglandins. This was probably attributable
to the fact that the amounts of prostaglandin developed
were low, often approaching the limit of sensitivity of the
mass spectrometer which was 200 ng of each standard prosta¬
glandin. The presence of biological material, even after
careful extraction of samples, makes it almost impossible to
detect amounts of prostaglandin which are close to the limit
of detection of the machine.
Conclusion
The output of prostaglandins from the kidney under
the experimental conditions described was variable and
difficult to correlate with alterations in either systemic
blood pressure or renal blood flow. Prostaglandin levels
appeared to stabilise somewhat from sample 5 onwards, however.
In order that the effect of drugs (e.g. noradrenaline) on
prostaglandin output might be investigated, it would be
necessary to begin control blood sampling only after reaching
a stable blood pressure. Control and test blood samples
should preferably be collected within short time intervals
of each other.
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Experiments 3 and 4: Effect of intra-aortic noradrenaline
infusion on output of prostaglandins from the rabbit kidnev
jjj^vivo, as measured by bloassay.
When studying the effect of noradrenaline on the out¬
put of prostaglandin from the dog kidney, McGiff et al.,
(1972) infused the drug at concentrations of 50-250 ng/kg/
min directly into the renal artery. It was decided, there¬
fore, to utilise a similar dose range in the present
experiments, although infusion was in this case intra-aortic
rather than renal arterial.
In Experiment 3, doses of 50 and 100 ng/kg/min were
tested and in Experiment 4, doses were 200, 500 and 1000
ng/kg/min. Details of collection timing and volumes of
blood samples are indicated in Tables lh and li. Plasma
levels of prostaglandin were measured by bioassay and some
samples fl?om Experiment 4 were submitted to combined GLC/MS.
Positive identification of prostaglandin by GLC/MS is
indicated in Table li.
Results
a) Experiment 5
A summary of results for Experiment 3 is presented in
Table lh. It was desirable to find out whether sub-vaso¬
constrictor doses of NA would affect prostaglandin release.
In Experiment 3, 50 ng/kg/min was sub-vasoconstrictor
whilst 100 ng/kg/rain produced a slight decrease in renal
blood flow. The first infusion of 50 ng/kg/min showed
little effect on output of prostaglandins (samples 3 and 4)
although a repeat of this dose produced a near doubling of
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both PGE2 and PGF^output (samples 7 and 8). A final
infusion of 100 ng/kg/min, although slightly vasoconstrictor,
produced a reduction in prostaglandin output (sample 10).
The final post-test sample showed a further reduction in
prostaglandin content (sample 11). It is possible, however,
that there was an insufficient time interval between the
penultimate and final noradrenaline infusion (40 min) which
may have led to tachyphylaxis of the renal vasculature to NA.
Alternatively, the possibility existed that the higher dose
of NA did reduce prostaglandin output.
b) Experiment 4
In an attempt to ascertain whether or not doses from
100 ng/kg/min upwards reduced prostaglandin output from the
kidney, three higher doses of NA were infused, as previously
described. The results are summarised in Table li. Doses
of 200 and 500 ng/kg/min caused an increase in the output
of PGE2 . During the infusion of 200 ng/kg/min, a maximum
output was attained during the first test sample (sample 3)*
During the subsequent infusion, maximum output occurred in
the second test sample (sample 8). An increase in PGF2rf
output was observed only during the first two NA infusions
and in both cases levels were higher in the first test
samples, 3 and 7, than in the second test samples, 4 and 8.
Infusion of 1000 ng/kg/min NA did not increase the output of
either PGE2 or PG^a i-n^° renal venous blood.
Conclusion
Experiments 3 and 4 indicate that NA is capable of
increasing prostaglandin output from the in vivo rabbit
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kidney. It must be pointed out, however, that there was
no check that mixing of NA with aortic blood was consistent.
Thus the amount of NA entering the renal artery was not
necessarily a constant proportion of the intra-aortic dose.
The effect of NA on output of prostaglandin-like substances
from the dog kidney has also been described as variable,
however (McGiff et_al., 1972). In their experiments the
concentration of NA reaching the kidney was controlled by
administering the drug via the renal artery. They found,
firstly, that NA produced an increased output of PGE but
not of PGF. Furthermore, the increase in concentration of
PGE was unrelated to the dose of NA but was inversely
related to the plasma renin activity. Plasma renin was
considered an index of sodium balance. Thus the release
of prostaglandin seems to be influenced by an interplay of
several factors. The lack of increase in the output of
PGF during NA infusion into the dog kidney may simply be
explicable in terms of species variation. Dunham and
Zimmerman (1970) showed that the increase in biological
activity obtained in renal venous plasma of the dog during
RNS was mainly accounted for in terms of PGE. The amount
of PGF-like activity was very small. Present results, on
the other hand, are consistent with those of Davis and
Norton (1972) who found that output of both PGE2 and
from the rabbit kidney was increased during RNS.
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Experiments 5. 6 and 7: Effect of Intra-aortic noradrenaline
infusion on output of prostaglandins from the rabbit kidney,
in vivo, as measured by radioimmunoassay
These experiments were an extension of Experiments
3 and 4, using radioimmunoassay in place of bioassay. This
method of assay permitted frequent collection of small blood
samples (3 ml) at regular intervals to monitor more closely
the effects of NA on prostaglandin output. The time inter¬
vals between sample collections are indicated in Table lj.
A detailed description of radioimmunoassay is presented
under General Methods. In Experiment 5> two infusions of
NA were made, one at 200 ng/kg/min and the other at 500
ng/kg/min. In both Experiment 6 and Experiment 7, three
infusions of NA were made at 200, 500 and 1000 ng/kg/min
respectively.
Results
The prostaglandin content of samples from each of
the three experiments is summarised in Table lj. In all
three experiments, a clear-cut rise in output of OTa.
during NA infusion was observed. The output of PGE2 also
increased during some infusions of NA but the levels of PGE2
were considerably lower than those of PGF2n, in both control
and test samples. It is difficult to understand why the
levels of PGE2 were so low since values from experiments
utilising bioassay methods indicated that the efflux of PGE2
was at least as high and often higher than that of PGB'2rt at
any one time. This anomaly is probably attributable to the
fact that chemical conversion of low amounts of PGE2 to PGB2
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is rather unreliable and usually incomplete. Although
standard conversions were attempted in parallel with those
for biological samples (see General Methods), the background
medium used for these standards was arterial rather than
venous plasma as it contains little, if any, endogenous
prostaglandin. It is possible, therefore, that substances
present in the venous plasma interfered with the conversion
procedure. The use of tritium-labelled PGE2 as an internal
standard would have provided a suitable check on the extent
of conversion to PGB2 in each sample. However, this pro¬
cedure would have involved separation of radioactivity by
thin-layer chromatography, thus defeating the purpose of
the method as a specific and rapid one for dealing with
large numbers of samples.
The output of (PGA+PGC+PGB) in each experiment
appeared to follow closely that of PGE2. There is increasing
evidence which suggests that these prostaglandins derive
solely from PGE2 during extraction and purification procedures
(see General Introduction). The tendency of their release
to reflect that of PGE2 in present experiments supports this
view. If not derived from PGE2, the amounts of (PGA+PGC+PGB)
measured were too low to produce any significant effect in
themselves.
Conclusion
It is concluded from these three experiments that the
output of PGE2, PGF2o and (PGA+PGC+PGB) can be increased by
intra-arterial infusion to the kidney of NA. Radioimmuno¬
assay provides a very satisfactory and sensitive method for
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measurement of PGF2 > but measurement of PGE2 by its
conversion to PGB2 would seem to be rather unreliable if
exact quantitation is desired. It is proposed that the
relative comparison of one sample with another for PGE2
content is valid but that the actual amounts measured may be
inaccurate by a common factor relating to the success of
chemical conversion in the presence of a common biological
background. It is possible, however, that the low levels
of PGEQ are accurate and that values obtained using bioassay
are misleadingly high because of the inherent non-specificity
of the method.
Experiments 8, 9. 1C and 11: Effect of ENS on output of
prostaglandins in Dextran-Tyrode perfusate obtained from
the isolated kidney
In these experiments, perfusate prostaglandin
content was measured by MID mass spectrometry. Perfusate
was collected in 1 min fractions (10 ml) prior to, during
and following RNS (5 Hz, 30 s, 10-13 V). Four samples
obtained at the same stage in the stimulation cycle were
pooled for each estimate (see"General Methods, MID mass
spectrometry: Preparation of biological samples" for full
details of procedure).
Results
The results are summarised in Table lk. It may be
observed that PGE2 and PGF2r[ output (ng/ml) increased either
during or immediately following RNS, in every experiment.
In Experiments 8 and 9 (samples obtained from the same kidney),
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Table lk Experiments 8, 9. 10 and 11
Amounts of PGEo and PGF^ (ng/ml) measured in Dextran-Tyrode
perfusate from the isolated kidney, prior to. during and
following RNS
Experiment Sample PGE2 TOF2a













11 R 5.0 11.4




R = 1 min prior to stimulation
S = 1 min during stimulation
PS = 1 min following stimulation
P2s = 2 min following stimulation
Pyj - 3 min following stimulation
86
the levels of PGE2 were approximately twice those of PGF2^»
whilst in Experiments 10 and 11 (samples obtained from the
same kidney but not that used for Experiments 8 and 9), the
opposite was observed. This discrepancy between the two
kidneys in their ability to release each prostaglandin
is difficult to explain since experimental conditions
were apparently comparable. Unfortunately time did not
permit extension of the investigation to include a larger
number of kidneys.
Conclusion
It is concluded that RNS is capable of increasing
the output of prostaglandins from the isolated kidney. The
absolute levels and the relative Increases are comparable
to those observed in vivo by Davis and Horton (1972). The
results provide positive evidence that the isolated kidney




Ischaemia and manipulation of organs are known to
stimulate prostaglandin release (see General Introduction).
The high levels of prostaglandin measured in renal venous
blood within an hour or so of completing dissection
procedures in Experiment 1 may, therefore, have resulted
from the manipulative procedures required for cannulation
of the renal vein. The temporary ischaemia caused by
clamping the renal artery did not appear to be a contributory
factor, as clamping interventions later in the experiment
failed to induce a rise in prostaglandin output. Haemorrhagic
shock was unlikely to stimulate prostaglandin release since
blood withdrawn for analysis was simultaneously replaced by
donor blood. In Experiment 2, particular care was taken
to minimise manipulation of the kidney and its blood vessels
during the cannulation procedure.' Samples collected
shortly after completion of the procedure contained low
amounts of prostaglandin. It was concluded from these two
experiments that the experimental animal should be left for
at least one hour post-operatively to stabilise prior to
collection of control blood samples.
Experiments 3 to 7 have provided evidence that intra¬
arterial infusion of HA to the kidney increases the output
of prostaglandin into renal venous blood. An increased
output was not observed during every infusion, however. in
some cases this may have been attributable to tachyphylaxis
to infused NA. The apparent variations in responsiveness
to any one dose of HA may have been due to the variable mixing
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of NA with aortic blood, before passing into the renal artery.
Renal arterial concentrations of NA in these experiments
could not, unfortunately, be monitored. Renal perfusion
pressure could be gauged by observation of systemic
arterial blood pressure. Alterations of renal blood flow
could also be detected during collection of blood samples
in Experiments 3 and 4. It was impossible to detect such
changes in Experiments 5» 6 and 7» however, where blood
samples were collected in 3 ml amounts for radioimmunoassay.
Increased release of prostaglandin from the kidney did not
seem to be directly correlated with reductions in renal blood
flow, unlike results obtained in the dog by Herbaczynska-Cedro
and Vane (1973). These authors also demonstrated that a
reduction in renal perfusion pressure caused release of
prostaglandins from the dog kidney. The reductions in
perfusion pressure in their experiments were as large as
50-100 mm Hg. In general, the reductions in systemic blood
pressure, if any, observed during present experiments were
very small and probably did not affect prostaglandin output
from the kidney. In one instance, however, there was a fall
of about 33 mm Hg during collection of a sample in Experiment
2, which may well explain the increased levels of prosta¬
glandin present in that sample.
Mechanism of prostaglandin release
The present experiments indicate that prostaglandins
may be released from the kidney by NA in the absence of any
vasoconstriction. Similar results have been obtained in
the rabbit heart where the vasoconstrictor effect of NA
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was abolished by the ^.-blocker, phenoxybenzaraine (Jtmstad
and Wennmalm, 1973a). In these experiments, NA continued
to release prostaglandins. Terashima et al. (1974) have
also demonstrated the release of prostaglandins from the
dog kidney by NA in the presence of a-blockade by phenoxy¬
benzamine. Other authors, however, have shown that
phenoxybenzamine does inhibit NA-induced prostaglandin
release from the dog spleen (Davies, Horton and l/ithrington,
1968; Ferreira and Vane, 1967). The apparent requirement
of vasoconstriction for the release of prostaglandins from
canine organs is further documented by experiments demon¬
strating that angiotensin II releases prostaglandin-like
substances from the dog kidney (McGiff, Crowshaw, Terragno
and Lonigro, 1970b; Aiken and Vane, 1971, 1973) and that
both angiotensin II and histamine cause release of prosta¬
glandin-like material from the dog spleen (Ferreira and
Vane, 1967). Thus vasoconstriction rather than specific
a-receptor activation seems to be the stimulus for prosta¬
glandin release in the dog. It is probable that the
various substances which provoke release of prostaglandin,
do so by acting on a common biochemical pathway.
In agreement with present results in the isolated kidney
(Experiments 8 to 11), Needleman, Douglas, Jakschik,
Stoecklein and Johnson (1974$ have demonstrated the ability
of RNS to release a prostaglandin-like substance from the
isolated Krebs-Henseleit-perfused rabbit kidney. Noradrenaline
and adrenaline also stimulated prostaglandin release and the
effects of all three adrenergic stimuli were blocked by the
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a-receptor antagonist, phenoxybenzamine, indicating that
the effects were a-receptor mediated. Angiotensin II
infusion and renal ischaemia (for a 4 min period) caused
a release of prostaglandin which was unaffected by phenoxy¬
benzamine. The effects of both stimuli were blocked by
the prostaglandin synthesis inhibitor, indomethacin, and
that of angiotensin II could also be blocked by the specific
angiotensin antagonist, cysteine-3-angiotensin II (Needleman,
Kauffman, Douglas, Johnson and Marshall, 1973). These
results extend the evidence previously discussed that
prostaglandin release seems to be multireceptor activated.
A common pathway of action via adenyl cyclase/cyclic AMP
seems unlikely, however, in view of the findings that
cyclic-AMP, dibutyryl cyclic AMP and theophylline were
inactive as inducers of prostaglandin release (Needleman
et al., 1974a). It should be emphasised that in the fore-
mentioned experiments, evidence of prostaglandin release
relied solely upon superfusion bioassay. No chromatographic
purification or chemical identification of prostaglandins
was performed.
The nature of the prostaglandin-release mechanism is
evidently complex and the common stimulus, if any, remains
to be elucidated.
Site of prostaglandin release
As described in the introduction to this section, the
site from which prostaglandins are released into renal
venous blood in response to adrenergic stimuli may be
either prejunctionally or postJunetionally located, i.e. at
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the adrenergic nerve ending or at the effector cell. The
experiments from this section point to a probable post¬
junctional site of release, as both RMS and NA are capable
of stimulating the release of prostaglandin. The existence
of ^-adrenoceptors on the adrenergic nerve ending itself
does confuse the argument, however. For this reason,
a-blocking drugs were not used in the present experiments as
it was thought that their ability to block both pre- and post¬
junctional adrenoceptors would not clarify the situation.
However, more recent evidence indicates that the rr-blocking
drug phenoxybenzamine can selectively block postjunctional
_Q
receptors at lower concentrations, up to 2.9 x 10 M. A
tenfold increase in dose seems to act both pre- and post-
junctionally (Dubocovich and Langter, 1974). The possibility
still exists, therefore, that NA acts on both pre- and post¬
junctional receptors and may release prostaglandins from
either or both sites. There is one piece of evidence
which suggests a prejunctional release of prostaglandin.
StjSrne (1972) has demonstrated that when the contractile
response of the isolated guinea pig vas deferens is blocked
by reducing the external calcium concentration of the bathing
medium to a degree which still permits some adrenergic
transmitter release in response to field stimulation, the
overflow of transmitter is elevated by the addition of a
prostaglandin synthesis inhibitor (eicosatetraynoic acid)
to the medium. Prostaglandin may, in this case, be con¬
trolling transmitter release from a prejunctional site. It
is conceivable, however, in the light of the evidence
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discussed under "Mechanism of prostaglandin release",
that prostaglandin may continue to be releasable from a
postjunctional site in the absence of contraction. The
evidence against a prejunctional site of release of
prostaglandin is quite considerable. Chemical denervation
of the kidney to prevent reflexogenic sympathetic stimu¬
lation did not modify the increase in output of prostaglandin
during reduction of renal blood flow (Herman and Vane, 1974).
Similarly, denervation of the rabbit heart did not signifi¬
cantly alter the outflow of PGE2 in response to NA infusion
(Junstad and V.ennmalra, 1973a). Further evidence against
a prejunctional site of release is the knowledge that
prostaglandin release is not dependent upon the activation
of adrenergic receptors (by either nerve stimulation or NA).
Angiotensin and histamine also stimulate the release of
prostaglandins (Aiken and Vane, 1971, 1973; Ferreira and
Vane, 1967).
It is concluded that prostaglandins are released in
response to various substances which are known to act on
different receptors. This would suggest that their release
is triggered by an action on some common biochemical path¬
way at the level of the effector cell. The possibility
that some prostaglandin is released from adrenergic nerves
during stimulation has not yet been eliminated.
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SECTION 2
A comparison of the influence of prostaglandins Ao, En
and Fo^ on vascular responsiveness to noradrenaline and
renal nerve stimulation in the rabbit kidney
The ability of noradrenaline to increase prosta¬
glandin output in renal venous blood described in
Section 1 indicates that there is some interaction between
prostaglandins and the adrenergic system in the rabbit
kidney. The present experiments were designed to investi¬
gate this interaction from another angle, namely the
effect of prostaglandins on responses to adrenergic stimuli.
Such interactions have been widely studied in various
systems (see Norton, 1969, 1972, 1973; Brody and Kadowitz,
197A; Vane and McGiff, 1975 for references), and are thought
to involve two components (i) an action of prostaglandin on
the adrenergic transmitter release mechanism, henceforth
designated a •prejunctional' action, and (ii) an action of
prostaglandin on the post-synaptic effector cell, or
•postjunctional' action.
In this section an attempt is made to dissociate the
possible prejunctional and postjunctional influence of
prostaglandins. This involves a comparison of the action
of prostaglandins on vascular responses of the kidney to
direct (NA) and indirect (RNS) adrenergic stimuli.
Emphasis has been placed upon the study of PGE2 since it
is the most abundant renal prostaglandin (see Daniels,
Hinman, Leach and Muirhead, 1967; Larsson and Snggard,
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1973a, for references) and has been proposed as a regulator
of adrenergic neurotransmission in several other tissues
and organs.
The ubiquity of PGF^^ in many tissues and its
ability to be released from them during sympathetic nerve
stimulation has led various workers to investigate its
interaction with the adrenergic nervous system (Kadowitz,
Sweet and Brody, 1971a, 1971b, 1972; Hedqvist and V.ennmalm,
1971; Davies and Vvithrington, 1971; Hedqvist and von Euler,
1972). Since is also produced in large quantities
by the rabbit kidney (Davis and Horton, 1972; Larsson and
Aiiggard, 1973a), its effects on adrenergic neurotransmission
are investigated in this section and in Section 3«
The paucity of information on the interactions of A
prostaglandins with adrenergic neurotransmission is sur¬
prising in view of its well-established vasodilator
activity (see Lee, 1973» for references) and ability to
withstand passage through the lungs without undergoing
degradation (Horton and Jones, 1969; McGiff, Terragno,
Strand, Lee, Lonigro and Kg, 1969). On account of these
properties, it has been postulated that prostaglandins of
the A series may be circulating anti-hypertensive hormones.
The possibility of such a function merited an investigation
into the interactions of PGA2 with adrenergic neurotrans¬
mission in the kidney.
The isolated perfused rabbit kidney was used in most
experiments, being chosen with a view to its future
adaptability for transmitter studies. Lome in situ experi-
95
ments were also conducted, however, as a check on the
validity of the in vitro situation.
Experiment 1: Effect of PGE^ on vascular responses of the
isolated perfused rabbit kidney to nerve stimulation and
noradrenaline infusion
Methods
Twenty rahbits weighing 2.0-2.5 kg were anaesthetised
with 25% urethane, 7 ml/kg. The abdomen was opened along
its midline and the left kidney exposed. The left kidney
was used in preference to the right in all experiments as
a result of its anatomical advantages, namely, its longer
artery, vein and nerve. The kidney, with its nervous and
vascular supply, was dissected free from the surrounding
tissue. The nerve was then freed from the artery. After
heparinisation of the animal (1 i.u./g body weight) the
blood vessels and ureter were cannulated, the nerve was cut
and the kidney was flushed with warm 0.9% saline containing
50 i.u. heparin/ml. The preparation was then transferred
immediately to a perfusion chamber maintained at 37°C for
perfusion with Tyrode solution (mM concentrations: NaCl
136.7, KC1 2.7, CaCl2 1.8, MgCl2, 1.0, NaHCO^ 11.9, NaHgPO^
0.4, glucose 5.5) also at 37°C, containing 2% dextran (MW
60,000 - 90,000) and gassed with 5% C02 in 02 (see Fig. 2a).
Constant flow perfusion was chosen in preference to
the free-flow method to facilitate fractionation of the
perfusate for transmitter or prostaglandin analysis. Flow
rate was kept at 10 ml/min using a Yfatson-Marlow pump and
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Figure 2a: Diagrammatic representation of the















perfusion pressure was recorded on a Grass model 5 poly¬
graph using a Statham (P23AC) pressure transducer.
The nerve was placed on platinum electrodes, pro¬
tected from drying with Plastibase (Squibb) and stimulated
with a Grass S5 stimulator at 10 min intervals.
Changes in perfusion pressure, henceforth called
vascular responses, were induced using the following
stimulation parameters:
Impulse duration: 2 ms
Stimulation frequency: 8-10 Hz
Voltage: 5-15 V
Period of stimulation: 15-30 s
Vascular responses to HA, comparable to those pro¬
duced by RNS, were induced by intra-arterial infusion of
HA (0.25 - 0.52 Mg total) over a 20-30 s interval. PGE£
(1.5 x 1Q~8 to 1.5 x 10~"^M) was infused intra-arterially
for 2 min prior to and also during RNS or NA administration.
Braun-Melsungen pumps were used for all infusions. The
effect of PGE2 on vascular responses to RNS or NA was
estimated by calculating the height of a vascular response
obtained during PG administration as a percentage of the
preceding vascular response. At least two control vascular
responses were obtained prior to the administration. If
k. *
there was a gradual but regular decrease in amplitude of
control responses, the vascular response obtained during




It was consistently observed that concentrations of
PGE2 ranging from 3.8 x 10""^ to 1.5 x 10~8M, which did
not alter basal perfusion pressure on infusion, caused
significant inhibition of vascular responses to RNS (NS,
Fig. 2d). There was partial or complete recovery from
this inhibition 10 to 20 min after ending the infusion of
PGE2. At dose-levels of 1.5 x 1CT8 to 3.8 x 10~8M, PGE2
showed no significant effect on responses to RNS in most
cases, although weak inhibition or even slight enhancement
of responses was occasionally observed.
_7
At higher dose-levels, 3-8 x 10 'M, the inhibitory
effect of PGE2 was found to be statistically significant
(p < 0.05 to p < 0.001), according to Student's t-test for
paired variates (see Fig. 2b).
In contrast to its effect on responses to RNS, PGE2
in the same concentrations did not produce well-defined,
dose-dependent effects on vascular responses to NA. The
most commonly observed effect was that of enhancement of
responses, although in some experiments either no effect or
moderate inhibition was observed. The mean values of
responses obtained during infusion of different dose-levels
of PGE2 (1.5 x 10~8 - 1.5 x 10"~8M) were all the same as, or
slightly greater than, mean control values and a statistical
analysis showed that they were not significantly altered
from control level by PGE~ (NA, Figs.2b and 2d).
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Figure 2b: Isolated, perfused rabbit kidneys. Effect
of different doses of PGE2 on pressor responses to
renal nerve stimulation, NS and to noradrenaline, NA.
All values presented as per cent of the preceding control
stimulation. Vertical bars = mean values +_ S.E.M.
Figures within brackets = no. of expts. * p < 0.05,
**
p < 0.01, *** p < 0.001 according to Student's




































PGE9 inhibits responses of the in vitro rabbit kidney
to RNS but its effects, in similar dose-levels, on
responses to NA are less well-defined and are statistically
insignificant. These results suggest that PGE2 is
producing its inhibitory effect on vascular responses to
RNS mainly at a prejunctional level, since its post¬
junctional effects on NA responses are apparently negligible.
Experiment 2: Effect of PGEo on vascular responses of the




Four rabbits were anaesthetised as described
previously and a tracheal cannula was inserted. The
femoral artery was cannulated for measurement of systemic
blood pressure. The abdomen was opened along its midline
and the left renal nerve was freed from the artery. The
nerve was tied into a perspex box-electrode. Heparini-
sation of the animal was maintained by administration of
1 i.u./g body weight every two hours. The right carotid
artery was then cannulated. The carotid cannula was
linked through a constant-rate pump to the renal artery.
The pump rate was adjusted so that the renal perfusion
pressure approximated normal systemic pressure (90-110 mm
Hg). The use of constant flow again facilitated the
administration of drugs at constant concentration. A side-
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arm for perfusion pressure measurement and two drug inlets
respectively were positioned between the pump and the
kidney. The renal perfusion pressure thus took into
account any additional pressure resulting from drug
infusion.
Experimental procedure:
Vascular responses to RNS were obtained by stimulating
the renal nerve at 5-8 Hz and 2 ms duration for 15 s periods.
To enable a direct comparison of effects of PGEP on RNS and
NA responses, an attempt was made to match responses to NA
with those to RNS. This involved infusion of a suitable
NA concentration over a 15 s period.
PGE2 was infused for 3 min prior to RNS or NA
infusion and for the duration of the vascular response
(about 4 min in total). Both NA and PGE2 were infused in
Tyrode solution at rates not exceeding 0.3 ml/min.
Results
As observed in vitro. PGE2 consistently inhibited
vascular responses resulting from RNS, with complete
recovery from inhibition occurring about 10 min after
ending the PGE2 infusion. The in, situ kidney proved more
sensitive to the inhibitory effect of PGE2 than that in
vitro, marked inhibition of RNS responses being produced
—7 —7
even in the lower dose-range, 1.5 x 10 - 3 x 10 'M (NS,
Fig. 2c).
Within the same dose-range, vascular responses to NA
were also inhibited by PGE2, although the inhibition was
much less marked than that observed on responses to RNS
(NA, Fig. 2c).
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Figure 2c: Blood perfused rabbit kidney in situ.
Effect of PGE2 on pressor responses to renal nerve
i




























PGE2 inhibits vascular responses of the in situ
rabbit kidney to RNS. There is a quantitative difference
in effectiveness of PGE2 in this preparation when compared
with that in vitro. The greater sensitivity of the
.in situ preparation may be attributable to the fact that
a lower stimulation frequency (5-8 Hz) was required to
induce suitable pressor responses than was required in vitro
(10 Hz). It has been demonstrated that the inhibitory
effect on responses to field or nerve stimulation diminishes
as the frequency of stimulation is increased (see Section 3).
In contrast to its lack of effect on vascular
responses of the in vitro kidney to NA, PGE2 inhibited
vascular responses of the in situ kidney to NA. The effect
was, however, less marked than that produced on responses
to RNS. These experiments point to some postjunctional
inhibitory action of PGE2 in the kidney. It is unlikely
that such an action can account for the total inhibitory
action of PGE2 on RNS, since the inhibition of NA
responses by the same PGE2 dose-level was approximately
half of that observed during RNS.
Experiment 3: Effects of prostaglandins A2 and F2a on
vascular responses of the isolated perfused rabbit kidney
to RNs or NA administration
Methods
Twenty-seven rabbit kidneys were set up for isolated
perfusion with Eextran-Tyrode solution at 10 inl/min and
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perfusion pressure was recorded, as described in
Experiment 1.
Vascular responses were induced at 10 min intervals
as before by infusing NA over a 30 s period or by stimu¬
lating the renal nerve for 30 s (5 Hz, 2 ms duration, 7-15 V).
The effect of each prostaglandin on vascular responses
to NA and RNS was studied by infusion of the former for
2 min prior to and also during RNS or NA administration
(2.5 min infusion). This procedure permitted a direct
comparison of results with those obtained in Experiment 1.
-7 -6
Drug concentrations were: PGA2 7.5 x 10 M to 3 x 10 M;
?GF2a 4.2 x 10~7M to 5.7 x 10~bM.
Results
The dose-levels of each prostaglandin used in these
experiments usually produced a negligible effect on basal
perfusion pressure. Occasionally, however, both PGA2 and
PGF2a caused a slight vasoconstriction.
After obtaining a minimum of two control vascular
responses to either NA or RNS, prostaglandin was admini¬
stered as described in Methods. PGA2 infusion at the above
concentrations caused potentiation of vascular responses to
both NA and RNS (Fig. 2d). it potentiated vascular
responses to NA in four out of five observations at the
highest dose-level. In the fifth observation, it had no
effect. PGA2 produced potentiation of vascular responses
to RNS in all observations (7) throughout the dose range.
PGF2a, in the doses indicated, similarly enhanced responses
to both NA and RNS (Fig. 2d). Potentiation of four out of
five responses to NA and of sixteen out of nineteen responses
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Figure 2d: Isolated, perfused rabbit kidneys.
Effect of prostaglandins A2, E2 and F2ft on
vascular responses to renal nerve stimulation (NS)
and noradrenaline (NA).
































































to RNS was observed.
An insufficient number of observations was made at
each dose-level to allow statistical analysis of the
effects of PGA2 and PGF2a.
Conclusion
Since the effect produced by prostaglandins A2 and
F2^ was consistent and similar for each type of adrenergic
stimulus, it seems probable that these prostaglandins
* .1
influenced the adrenergic neuro-effector system at a post¬
junctional level. An investigation into the prejunctional
effects of these prostaglandins is required, however,
before any final conclusion may be drawn.
Discussion
The results in this section indicate that PGE2 pro¬
duces effects on renal vasculature which may be differen¬
tiated from those of PGA2 and PGF2ft. Furthermore, since
the effects of PGE2 on vascular responses to RNS and NA
are quantitatively different, it seems probable that it
has two components of action, one prejunctionally and the
other postjunctionally located. In contrast, PGA2 and
PGF2^ seem to act primarily at a postjunctional level,
producing consistent effects on vascular responses to
both RNS and NA.
The proposed existence of a prejunctional site of
action for PGE2 in the rabbit kidney is further documented
by the work of Malik and McGiff (1975) whose results
resemble those found in this study. They found that both
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PGE1 and PGEo, at infusion concentrations as low as
0.1 ng/ml (sub-vasodilator), inhibited vasoconstrictor
responses of the isolated, Tyrode-perfused rabbit kidney
to RNS (1-2 Hz) without altering those induced by HA. The
extreme sensitivity of the kidney to PGE-; in these experi¬
ments compared with present experiments may be attributable
to two factors:
(a) a very low stimulation frequency was employed, at which
adrenergic transmission has been shown to be particularly
sensitive to PGE (see Section 3); (b) the pressor responses
induced were rather small, of the order of 10 mm Hg, such
that a 50% reduction in response by PGE£ would only involve
a change of abotit 5 mm Hg. Pressor responses in the
present experiments were considerably larger (20-30 mm Hg).
so that changes less than about 2.5 mm Hg were almost
certainly overlooked.
In identical experiments carried out on the rat kidney,
however, these authors found, curiously, that PGE-^ and PGE^
-potentiated vasoconstrictor responses to RNS (1 Hz) whilst
exerting a lesser or no effect on equiconstrictor responses
to injected NA. These experiments challenge the extension
of the Hedqvist hypothesis to all species, although other
results obtained by Needlernan, Marshall and Johnson (1974b)
using the isolated Krebs-Henseleit-perfused rat kidney
indicate general agreement with the hypothesis. Infusion
of indomethacin caused potentiation of renal vascular
responses to both RNS (3-6 Hz) and NA. In addition, a
mixture of PGE-^ and PGE^, when infused simultaneously with
108
indomethacin, inhibited vascular responses to RNS. Thus,
there is apparent controversy over the intrarenal
vascular effects of PGE in the rat kidney. An explanation
of the anomaly may be that Needleman et al. used doses of
indomethacin which were considerably higher than those
*
employed by Malik and McGiff: indomethacin 2.5 Mg/ml cf.
100 ng/ml respectively; doses of PGE^ + PGE2 were lower,
however, at 0.5 ng/ml cf. 5 ng/ml. The perfusion media
were also different as described, as were perfusion rates
(4 ml/rain and 6 ml/min respectively) but there is no
evidence to suggest that such factors could account for
such major differences in the results obtained. S-tu4.es
of- PGE/adrenergic-effector interactions in the kidney
have been carried out to a large extent in the dog.
Kadowitz et al. (1971c) showed, in agreement with present
in situ results, that infusion of PGE1 (2-4 Mg/min) into
"t^te in situ, blood-perfused dog kidney reduced vasocon¬
strictor responses to NA. The effect of PGE-j_ on
responses to RNS was not examined. McGiff and coworkers
have accumulated evidence suggestive of a role for
prostaglandins as regulators of the renal actions of
pressor hormones in the dog (for earlier references
describing release of prostaglandins from the dog kidney
and subsequent effects on renal blood flow, see Section 1).
They have shown that infusion of PGE2 into the dog renal
artery, in vivo, reversibly inhibits the vasoconstriction/
antidiuresls produced by RNS and, to a lesser extent,
inhibits that produced by NA. (Lonigro, Terragno, Malik
and McGiff, 1973a). These results are compatible with
^ See J> IS"a>
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results in this section and with the view that PGE-like
OA
substances released from the dog kidney^RHS (Dunham and
Zimmerman, 1970) or NA administration (McGiff et al., 1972)
may serve to attenuate the resultant vasoconstriction,
thus allowing eventual resumption of normal renal blood
flow. Intra-arterial administration of PGE cannot be
equated with its physiological availability, as indicated
in Section 4. However, the results discussed do display
reasonable parallelism.
Experiments in which H*F2a was administered to the
isolated rabbit kidney as in this section, were similarly
conducted by Malik and McGiff (1975). They found that
2GF2n, (5-25 ng/rnl) j>otentiated equi-constrictor responses
to HNS (2Hz) and NA, with greater effect on responses to
RNS. Higher doses (25-50 rig/ml) also produced a slight
direct vasoconstriction on infusion. This is in agreement
with the results in this section, although once more there
is a large discrepancy in the dose-levels utilised. The
possible explanations (a) and (b) advanced to explain dis¬
crepancies in PGE concentrations similarly apply here.
In identical experiments on the rat kidney,,these
authors found that PGF2a did not produce, as one might
esqiect from the results obtained with PGE2, effects opposite
to those in the rabbit kidney, but rather concordant effects.
In a series of experiments in the dog kidney (cf.
those done with PGE), PGF^ did not modify vasoconstrictor
responses to either RNS (1-6 Hz) or NA. In addition, it
did not alter renal blood flow (Loaigro et al.. 1973a).
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Thus PGF2a shows little potency as a vasoconstrictor/
adrenergic modulator in the dog kidney compared with the
rat and rabbit.
Contrary to results observed with PGA2 in this
section, Malik and McGlff (1975) obtained results in which
PGA2 produced effects similar to those of PGE2 in the
rabbit kidney; PGA2 (5-25 ng/ml) reduced vasoconstrictor
responses to RNS and to a lesser degree (only at 25 ng/ml)
responses to NA. It also caused a fall in basal perfusion-
pressure at the high dose. It is difficult to reconcile
present results with these and with the accepted vasodilator
action of PGA2. It is conceivable, however, that PGA2 has
a biphaslc effect according to dose-level, as has been
demonstrated with PGE2 on pressor responses of the cat
spleen, where low doses inhibited and high doses potentiated
the responses (hedqvist, 19?ob).
PGA2 correspondingly mimicked PGE2 in the rat kidney,
producing vasoconstriction and potentiation of responses
to RNS and NA. It was again approximately five times less
potent than PGE2 (Malik and McGiff, 1975).
In the dog kidney, PGA2 also produced effects
resembling tnose of PGE2 with the ft
pga2w\ola.r ratio, of about 5 (Lonigro et al., 1973a).
It is concluded from this section that the discernible
selectivity of action of PGE2 on vascular responses to
RNS may assign it a possible role as negative modulator
of adrenergic transmitter release in the kidney. The
actions of PGA2 and P0F2(J seen to be explicable either in
Ill
terms of a direct postjunctional action on the effector
cell or in terms of an ability to release adrenergic
transmitter. Both mechanisms would account for the
direct increase in perfusion pressure and the potentiation
effects observed. A knowledge of the prejunctional
effects of all three prostaglandins is evidently desirable




A study of the prejunctional effects of prostaglandins
Ao. Eo and F2 on adrenergic neurotransmission in the
isolated rabbit kidney
The results in the previous section have provided an
indication of the probable site/s of action of each prosta¬
glandin in adrenergic neurotransmission. The inferences,
however, were based solely upon observations at the
effector cell level. This section attempts to elucidate
whether the primary action of each prostaglandin is:
(i) to affect the postjunctional effector cell directly,
(ii) to alter responsiveness of the effector cell to
catecholamines (circulating or locally formed),
(iii) to affect prejunctional release of adrenergic
transmitter.
This involves an investigation of pre- as well as post¬
junctional events. PGE2 has been shown to have a primary
prejunctional action on adrenergic transmitter release in
various tissues and organs (Hedqvist, 1970a; see also
General Introduction for references). The prejunctional
actions of prostaglandins A2 and F2 have not been studied
extensively, however.
In this section, the effect of each of the above-
mentioned prostaglandins on adrenergic transmitter release
in response to HNS is investigated. The overflow of
noradrenaline from an adrenergically-innervated organ can
be monitored by determining the efflux of tritiated
noradrenaline ( H-NA) previously taken up by the nerves
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(Hertting and Axelrod, 1961; Rosell, Kopin and Axelrod,




The isolated rabbit kidney preparation was used in
all experiments to facilitate transmitter studies. Kidneys
from male or female rabbits (2-3 kg) were set up for per¬
fusion with Dextran-Tyrode solution, as described in
Section 2. Radioactive labelling of the noradrenaline
stores of each kidney was effected by slow infusion of
25 bCi (1 pCi/min, 7.2 Ci/mmole) of L-[7-"^H]-noradrenaline
(•%-NA). The ^H-NA was infused in Tyrode solution con¬
taining approximately 200 Mg/ml ascorbic acid to protect
the noradrenaline from oxidation. The kidney was then per¬
fused with isotope-free Tyrode solution for at least 30 min
3
before starting an experiment to remove surplus H-NA.
The renal venous cannula was directed into a funnel
with the outflow positioned slightly above the kidney to
provide a positive venous pressure of about 10-20 mm Hg.
The funnel was connected to a 10 ml siphon which emptied
into an LKB fraction collector. The rate of perfusion was
maintained at 10 ml/min as before, thus providing fraction¬
ation into 1 min samples.
The tritium content of samples obtained before, during
and after RNS was determined by counting 0.5 ml aliquots in
a Packard liquid scintillation spectrometer with quenching
monitored by internal standards. Twenty ml of a 3:7 ethanol-
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toluene mixture containing 4 g of ?P0 and 0.1 g of P0P0P,
per litre of toluene was used as a counting medium for each
sample. The efficiency of counting averaged about 45%.
The radioactivity of some perfusate samples was
separated into that of intact NA and that of its metabolites
by cation exchange column chromatography (Stjarne and
Liskajko, 1966; Fredholm and Hedqvist, 1973). In this way
it could be decided v/hether total radioactivity overflowing
3
during PUS was an appropriate indicator of H-NA and. hence
endogenous NA overflow.
Amberlite column chromatography
Cation exchange chromatography of perfusate samples
was performed using Amberlite CG-120, Type II (Rohm and
Haas, Philadelphia). The Amberlite was placed in a beaker
and mixed with water. The water was drained and the
Amberlite rinsed in the following cycle: (1) 3 M NaOH con¬
taining 1% EDTA (2) H20 (3) 2 M HC1 (4) H£0 (5) 1 M NaAc-
buffer, pH 6.0 containing 1% EDTA (6) H20. After rinsing,
Amberlite was packed to a height of 10 cm in columns of 5 mm
internal diameter. The rinsing cycle was then repeated.
After removing 1 ml for radioactive counting, perfusate
samples were prepared as follows:
To each sample were added:
10-20 pg ascorbic acid/ml sample
1 pg norraetanephrine/ml sample
0.1-1% EDTA
1 ug noradrenaline/ml sample
1/10 vol NaAc pH 4.0
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Tne pH of the sample was adjusted to 4.0 with 1 M KOH.
The prepared sample was applied to the column and eluted at
reduced pressure with the following:
1. 10 ml NaAc pH 6.0 containing 1% EDTA
2. 10 ml ri20
3. 7 ml 1 M HC1
4. 9 ml 1 M HC1 (NA)
5. 1 ml 1 M HC1
6. 1 ml 1 M HC1
7. 10 ml 2 M HC1 (Normetanephrine)
The rate of elution was 4 to 5 drops/minute. 1 ml of each
effluent fraction (sample effluent + fractions 1-7) was
counted in 10 ml Insta-gel (Packard). The values obtained
(c.p.ra.) were corrected for quenching. The results are
shown in Table 3a. The recovery of authentic NA added to
the samples and carried through the entire chromatographic
procedure was 73.3 ± 2,3% (mean +_ S.E.M., n = 4).
Since the majority of the radioactivity overflowing in
response to RNS ('stimulated') was represented by intact
•^H-NA (81.3%)» total radioactivity was considered an
appropriate indicator of endogenous NA overflow. Conversely,
since the majority of the 'background' radioactivity over-
3
flowing during resting periods was not intact H-NA but rather
'acid metabolites' (74.4%), the amount of ^H-NA overflowing as
a result of RNS was calculated by subtracting total background
radioactive overflow from total 'stimulated' radioactive
overflow.
Table5a
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Experiment 1: Pattern of adrenergic transmitter overflow
during control and stimulation periods
In this experiment the minute to minute overflow of
transmitter from the isolated rabbit kidney was monitored,
prior to, during and following RNS. This involved sampling
every perfusate fraction for radioactive content.
Results
The radioactive overflow during a typical experiment
is shown in Fig. 3a. There is a gradual decrease in back¬
ground radioactive overflow throughout most experiments and
a resultant slope in the overflow of radioactivity during
RNS. At stimulation frequencies of between 2 and 10 Hz,
the ratio (^-overflow during ENS) varled between 4 ^ 20-
resting H-overflow
The total number of pulses was kept constant at 150,
regardless of frequency.
At all stimulation frequencies employed, ^H-overflow
increased in response to RNS, reaching a maximum within the
first or second fraction collected from the onset of
stimulation. At the highest frequency of 10 Hz, a maximum
was generally reached in the first 'stimulation fraction',
i.e. the first fraction collected after the onset of
stimulation. At a frequency of 5 Hz, the maximum tended to
occur in the second 'stimulation fraction' whilst at the
lowest frequency of 2 Hz, the maximum always occurred in the
second 'stimulation fraction', the total stimulation time
having been extended to 75 seconds. As shown in Fig. 3a,
transmitter overflow returns to, or almost to, resting level
by the third 'stimulation fraction' (see Fig. 3a, samples 8,
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Figure 3a: Isolated, perfused rabbit kidney. Tritium
content of perfusate sampled at one minute intervals
prior to, during and after renal nerve stimulation (NS).
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18, 27 etc.). It was decided, therefore, to calculate the
total overflow of tritium resulting from RNS as follows.
Radioactive counts from 'stimulation fractions' 1 to 3 were
summed and background counts were subtracted:
Total stimulation-induced overflow of tritium
= (stim. fractions 1+2+3) - (3xpre-stim. background)
This procedure permitted a more accurate assessment of
tritium overflow resulting from RNS since it eliminated
effect o| a decreasing background overflow.
Conclusion
At stimulation frequencies from 2-10 Hz, the maximum
increase in tritium overflow in response to RNS always
occurred within the first two 'stimulation fractions'.
Furthermore, tritium overflow always returned to background
level by the fourth 'stimulation fraction'. It was concluded
that an accurate estimate of transmitter overflow per,
stimulation period could be obtained by sampling two background
fractions prior to RNS and three 'stimulation fractions'
from the onset of RNS.
In any experiment where a drug was infused for 2 min
3
prior to RNS, its effect on background H-overflow was
checked by sampling a background fraction prior to drug
infusion in addition to the standard sampling described above.
Experiment 2: Effect of exogenous PGB2 on transmitter over¬
flow in response to RNS
In this experiment, the action of PGE2, at three dose-
levels, on transmitter overflow resulting from RNS was examined.
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Methods and Results
thirteen rabbit kidneys were set up for isolated
perfusion with Dextran-Tyrode solution at 10 ml/rain, as
described in Section 2. Each kidney was labelled with
25 MCi %-NA (see General Methods) and the renal nerve was
stimulated for 15-20 seconds every 10 rain at frequencies
ranging from 8-10 Hz (2 msec duration, 7-15 V, 150 pulses).
PGE2 was infused intra-arterially to the kidney in lextran-
Tyrode solution at concentrations ranging from 1.8 to 9.1 x
10~7M.
Perfusate was collected for liquid scintillation
counting and the total tritium overflow resulting from RN£
calculated (see General Methods) for each stimulation period.
At least two control stimulation periods were allowed prior
to application of PGE2. The effect of the drug on trans¬
mitter overflow in response to HNS was calculated by
expressing transmitter overflow during PGEo administration
as a percentage of preceding control overflow, with the
proviso that the two preceding controls had shown regularity
in their vascular responses and tritium overflow.
It was consistently found that infusions of PGE2 (1.8
to 9.1 x 10"?M), for 2 rain prior to and also during HNS,
decreased the overflow of transmitter in the 'stimulation'
perfusate in a dose-dependent manner (Fig. 3b, Table 3b).
At these dose levels PGE2 did not alter basal arterial
pressure, nor did it affect 'resting' transmitter overflow.
Vascular responses to RNS were similarly inhibited by PGE2,
as previously observed in experiments of Section 2. Partial
3
or complete recovery from both H-NA overflow and vascular
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Figure 5b: Isolated, perfused rabbit kidney. Effect
of PGE2 on overflow of tracer resulting from renal
nerve stimulation (NS). Time in min = fraction numbers.
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inhibition occurred about 10 min after ending the infusion
of PGE2•
Table 5b
Percentage inhibition of transmitter overflow to RNS
(8-10 Hz. 150 pulses) by PGE2»
PGEp concen. Percentage Inhibition
1.8 x 10~7M 18.1 + 2.3 (n « 9)
4.5 x 10"7M 29.1 +3.3 (n » 9)
9.1 x 10~7M 30.6 + 2.9 (n = 8)
Mean values + S.E.M. figures within parenthesis =*
number of observations.
Conclusion
PGE2 inhibited the overflow of transmitter resulting
from RNS. Its effect was dose-dependent, although the log
dose-inhibition curve obtained was rather flat and appeared
to be approaching a maximum inhibition at 30.6%. Since it
has been observed in previous studies that the inhibitory
effect of PGE2 is reduced at higher frequencies of sympathetic
nerve stimulation (10 Hz) (Baum and Shropshire, 1971;
Junstad and Wennmalm, 1973b), the influence of frequency on
the PGE2-log dose/inhibition curve was investigated.
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Experiment 3: Influence of stimulation frequency on the
inhibitory effeet of PGE^
It has previously been shown in the rabbit heart
(Junstad and Vennmalm, 1973b) that the sympathetic
transmitter-release mechanism becomes less sensitive to
exogenous PGE2 as the frequency of stimulation is increased
from 2 to 10 Hz. In those experiments, however, the
number of pulses was not kept constant for the two fre¬
quencies but rather the length of the stimulation period,
which was 20 seconds. In the present frequency study, it
was thought preferable to keep the total number of pulses/
stimulation period constant, regardless of frequency. Thus
periods of stimulation ranged from 15-75 s. Brown and
Gillespie (1957) have shown that noradrenaline release from
the cat spleen is almost complete within 20 s of ending
sympathetic nerve stimulation (20 s at 10 or 30 Hz). It was
assumed, therefore, that measurement of transmitter overflow
for 3 min from the beginning of a 15-75 s stimulation period
would be adequate for collection of all the transmitter
resulting from RNS.
Methods
Twelve rabbit kidneys were set up for isolated perfusion
and transmitter collection precisely as in Experiment 2. The
renal nerve was stimulated at 2 Hz for 75 s or 5 Hz for 30 s,
to enable comparison of the results with those in Expt 2,
i.e. the total number of pulses was maintained at 150.
PGE2 was infused in concentrations equivalent to those
-7
in Experiment 2, 1.8 to 9J-x 10 M, for 2 min prior to and
124
also during RNs. The variation in PG infusion times
resulting from corresponding variation in stimulation
periods was assumed to be unimportant since the PGE2 concen¬
tration and the rates of infusion were kept constant for
all frequencies.
Results
The degree of inhibition of transmitter overflow
resulting from RNS (calculated as described in Experiment 1)
produced by a given dose of PGE2 was found to vary inversely
with the stimulation frequency employed. The results are
shown, together with those from Experiment 2, in Table 3c.
Figure 3c shows a plot of log dose Ep (abs) versus
percentage inhibition of transmitter overflow (ord), at the
three stimulation frequencies. The curves for the higher
frequencies, 5-10 Hz, appear to flatten off with increasing
concentration of PGEp, suggesting that the inhibition is
approaching a maximum. The curve for 2 Hz, although
approaching a maximum, does not flatten to the same degree.
Conclusion
These results suggest that an endogenous prosta-
glandin-mediated braking mechanism would operate more readily
at low than at high impulse activity.
Experiment 4: Effects of prostaglandins Ao and Foa on
transmitter overflow resulting from RNS
The previous section demonstrates that prostaglandins
Ap and F2rt nave a potentiating effect on vascular responses
of the isolated kidney to both RNS and NA. Since the degree
Table5c
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Figure 3c: Isolated, perfused rabbit kidney.
Inhibitory effect of PGE2 on tritium overflow resulting
from renal nerve stimulation (RNS), 150 pulses,
2-10 Hz. Vertical bars = mean values _+ S.E.M.
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of potentiation is similar for each type of adrenergic
stimulus, it seems probable that these prostaglandins
influence the adrenergic neuro-effector junction at a
post-junctional level. A pre-junctional action on the
transmitter release mechanism or on the re-uptake mechanism
cannot be excluded, however. These possibilities are
investigated in the present series of experiments on the
isolated rabbit kidney. »
Methods
Twenty-five rabbit kidneys were set up for isolated
perfusion with Pextran-Tyrode solution as in Section 2.
Labelling was carried out as described in this section. In
choosing a suitable stimulation frequency with which to
activate the renal nerves in these experiments, the criteria
were that it should provide reasonable vascular responses
and yet be fairly sensitive to the PGE2-braking effect. A
frequency of 5 Hz (2 ms, 7-15 V) fulfilled these requirements,
total number of pulses being maintained at 150 as in all
previous experiments. Perfusate was monitored for tritium
content, as described in Experiment 1 and, after a minimum
of two control stimulation periods, prostaglandins were
infused as previously, for 2 min prior to and also during
-7
RNS. Concentrations employed were: PGA2, 7.5 x 10 to
3 x 10~6M; ?GF2^, 10~6 to 5.7 x 10*"6M.
Results
PGA2, infused at concentrations ranging from 7.5 x
10 M to 3 x 10" M, produced a dose-dependent inhibition of
transmitter overflow resulting from RNS (Table 3d). This
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Table 3d
Percentage inhibition of transmitter overflow
to RNS (g Hz, Igo pulses) by POA-, and PGF^.
PGA2 % PGF2T ——
Concentration Inhibition Concentration Inhibition
7.5 x 10~7 12.2 + 5.1
(p < 0.05)
10~6 10.9 + 3.6
(p < 0.05)
1.5 x 1CT6 26.6 + 3.2
(p < 0.005)
1.4 x 10"° 22.5 + 4.1
(p < 0.01)










Mean values +. S.E.M. Significance according to
Student's t-test for paired variates.
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Figure 3d: Isolated, perfused rabbit kidneys. Effect
of prostaglandins A2, E2 and F2a on overflow of
tritiated noradrenaline (^H-NA) resulting from renal























was a surprising observation in view of the simultaneous
potentiation of vascular responses (Fig. 2d). The effects
of PGF~ on transmitter overflow were comparable to those of
PGA2. There was a dose-dependent inhibition of transmitter
overflow (Table 3d), accompanied by a concomitant potentiation
of vascular responses to RNS.
Figure 3d shows the log dose/inhibition curves for A2
and F2^ with that of E2 included for comparison.
Conclusion
It is apparent from these experiments that transmitter
overflow resulting from RNS is dose-dependently and
reversibly inhibited by both PGA2 and PGF^. Their potency
is, however, only about one-tenth of that of PGE2, on an
equimolar basis (Fig. 3d).
Discussion
(i) Transmitter labelling
It is generally found that tissues and organs in
which the concentration of endogenous catecholamines is
high are also those which show the highest degree of uptake
of tritiated catecholamines. The kidney is capable of
binding catecholamines (Axelrod, Weil-Malherbe and Tomchick,
1959; Inouye and Tanaka, 1964) and preferentially nor¬
adrenaline (demonstrated with ^H-NA; Whitby, Axelrod and
Weil-Malherbe, 1961). This preference for binding of -%-NA
is useful for transmitter studies over long periods of time
since the organ is capable of taking up a large amount of
^H-NA. The uptake is selectively into sympathetic nerve
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endings since chronic denervation of sympathetically-
innervated structures decreases their ability to take up
administered ^H-NA (Hertting, Axelrod, Kopin and Whitby,
1961).
x
The radioactivity emanating from H-NA-labelled
organs, either spontaneously or as a result of NS, may be
x
separated by cation exchange chromatography into H-NA and
its metabolites (Stjarne and Lishajko, 1966). The major
metabolites are the 3-0-methylated product, normetanephrine
X
and the deaminated or 'acid metabolites', •>H-3-methoxy-4-
hydroxymandelic acid (VMA) and ^H-3»4~dihydroxymandelic
acid (DHMA).
The results of cation-exchange chromatography of
perfusate samples from experiments in this section showed
x
that output of intact ^H-NA increased considerably from
l4.4ro to 81.3% of the total radioactivity during RNS. In
contrast, the acid metabolite content of the perfusate
decreased from 74.4% to 16.0% during RNS. Normetanephrine
content also decreased from 10.0% to 1.3%» These results
are in good agreement with those obtained by Hedqvist,
Oliverio and Stjarne (1968) in the dog spleen, where ^H-NA
accounted for more than 80% of the radioactivity during NS
and less than 10% during resting periods. In other tissues
such as adipose tissue (Fredholm and Hedqvist, 1973), skeletal
muscle (Rosell et al., 1963), the cat spleen (Hertting and
Axelrod, 1961) and the cat nictitating membrane (Langer,
"Z
1970), an increase in .H-NA overflow was observed during
nerve or field stimulation, although it made up only 35-50%
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of the total radioactivity. In the last two studies
there was also an increase in the normetanephrine content
of the radioactivity. This indicates that there was
high catechol-G-methyl transferase (COMT) activity,
3 3
degrading the intact H-NA. The escape of H-NA from
renal COMT activity in the present experiments may be
explicable by the constant-flow perfusion which would
•*
enable an effective washout of any "h-NA overflowing,
hence reducing its availability for degradation.
(ii) Presynaptic effect of PGE
The present experiments clearly demonstrate that
PGE2 inhibits adrenergic transmitter release from renal
nerve endings. Prior to this study, the presynaptic
actions of PGE's in adrenergic transmission have been
investigated largely outwith the kidney, in the cat
spleen, guinea-pig vas deferens, rabbit heart and in
canine subcutaneous adipose tissue.
In early experiments on the isolated cat spleen
(iiedqvist, 1970b), the technique of transmitter
labelling was employed, allowing measurement of
perfusate radioactivity prior to and during splenic
nerve stimulation. The radioactivity was not split
into intact "N-NA and its metabolites but instead
a parallel fluorimetric determination of perfusate
NA content was carried out, as described by von Euler
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and Lishajko, 1961. PGE2 (6 x 10~a to 6 x 10~6M) caused
a closely parallel reduction in the overflow of radio¬
activity and fluorimetrically-determined NA resulting from
splenic nerve stimulation, indicating that the metabolic
degradation of NA was not apparently altered. This is in
agreement with present results in the kidney where, although
the -Ti-NA overflow in the perfusate decreased during PGB2
administration, so did the overflow of metabolites, such
3
that the distribution of -T3-NA and its metabolites on a
percentage basis was not altered. The uptake of exo¬
genous NA by the spleen and thus probably also re-uptake of
endogenously released NA, was not affected by PGE2, which
suggested that its inhibitory effect was not the result of
facilitated re-uptake of released NA. Hedqvist concluded
that PGE2 actually depressed the release of NA from the
nerve terminals. The highest concentration produced as
much as 80$ Inhibition of NA overflow resulting from NS and
this effect was antagonised by increasing the calcium
concentration of the perfusate. Thus it was postulated that
PGE2 might act by immobilising the calcium which is required
for adrenergic transmitter release (Hedqvist, 1970c).
The effect of PGE^ on adrenergic transmitter overflow
from the isolated cat spleen during NS was less well-defined.
Concentrations of 3*3 x 10""® to 3.8 x 10~"®M were found to
inhibit overflow in 4 out of 10 experiments, whilst having
no effect in the other 6 experiments (Hedqvist and Brundin,
1969). was utilised in the present experiments
since only the 2-series of prostaglandin types have been
conclusively identified in renal venous effluent or in renal
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horaogenates.
When PGE2 was added to the superfusion fluid of the
isolated guinea-pig vas deferens in concentrations as low
—Q —8
as 3 x 10 7 to 3 x 10 M, overflow of VH-NA in response to
field stimulation was reversibly and dose-dependently
inhibited (Hedqvist, 1974b). This inhibitory effect of
PGE2 was similarly observed in present kidney experiments
although at considerably higher concentrations (10-100 fold).
The requirement of such high doses is probably explained by
the high capacity of the renal cortex for enzymatic
degradation of prostaglandins by the enzyme 15-hydroxy
prostaglandin dehydrogenase. Intra-arterial administration
of prostaglandin to the kidney does not mimic the in vivo
situation with the result that penetration to the main site
of action may prove difficult. In the vas deferens, on
the other hand, penetration difficulties are minimal. PGE^
in similar concentrations produced closely similar effects
on the vas deferens to those of PGE2 (Hedqvist, 1973a), thus
showing a more conclusively presynaptic effect in this
preparation than was observed in the cat spleen. As in the
spleen, the inhibitory effect of each prostaglandin was
antagonised by increasing the external calcium concentration.
In addition, it was demonstrated by StjSrne (1973a) that the
secretion of NA becomes very sensitive to the inhibitory
effect of PGE2 at low calcium (0.55 to 1.10 raM). It was
suggested that PGE2 may act by depressing the affinity of
the secretory mechanism for calcium ions and that this action
becomes progressively stronger with falling calcium concen¬
tration (StjSrne, 1973c).
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An inhibitory effect of PGEo on adrenergic trans¬
mitter release has been further confirmed in the isolated
rabbit heart (Langendorff preparation), where concentrations
—Q —6
of 3 X 10 7 to 1.5 x 10 H markedly reduced the overflow of
NA (fluorimetrically determined) and distinctly counteracted
the increase in heart rate to sympathetic nerve stimulation
(Hedqvist, StjSrne and Wennmalm, 1970; Hedqvist and Wennmalm,
1971). In this preparation PGE-^ showed similar inhibitory
effects at the above dose levels (Wennmalm and Hedqvist,
1971; Hedqvist and Wennmalm, 1971).
The experimental results in this section support the
hypothesis that ?GE2 is involved in the control of adrenergic
neurosecretion. Since this evidence is backed up by results
in several other tissues and by the release of prostaglandins
observed in experiments of Section 1, it is tempting to infer
that the prostaglandin-feedback mechanism exists as a
general phenomenon in all adrenergic neurosecretory processes.
This inference is impeded, unfortunately, by an exception to
the rule. Although PG's and produce a dose-dependent
inhibition of lipolysis induced by sympathetic NS in canine
subcutaneous adipose tissue (Fredholm and Rosell, 1970), and
PGE's are released from white adipose tissue during
stimulation of lipolysis in the rat (Shaw and Ramwell, 1968;
Christ and Nugteren, 1970), the effect of PGE2 on transmitter
overflow in response to sympathetic NS is variable. PGE2
seems to inhibit lipolysis without markedly affecting
adrenergic transmitter release, suggesting that it acts
predominantly at a post-junctional level (Fredholm and
Hedqvist, 1973). This is further documented by the fact
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that PGE-^ inhibits the lipolytic action of noradrenaline
and adrenaline (Steinberg, Vaughan, I.estel and Bergstrbm,
1963).
(iii) The effect of frequency on the PG mechanism
In studies of the isolated rabbit heart (Hedqvist,
Stjarae and Wenrunalm, 1970), the overflow of NA resulting
from stimulation of the sympathetic nerves at frequencies
of 1, 5 and 10 Hz was determined fluorimetrically. Measurable
quantities of HA were obtained only at frequencies of 5
and 10 Hz. PGE2 x caused a marked reduction in
the overflow at both frequencies although there was a greater
percentage decrease in NA at the lower frequency of 5 Hz.
This is not surprising since the rate of release of HA is
considerably less at the lower frequency and might conceivably
require less PG to restrict its release by say 50%, than
would be required to restrict release at 10 Hz by 50%. The
results were based upon the use of only one dose-level of
PGE2, however, which limits extrapolation of such a theory.
The experiments in this section do show, however, that the
transmitter release mechanism becomes less sensitive to in¬
creasing doses of PGE2 as the frequency of RNS is increased
from 2 to 10 Hz. A decrease in sensitivity of the sympa¬
thetic transmitter release mechanism to PGE2 with increasing
frequency has also been demonstrated in the rabbit heart
(Junstad and Vennmalm, 1973b).
Prostaglandins E-, and E2 have been shown to reduce
responses of the transmurally-stimulated guinea-pig vas
deferens whilst potentiating responses of the organ to
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exogenous NA (Baum and Shropshire, 1971). This pointed
to a presynaptic site of action in the stimulated organ
and the magnitude of inhibition was found to be
inversely related to the stimulation frequency employed
(5, 10 or 20 Hz). In these experiments the period of
stimulation (2 s) rather than the total number of
pulses was kept constant. The degree of inhibition of
adrenergic transmitter release from the kidney during
RNS was found to vary inversely with the frequency of
stimulation employed. A comparison of the log dose/
inhibition curves for the three stimulation frequencies
has shown that the sensitivity of the release mechanism
to PGE2 apparently decreases as the frequency increases.
borne workers have concluded that the length of the
impulse train rather than the frequency of stimulation
determines the inhibitory effect of PGs in adrenergic
neurotransmission. In the isolated guinea-pig vas
deferens, PGE2 (2.3 to 5 ng/ml) lias been shown to
inhibit contractions elicited by field stimulation whilst
potentiating contractile responses to NA (Ambache and
2ar, 1970, 1971). In agreement with Baum and Shropshire
(1971) this indicated that the inhibitory effect was
probably prejunctional. This effect was greater when
trains of 5 to 10 pulses were applied to the preparation
at 50 Hz, than when 50 pulses were applied at 50 Hz. This
is not entirely une:>qpected since the longer pulse train at
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such a high frequency presumably causes a considerably
higher release of NA than does the short train and probably
requires a greater concentration of PG to control this
release. The use of such an unphysiological high stimu¬
lation frequency unfortunately sheds doubt on the interpre¬
tation of these results. They do gain support, however,
from experiments carried out by other workers (Ill£s,
Hadhazy, Torma, Vizi and Knoll, 1973) on the isolated guinea-
pig vas deferens and atria and the rabbit Jejunum. These
workers found that the higher the number of pulses applied
at a given frequency, the smaller the inhibition by PGE-^ of
neuroeffector transmission. PGE^ also produced a frequency-
dependent inhibition of sympathetic NS in the rabbit
jejunum (3-15 Hz).
In conclusion, it would appear that the inhibitory
effect of prostaglandins E1 and E2 on adrenergic neuro¬
transmission is dependent upon both the frequency of nerve
or field stimulation and the total number of pulses applied.
The reduction in this effect at higher frequencies or higher
pulse number may result from (a) a reduction in the sensiti¬
vity of the release mechanism (b) an insufficient release of
PG relative to NA (c) a combination of (a) and (b)
(Junstad and Wennraalm, 1973b). Mechanism (a) seems probable
in view of the present results and also those of Baum and
Shropshire (1971). With reference to mechanism (b), the
release of endogenous prostaglandin during sympathetic nerve
stimulation of the dog kidney and the rabbit heart shows no
apparent linear correlation with either the frequency or
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the transmitter overflow (Dunham and Zimmerman, 1970;
Junstad and \«ennaalm, 1973b). Thus an increase in stimu¬
lation frequency from 2 to 10 Hz only approximately doubled
the efflux of prostaglandin E2~like material per unit time
whilst the transmitter overflow increased tenfold. It
would seem, therefore, that the endogenous transmitter
braking-mechanism is limited by both (a) and (b), leading
to suggested mechanism (c).
(iv) Presynaptic effects of prostaglandins Ag and
There are numerous reports in the literature regarding
the influence of PGs A2 and F2^ on vascular or contractile
responses to sympathetic stimuli (see Discussion, lection 2),
although virtually none has described the presynaptic effects
of these prostaglandins on adrenergic transmitter release.
As a result of the potentiating effects of PGF2r[ on most
adrenergic systems (see Brody and Kadowitz, 1974, for
references), it has been suggested that it probably facili¬
tates the release of noradrenaline from nerve endings. The
present results have shown that PGF2rf does not potentiate
transmitter overflow from the kidney in spite of its
apparent potentiation of vascular responses to RN5. In
addition, ten times as much PGF2a was required to produce
overflow inhibition as was required of PGE2• Hedqvist and
Vennmalm (1971) demonstrated that FGF2 was ineffective in
producing inhibition of transmitter overflow from the
rabbit heart in response to sympathetic NS when compared
with identical doses of PGE2» Malik and McGiff (1975)
have shown that the vasoconstrictor effect of PGF2fT in the
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rat and rabbit kidney is not due to release of catechol¬
amines from sympathetic fibres since chemical sympathectomy
did not alter these vasoconstrictor actions. It may be,
therefore, that an effect on transmitter release can be
induced by sufficiently high concentrations of PGF2f?, although
its primary effect, as evidenced by consistently potentiated
vascular responses, is not presynaptic but rather at the
postjunctional effector cell.
The requirement of high doses of PGA2 in the present
experiments to inhibit transmitter overflow is probably also
an indication that its primary site of action is postjunctional.
There have been no other transmitter studies reported to
date but many experiments, unlike the present results, have
shown a direct vasodilator action of PGA-^ and PGA2 as well
as an ability to reduce vascular responsiveness to NA and
nervous stimulation (Horton and Jones, 1969; Kadowitz et al.,
1971c; Malik and McGiff, 1975). Only in the rat kidney has
PGA2 been shown to constrict the vascular bed and facilitate
adrenergic responses (Malik and McGiff, 1975). Although
the presynaptic inhibition of NA release in the present
experiments by PGA2 is in accordance with its vasodilator
action in the rabbit kidney, as demonstrated by these last
authors, the induction of such an effect requires a high
concentration of PGA2 (10 times that of PGE2).
It is concluded that, unlike PGE2, PGs A2 and F2q(
exert their influence on adrenergic neurotransmission
primarily at a postjunctional level.
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SECTION 4
The effect on adrenergic neurotransmission of altering
endogenous prostaglandin synthesis In the kidney
Experiments in the previous two sections have demon¬
strated that intra-arterial administration of prostaglandins
to the kidney produces profound effects on the renal
vasculature and on its responsiveness to adrenergic stimuli.
In various attempts to assess the importance of endogenous
prostaglandins in autoregulatory function and control of
blood flow distribution in the kidney, the technique of
reducing or abolishing endogenous prostaglandin biosynthesis
has been employed (Herbaczynska-Cedro and Vane, 1973;
Itskovitz, Terragno and McGiff, 1974; Needleman, Marshall
and Johnson, 1974b). This method of study affords several
advantages over that of exogenous prostaglandin administration
(see introduction to Part 4a) but has the disadvantage of
producing inhibition of all prostaglandin synthesis rather
than inhibition of a particular prostaglandin. An alternative
method of altering endogenous synthesis is to stimulate
prostaglandin synthesis by administration of precursor acid
(see introduction to Part 4b for references). In this way
the type of prostaglandin formed is predetermined according
to which precursor acid is used.
This section explores the use of both techniques.
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Part 4a: Inhibition of endogenous prostaglandin synthesis
in the kidney and subsequent effects on
adrenergic neurotransmission
The discovery by Vane and his colleagues (Vane,
1971; Ferreira, Moncada and Vane, 1971; Smith and Willis,
1971), that aspirin-like drugs reversibly inhibit or abolish
prostaglandin biosynthesis, has provided workers in the
field of prostaglandin research with an invaluable pharma¬
cological tool. In assessing the possible physiological
role of a naturally occurring body substance, it is clearly
advantageous to be able to examine the effect on body
function of eliminating that substance. The following
experiments were designed in the hope of strengthening the
hypothesis that endogenous prostaglandins have a role in
the control of adrenergic transmitter release. The two
non-steroidal anti-inflammatory compounds, indomethacin and
meclofenamate have been found to be even more potent than
aspirin in their ability to inhibit prostaglandin bio¬
synthesis (Flower, Gryglewski, Herbaczynska-Cedro and Vane,
1972). For this reason they were used in preference to
aspirin in the present experiments.
Experiment 1: Effects of indomethacin and sodium meclo¬
fenamate on adrenergic neurotransmission in the isolated
rabbit kidney
Methods
Experiments were performed on eighteen isolated
kidneys which were dissected and set up for perfusion with
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lextran-Tyrode solution as described in Lection 2.
Transmitter stores were labelled by infusion of 25 uCi
x
*ui-NA and transmitter overflow was monitored by 1 min
fractionation of the perfusate for radioactive counting,
as described in detail in Section 3. The renal nerve was
placed on platinium electrodes and stimulated with a
Grass S5 stimulator delivering 30 s trains of pulses (5 Hz,
2 ms, 7-15 V).
Solutions of indomethacin (Merck, Sharpe and Bohrae) and
sodium meclofenaraate (Parke Davies) were made up freshly
immediately prior to use. Each solution was made up by
dissolving about 10 mg drug in approximately 0.5 ml pure
ethanol.
Solubility was maintained by adjusting the pH to 8 using
0.2 ml pHQ Tris buffer before final dilution with 0.9%
saline to a concentration of 1 mg/ml.
Vascular responses to nerve stimulation were obtained by
stimulating the renal nerve as above for 30 second periods
at 10 min intervals. Vascular responses to exogenous
noradrenaline were obtained by infusion over 30 seconds
of a suitable dose of noradrenaline, usually 0.25 - 1.0 pg
total.
Results a) Indomethacin
Infusion of indomethacin at a concentration of 4.4 x
—5
10 M into the isolated kidney sometimes caused a slight
increase in the resting perfusion pressure (up to 5 mm Hg)
and either no effect or a slight decrease in the pressor
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responses resulting from RNS. The slight inhibitory effect
on effector responses to RNS did not reflect a corresponding
decrease in transmitter overflow, however. On the
contrary, the overflow of tritium during RNS increased
significantly about 8 mln after the start of an infusion of
indonethacin and plateaued after about 15 min of infusion.
3
The average increase of H-NA overflow in response to RNS
was 41.5 +, 7% (Mean ± S.E.M.) in thirteen experiments. This
value was significant at the p < 0.001 level, according to
Student's t-test for paired variates. After ending the
infusion, the transmitter overflow fell off approaching the
pre-infusion level within ten to twenty minutes (Fig. 4a).
However, in some experiments the transmitter overflow remained
at a slightly elevated level throughout post-infusion
controls. Indomethacin did not affect resting transmitter
overflow (Fig. 4a).
In view of its potentiating effect on transmitter
overflow, the effect of indomethacin on pressor responses
to FINS was surprising. In order to investivate whether
this Inhibitory effect was primarily postjunctional, the
effect of indomethacin on pressor responses to NA was
examined. Infusion of indomethacin as above also produced
inhibition of pressor responses to NA (Fig. 4b) thus con¬
firming a postjunctional site of action.
Results b) Sodium meclofenamate
In three experiments, sodium meclofenaraate was infused
in place of indomethacin, also at a concentration of 5 x
—5
10 ■'M. Its effect on resting perfusion pressure was
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Figure 4a: Isolated, perfused rabbit kidney. Effect
of indomethacin on tritium overflow (%-overflow)
resulting from renal nerve stimulation (NS).
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Figure 4b: Isolated, perfused rabbit kidney. Effect
of indomethacin on vascular responses to renal nerve









negligible althougn it caused a slight inhibition of
effector responses to RNS. Its effect on transmitter
overflow was qualitatively similar to that of indomethacin.
It did not affect resting transmitter overflow but increased
overflow resulting from RNS. The average increase was
23.3 + 3*5:^ which was significant at the p < 0.05 level
according to student's t-test for paired variates. This
drug, therefore, was less potent than indo¬
methacin on an equimolar basis.
Conclusion
It may be concluded from these experiments that
prostaglandin synthesis inhibitors induce a marked elevation
of transmitter release from adrenergic nerve endings in the
kidney. This observation is to be expected if an
endogenous braking-mechanism has been partially or wholly
removed. The evidence, therefore, supports the view that
endogenous prostaglandins do exert a negative-feedback
control over adrenergic transmitter release. The question
now arises as to whether the potency of exogenous PGE as an
inhibitor of transmitter release is increased when the
competition of endogenous prostaglandin is removed by
synthesis inhibition. The following experiment was per¬
formed to examine the phenomenon of "endogenous PG" versus
"exogenous PGr" in the control of transmitter release.
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Experiment 2: Effect of PGEo on transmitter overflow in
the presence of indoznethacin
methods
This experiment was performed on three isolated
Dexrtran-Tyrode perfused kidneys. The renal nerve was
stimulated using parameters identical to those in Experiment 1
(5 Hz, 2 ms, 7-15 V for 30 s) at 10 min intervals, the
kidney having been labelled with 25 pCi H-NA. The per¬
fusate was fractionated as in Experiment 1 for radioactive
counting. After three control stimulation periods, indo-
methacin was infused as previously at a concentration of
—5
4.4 x 10 Mm Two stimulation periods were carried out
with indomethacin alone, thus allowing a plateau of its
activity to be reached. PGE2 was then infused at a concen-
_7
tration of 4.5 x 10 M for two minutes prior to and until
the end of the next stimulation period. At the end of this
stimulation period, infusion of both indomethacin and PGE2
was ended. Two or three further post-test control stimu¬
lations were collected.
Results
During indomethacin treatment, as described in
methods, transmitter overflow increased to a plateau level
before infusion of PGE2. PGE2, infused during indomethacin
treatment, was still effective in producing an inhibition
of %-NA overflow in response to FINS. The average inhibition
_7
produced by a concentration of 4.5 x 10 M PGE2 was 61.3 +,
4.b?6 (mean S.E.M., n = 3). This mean value was found to
be significantly greater (p < 0.02) than the inhibition of
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39.6 +_ 4*5% (n = 5) produced by PGE2 of the same concen¬
tration in the absence of indomethacin, according to the
Student's t-test for unpaired variates (See Table 4).
Conclusion
The primary effect of indomethacin, to increase the
transmitter overflow resulting from RNS, was again
observed in these experiments. Moreover, a given dose of
PGE2 showed an increased ability to inhibit transmitter
overflow during indomethacin treatment. This increased
potency of exogenous PGE2 may be attributable to removal of
a local braking mechanism, assuming that administered PGE2
normally has to compete with endogenous PG for active sites
in the nerve terminal.
Discussion
In view of the cumulative evidence in the previous
sections suggesting that PGE2 is the major intrarenal
prostaglandin (see also General Introduction), abolition of
prostaglandin synthesis by indomethacin or meclofenamate
would be expected to produce intrarenal effects opposite to
those incurred by PGE2 administration. These drugs might
be expected, therefore, to
i) increase basal renal vascular resistance
ii) increase responsiveness of renal vasculature to
circulating and locally-formed NA.
iii) increase the release of NA from adrenergic nerve
terminals.
The results obtained in this section are discussed
with reference to each of the above proposed modes of action.
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(i) Effect on basal renal vascular resistance
The use of the isolated kidney preparation afforded
the opportunity of examining the direct action of indo-
methacin on renal vasculature, since the possible inter¬
vention of systemic reflexes and/or circulating catechol¬
amines was eliminated.
If endogenous prostaglandins are responsible for
maintenance of resting renal blood flow, in part,by a direct
vasodilator action on renal vasculature, their removal
would be expected to result in an increased vascular
resistance and a resultant reduction in renal blood flow
through the isolated organ. In the current experiments,
indomethacin infusion (15.6 Mg/ml) did produce a slight
increase (ca. 5 mm Hg) in resting perfusion pressure, thus
reflecting an increase in vascular resistance, flow being
kept constant. Further evidence in support of mode of
action (i) has been provided by Malik and McGiff (1975),
also in the isolated rabbit kidney. These workers found
that doses of indomethacin from 0.1 - 1.0 pg/ml had no
effect on resting perfusion pressure whilst 5 Mg/ml caused
an increase in perfusion pressure of about 5.5 mm Pig.
Similarly, Lonigro, Itskovitz, Crowshaw and McGiff (1973b)
showed that application of indomethacin or meclofenamate
(concentrations not stated) to the blood-perfused isolated
dog kidney decreased the basal concentration of PGE-like
substance in the renal venous blood and caused a reduction
in renal blood flow in face of constant perfusion pressure.
This was confirmed by them in the in situ dog kidney. They
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carried out a parallel study on femoral blood flow and
showed that it was variably and insignificantly affected by
indomethacin or meclofenamate, suggesting some selectivity
of action of these drugs in different vascular beds.
Selectivity is further indicated by the results of Fredholm
and Hedqvist (1975) who have shown that indomethacin (5 ug/
ml) has no effect on blood flow through perfused canine
subcutaneous adipose tissue, in situ. Ferreira, Moncada
and Vane (1973) express some doubt as to the validity of
isolated organ studies, as they demonstrated in the isolated
spleen that indomethacin caused an increase in resting per¬
fusion pressure only after 2-3 hours of perfusion. (There
was usually an increase in basal output of prostaglandins at
this time in the absence of indomethacin.) If indomethacin
was infused in concentrations ranging from 0.3-5 Mg/cil
about 30-60 min from the start of the perfusion, no such
increase in basal perfusion pressure was observed. The
increased basal output of prostaglandins after 2-3 hours may
be attributable to tissue damage, a condition which is known
to release prostaglandins (Piper and Vane, 1971). The
experiments described in this section did not include
analysis of perfusate prostaglandin content but since kidneys
were perfused for more than an hour before indomethacin was
infused, the basal output may have been higher than normal.
An apparently selective action of indomethacin on inner
cortical vasculature has been observed, however, in the
isolated dog kidney by Itskovitz et al. (1974), where the
effect of prostaglandin on the distribution of renal blood
152
flow was examined. A bolus injection of 2-5 nig indo-
methacin into the blood-perfused isolated canine kidney-
not only reduced total renal blood flow but, in particular,
reduced inner cortical flow. Interestingly, infusion of
PGE2 up to a blood concentration of 2 pg/ml did not overcome
the reduction in renal blood flow induced by indomethacin.
The effect of indomethacin was reduced by 54?'o, however.
The most important observation was that the remaining effect
of indornethacin was accounted for almost entirely by a
decrease in the inner cortical component of blood flow.
Since PGE2 has been shown by Larsson and Anggard (1974) to
increase juxtamedullary or inner cortical blood flow,
indomethacin's action seems to result specifically from a
block in prostaglandin synthesis. The inability of PGE2
to reverse the effect of indomethacin completely in the
e>q?eriments of Itskovitz et al. (1974) is possibly attri¬
butable to its partial degradation in the renal cortex en
route before reaching its endogenous site of action.
In view of the various results discussed so far, it
seems probable that the action of indomethacin on basal
vascular resistance is dependent upon the degree of direct
control by prostaglandin at that time. Although a non-
prostaglandin-mediated action of indomethacin may exist in
the kidney, present results and the work of Itskovitz et al.
(1974) infer that indomethacin produces its vasoconstrictor
effect on renal vasculature by inhibiting prostaglandin
synthesis.
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(ii) Effect on vascular responsiveness to circulating and
locally-formed NA
If an inhibitory effect on vascular responsiveness to
catecholamines constitutes a part of the action of endogenous
prostaglandins in the kidney, inhibition of their synthesis
would be expected to augment the vasoconstrictor action of
catecholamines. The results in this section showed slight
augmentation of responses to RNS at a concentration of
1.8 x lCf^M indomethacin, but at a concentration of 4.4 x
-5 -5
10 and 5 x 10 M respectively, both indomethacin and
«
meclofenamate depressed vasoconstrictor responses to RNS
and NA. Malik and McGiff (1975), in a similar study of the
rabbit kidney, showed that indomethacin or meclofenaraate at
concentrations from 0.1 - 1.0 ug/ml augmented vasoconstrictor
responses to RNS but had no effect on equiconstrictor
responses to NA. This suggested a primary prejunctional
role for endogenous prostaglandin in the kidney. Needleman
et al. (1974b) on the other hand showed potentiation of
responses to both RNS and NA in the isolated rat kidney by
2.5 Mg/ml indomethacin. These results are in direct conflict
with those obtained by Malik and McGiff (1974, 1975) in the
isolated rat kidney, where they found that 1 Mg/ml indo¬
methacin or meclofenamate reduced to a similar degree the
vasoconstrictor responses to RNS and NA. The last authors
used Tyrode perfusion at 6 ml/min whilst Needleman et al.
used Krebs at 4 ml/min, but such differences are unlikely to
account for the discrepancy in results. The stimulation
frequencies employed varied from 2 Hz (Malik and McGiff) to
3-6 Hz (Needleman et al.). Although small, these differences
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may be important in view of the frequency-dependent effects
of indomethacin described later in this discussion. Malik
and McGiff have even suggested that the rat kidney is un¬
suitable for the study of prostaglandins as antihypertensive
agents, since PGE2 and PGA2 nay be prohypertensive there.
To compare, therefore, only the results obtained with the
rabbit kidney, the discrepancy between present results and
those of Malik and McGiff is almost certainly attributable
to the difference in the dose levels of indomethacin utilised.
Aiken and Vane (1973) provide supportive evidence for
the hypothesis that intrarenal PGE2 generation attenuates
increases in vascular resistance in the dog kidney. They
found that indomethacin, 0.1-2 mg/Kg, or meclofenamate,
1 mg/Kg, given intravenously, augmented renal vasoconstrictor
responses to NA.
Some interesting experiments have been conducted on
isolated blood vessel preparations. Gryglewski and Korbut
(1975) have demonstrated that application of indomethacin,
3 pg/ml, to the perfused rabbit ear artery did not potentiate
vasoconstrictor responses to NA but did effect an increased
tolerance to NA. Ee la Lande, Hall, Kennedy and Higgins
(1975) also examined the effect of indomethacin (3 Mg/ral) on
responses of the rabbit ear artery, this time to NS. They
found that it did not enhance responses to NS as would have
been expected if PGE2 were released physiologically during
stimulation to depress the responses. Jackson and Hall
(1973), on the other hand, found that aspirin, 200 Mg/ml did
potentiate responses to the rabbit ear artery to intraluminal
NA and to electrical stimulation. Cocaine partially
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inhibited these effects of aspirin and it is suggested that
the latter may act by a similar extraneuronal mechanism to
cocaine, preventing reuptake of MA. This seems feasible
since if aspirin's only action were to prevent the braking
effect of PGE2 on transmitter release, one would expect
cocaine to potentiate its action by preventing the reuptake
of the already-elevated transmitter released into the
synaptic cleft, hence producing a further augmentation of
the response to NS. Caution must be exercised, however, in
interpreting the results of experiments in which such high
dose-levels were employed. Certain effects of the aspirin
may have been non-specific.
The importance of species in the study of prosta-
glandin-indomethacin-catecholamine interactions is further
highlighted by a recent study in the isolated rat arteriole
(Horrobin, Manku, Karmali, Nassar and Tavies, 1974). These
workers showed that aspirin, 5-20 pg/ml, or indomethacin,
5 Mg/ml, could reversibly depress the responsiveness of the
arteriole to NA. Furthermore, PGE2 at a concentration of
1 pg/ml restored responsiveness of the arteriole to NA. The
depression by aspirin or indomethacin of vascular responsive¬
ness was not specific to alpha receptors, however, but also
occurred when vasoconstriction was induced with angiotensin
and vasopressin. This points to a more generalised action
of indomethacin, perhaps on excitation-contraction coupling.
The observations nevertheless suggest that the effect
results from a block in prostaglandin synthesis.
Greenberg (1974, 1975) has investigated the possibility
that stimulus frequency and train length may influence the
action of indomethacin on vasoconstrictor responses of the
rabbit portal vein to electrical stimulation. He dis¬
covered that indomethacin (10 ug/ml) caused significant
potentiation of responses to 2 Hz field stimulation at all
train lengths, but significantly reduced the response to
5 Hz at all train lengths. Inhibition of noradrenaline
synthesis with a-methyl-p-tyrosine abolished indomethacin's
potentiating effect. It is suggested that the noradrenaline
released at low frequencies is newly synthesised and that
its release is controlled by endogenous prostaglandins.
These results are in accordance with the frequency study
described in Section 3, where PGE2 produced its greatest
inhibitory effect on transmitter overflow at the lowest
frequency of 2 Hz. Greenberg does not proffer any explana¬
tion of the inhibitory effect of indomethacin observed at a
frequency of 5 Hz. It would be interesting to observe
whether in this preparation, as in that used by Malik and
McGiff, a dose of less than 5 Mg/ml indomethacin would
produce a potentiating rather than an inhibitory effect on
NS responses.
In conclusion, it seems that the effects of indo¬
methacin on vascular responsiveness are variable according
to the dose-level utilised, the animal species and, for
effects on responses to electrical stimulation, the frequency
of stimulation.
(iii) Effect on transmitter release from adrenergic nerve
terminals
There have been relatively few studies to date in which
the action of the anti-inflammatory drugs on sympathetic
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transmitter release has been examined. Junstad and
Wennmalra (1972) demonstrated an increase in renal excretion
of NA in rats after treatment with indomethacin (0.5 - 2.0
rag/Kg). Since the renal excretion of NA apparently
reflects the release of transmitter from adrenergic nerves
(Leduc, 1961; StjSrne, 1971), these results provide sub¬
stantial evidence in favour of prostaglandin-mediated
control of adrenergic transmitter release. In further
studies with indomethacin, Chanh, Junstad and Wennmalm (1972)
found that, in doses of ca. 16 ng/ml, it inhibited outflow
of prostaglandin and increased the release of NA from the
isolated rabbit heart during sympathetic NS. Indomethacin
did not alter the release of NA during resting periods,
however, nor did it affect reuptake of exogenous NA. The
authors concluded that indomethacin causes 'dis-inhibition'
of NA release. Fredholm and Hedqvist (1973a) have confirmed
this effect in the transmurally-stimulated guinea pig vas
deferens. They showed that indomethacin (2-10 pg/ml) did
not affect resting radioactive transmitter efflux but did
3
increase the overflow of H-NA in response to transmural
stimulation. The duration of the effect was similar to
that described in this section on the isolated kidney. The
same authors (1975) have demonstrated that indomethacin
(5 Mg/ml blood) was without effect on H-NA overflow before,
during and after NS at 4 Hz in perfused canine subcutaneous
adipose tissue. This was in agreement with their previous
findings (1973) that PGE2 had no consistent effects on vaso-
3
constriction or H-NA overflow induced by NS in that bed.
The lack of effect of indomethacin on blood flow, lipolysis
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3
or H-NA overflow throughout NS induced the conclusion that
endogenous prostaglandins are of minor importance as feed¬
back inhibitors of lipolysis in adipose tissue. These
workers emphasise, however, that conclusions as to the
role of endogenous prostaglandins in tissues cannot be .drawn
solely from results obtained by inhibition of synthesis
using the anti-inflammatory drugs. Indomethacin, for
example, does produce some biological effects which are
quite unrelated to inhibition of prostaglandin synthesis
(Fredholm and Hedqvist, 1975). The effect of indomethacin
on adrenergic transmitter release in this section, however,
does apparently relate to an inhibition of endogenous
prostaglandin synthesis, since PGE2 is capable of opposing
and overcoming that effect.
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Part 4b: Stimulation of endogenous prostaglandin synthesis
in the kidney and subsequent effects on
adrenergic neurotransmission
It is now well-established that prostaglandins are
not synthesised and stored in tissues prior to their
release (Ramwell et al.. 1966; Davies et al., 1968; Piper
and Vane, 1971). Synthesis occurs spontaneously in
response to various stimuli (see Introduction) and is
followed by an immediate release of the newly-formed prosta¬
glandin. In addition, prostaglandins of the E and F series
are rapidly metabolised on circulation through the lungs
(Ferreira and Vane, 1967; Vane, 1969). It has been con¬
cluded by Vane (1969) that this is an efficient mechanism
by which prostaglandins are prevented from reaching the
arterial circulation. These observations indicate that
prostaglandins are probably not circulating hormones, with
the possible exception of PGA2, which has been shown to
escape degradation by the lungs (Horton and Jones, 1969;
McGiff et al., 1969). They are rather formed and act
locally. It may, therefore, be regarded as unphysiological
to investigate the effects of prostaglandins on an organ
by intraarterial administration. Furthermore, the prosta¬
glandin may not reach its main site of action as a result
of metabolism en route. This is particularly relevant in
the kidney which possesses a high amount of the prostaglandin-
degrading enzyme, prostaglandin dehydrogenase, in its
cortex (Larsson and Xngglrd, 1973a). Thus a more physio¬
logical approach to the study of endogenous prostaglandin
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function would seem to be local stimulation of prosta¬
glandin synthesis. It has been shown that the rate-limiting
factor in the synthesis of prostaglandins is the availability
of precursor acid (Samuelsson, 1970). Consequently, the
synthesis of endogenous prostaglandin may be increased or
"stimulated" by administration of exogenous precursor
(Larsson and Knggard, 1973b, 1974).
Experiment 1: Stimulation of endogenous PG synthesis in the
Isolated kidney using the precursor, arachidonlc acid and
subsequent effects of this on adrenergic neurotransmission
As indicated in the introduction to this section,
prostaglandin biosynthesis may be evoked by administration
of exogenous precursor acid. Since the major renal
prostaglandins have been conclusively identified as PGE2
and PGF2rt (possibly some PGA2)(see Davis and Horton, 1972
for references), their precursor, arachidonlc acid, was
used in the present experiments. The primary aim of the
experiments was to assess the accessibility of newly-formed
prostaglandins to cortical nerve endings.
Methods
Preparation of arachidonlc acid
Arachidonic acid (Sigma Chemicals, Grade 1, 99% pure,
porcine liver) was purified and made into the sodium salt
shortly before use, as described by Larsson and Anggard
(1974). It was hoped that purification by silicic acid
column chromatography would eliminate prostaglandin contamin¬
ation, if any, in the 196 impurity.
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Columns (approximately 15 x 1 cm) were made up with
0.75 g silicic acid (Unisil, 100-200 mesh, Clarkson
Chemical Co) in hexane. Arachidonic acid (10 rag) was
applied to the column in 0.5 ml hexane. The column was then
washed with 20 ml hexane to remove non-polar lipids. This
was followed by elution of arachidonic acid from the column
with 20 ml 5% ether in hexane. A recovery experiment with
labelled arachidonic acid showed that 84% of it was recovered
in the ether-hexane fraction and a further 2% in the hexane
fraction. The recovery was assumed identical for other
columns made with the same batch of Unisil.
The purified arachidonic acid was then converted to
the anion by brief treatment with 0.5 N KOH in pure ethanol.
The ethanol was evaporated under nitrogen and the arachidonate
dissolved in 0.9% saline. Ascorbic acid, 50 Mg/ml was added
as an anti-oxidant. This solution was stored deep-frozen
under nitrogen for a maximum of 48 hours, at the advice of
Larsson (personal communication). The stock solution was
diluted as required with 0.9% saline.
Experimental procedure
Thirteen rabbit kidneys (from the left side) were set
up for isolated Dextran-Tyrode perfusion and perfusate
collection as previously described in Sections 2 and 3. Each
kidney was labelled with 25 pCi -%-NA for transmitter studies.
Parameters for stimulation of the renal nerve were chosen
midway in the range of frequencies previously studied, namely
5 Hz for 30 s (2 ms duration, 7-15 V). The period of
infusion of arachidonate was extended to approximately twice
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that used for prostaglandin infusion prior to RNS to allow
time for the former to reach the site of endogenous
prostaglandin synthesis. Thus arachidonate infusion was
begun 5 rain prior to RNS and continued throughout RNS. In
cumulative dose experiments, each concentration of
arachidonate was infused as just described, to successive
stimulations of the renal nerve. Infusion concentrations
-7 -5
ranged from 10 to 5.2 x 10 M. A minimum of three nerve
stimulation periods were monitored for transmitter overflow
prior to arachidonate application.
Results
In the first experiment, infusion of the lowest
_7
concentration of arachidonate, 10 M, produced neither
inhibition of transmitter overflow nor inhibition of vascular
responses resulting from RNS. At an infusion concentration
—ft
of 10" M, arachidonate again produced no inhibition of trans¬
mitter overflow although there was slight inhibition of
vascular responses to RNS. When the dose of arachidonate
—5
was increased to 2 x 10 "N for 5 min prior to and also
during RNS, transmitter overflow was inhibited by 35 • 3 +,
4.0?£ (n = 5* see Table 4).
On addition of cumulative doses of arachidonate,
—5 -5
10 to 5.2 x 10 M, a dose-dependent inhibition of trans¬
mitter overflow during RNS was observed. (Fig. 4c). This
inhibition was accompanied by concomitant inhibition of
vascular responses to RNS (Fig. 4d). In most experiments,
a slight reduction in perfusion pressure was observed
throughout the duration of arachidonate infusion. Partial
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Figure 4c: Isolated, perfused rabbit kidney. Effect
of cumulative doses of arachidonic acid on tritium
overflow (^H-overflow) resulting from renal nerve
stimulation (NS).
cpm/aliquot
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Figure 4d: Isolated, perfused rabbit kidney. Effect of
arachidonic acid alone and of arachidonic acid in the
















or complete recovery from inhibition of transmitter over¬
flow usually occurred within 10-20 min of ending the
infusion although in some experiments the overflow remained
depressed. Recovery of vascular responses was generally




These experiments have shown that arachidonate, in
concentrations ranging from 10~^ to 5*2 x 10~^M, is capable
of mimicking the effects of PGE2 on transmitter overflow
apd vascular responses to RNS (Table 4). Since arachidonate
is apparently pharmacologically inactive in itself
(Dakhil and Vogt, 1962), its action is probably attributable
to the spontaneous synthesis of prostaglandin within the
kidney. Prostaglandin formation was not monitored either
in renal venous effluent or in urine. Consequently, it
was necessary to investigate whether the effects of
arachidonate could be abolished by inhibiting prostaglandin
biosynthesis.
*
4 ■ ■ ■** *ru ' ' *
Experiment^; Inhibition by indomethacin of endogenous
prostaglandin biosynthesis from arachidonate and subsequent
effects on adrenergic neurotransmission
By administering arachidonate to the isolated kidney
in the presence of the PG synthesis inhibitor, indomethacin,
it was hoped to find out whether arachidonate produces its
actions on neurotransmission per se, or as a result of
prostaglandin formation. If resultant from prostaglandin
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formation, the actions of arachidonate should be reduced or
abolished in the presence of indomethacin.
Methods
Five rabbit kidneys were set up for isolated perfusion
and transmitter collection as described in Experiment 1.
Three control responses to RNS were obtained by stimulation
to the renal nerve as before at 5 Hz for 30 s. Arachidonate
—5
was then infused at a concentration of 2.6 x 10 "14 for 5 min
prior to and also during RNS. A further three post-test
controls were obtained. Indomethacin, prepared as in
—5
Section 4a, was then infused at a concentration of 4.4 x 10 "14.
Three test samples were collected, by which time a plateau
of elevated transmitter overflow should be reached. Ara¬
chidonate was then infused, exactly as before, in the
presence of indomethacin. Infusion of indomethacin was
maintained for one post-arachidonate stimulation period and
was terminated immediately thereafter. One or more post-
indomethacin control stimulations were carried out. An
example of the sequence of arachidonate and/or indomethacin
administration can be seen in Fig. 4e.
Results
The results are presented in Table 4. Transmitter
overflow during arachidonate infusion was calculated as a
percentage of the preceding control output. The overflow
during arachidonate infusion in the presence of indomethacin
was calculated as
overflow during arachidonate + indomethacin iqo°d
previous overflow during indomethacin '
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Fl£ure__4e: Isolated, perfused rabbit kidney. Effect
of arachidonic acid (AA) alone and of arachidonic acid
in the presence of indoraethacin on tritium overflow
(overflow) resulting from renal nerve stimulation (NS).
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The percentage change in overflow during various treatment
was calculated by subtraction of the above-calculated
values from 100%.
Table 4 Percentage change of transmitter overflow to RNS
(5 Hz. 150 pulses) by PGB2 (4,5 x 10""7H),
arachidonate (2.6 x 1Q*"^M) and indomethacin
























Mean values _+ S.E.M., figures within brackets = number of
experiments. Statistical analysis according to Student's
t-test. NS » not significant.
9 4
Conclusion
It is apparent from these experiments that indomethacin
significantly reduces the biological activity of arachidonate.
Thus the inhibitory effect on vascular responses and trans¬
mitter overflow was primarily that of newly-formed prosta¬
glandin rather than that of arachidonate itself. A small
residual effect of arachidonate during indomethacin treatment
169
is not unexpected, since indoniethacin, in doses similar to
that used presently, has been shown to markedly inhibit
but not abolish the conversion of arachidonate to PGE2 in
rabbit kidney and in rat kidney homogenates (Larsson and
Anggard, 1974; Fredholm, Hedqvist and Larsson, unpublished
observations).
Discussion
The probable sites of action of arachidonate are
discussed in terms of (i) direct action on renal vasculature,
(ii) influence on vascular responsiveness to catecholamines,
(iii) influence on adrenergic transmitter release.
(i) Direct action
The use of an isolated organ preparation for this study
again eliminates reflex or systemic influences and hence
sympathetic tone. Any reduction in perfusion pressure
effected by arachidonate may be ascribed, therefore, to a
direct action on renal vasculature. The capacity of indo-
methacin to reduce or abolish arachidonate's action confirms
the belief that the latter is mediated by newly-formed
prostaglandins. It is curious that in these experiments,
arachidonate produced no effect on perfusion pressure at
concentrations of 10~* M (300 ng/ml) or less whilst in
similar experiments on the isolated kidney, Malik and McGiff
(1975) found that concentrations of 100 ng/ml produced a fall
in perfusion pressure. The arachidonic acid utilised by
them, however, was not subjected to further column chromato¬
graphy and may have contained an active contaminant. This
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possibility cannot be excluded since these authors only
showed an average of 57% reduction in the vasodilator action
of arachidonic acid during infusion of indomethacin (1 pg/ml).
An alternative explanation of the discrepancy is that in
present experiments, the concentration of arachidonate was
estimated assuming complete salt formation. It is possible,
therefore, that the concentration of arachidonate was over¬
estimated.
Arachidonic acid demonstrates an ability to redistri¬
bute renal blood flow in several in vivo kidney experiments.
Larsson and Xnggard (1974 ) have shown, using the radio¬
active microsphere technique, that sodium arachidonate
(15-25 pg/kg/min) increases the ratio of juxtamedullary to
superficial cortical blood flow in the rabbit kidney.
Indomethacin (10-20 mg/kg) was found to abolish this effect.
A similar investigation was performed by Chang, Splawinski,
Gates and Nies (1975) and their results confirmed this
ability of sodium arachidonate (3-10 pg/kg/min) to redistri¬
bute intrarenal blood flow in favour of the juxtamedullary
cortex, in the dog kidney. The possible intervention of
neurogenic or circulating factors in the two fore-mentioned
reports constitutes a major drawback to any deduction of
arachidonate's mode of action.
(ii) Influence of arachidonate on vascular responsiveness to
catecholamines
The ability of arachidonate at a concentration of 10""bM
to inhibit vascular responses to NS in present experiments,
without apparently altering transmitter overflow, indicates
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the existence of a postjunctional site of action. This is
not unexpected in view of the direct actions of arachidonate
discussed in (i). At dose-levels of 2 x 10"% and above,
a prejunctional site of action also becomes apparent. The
primary site of action may not be postjunctional, however,
despite occurrence of the latter prior to any effect on
transmitter release. It is possible that arachidonate
gains direct access to renal vasculature on infusion and is
synthesised there into prostaglandins, thereby accomplishing
rapid vascular effects. Penetration of arachidonate or
newly-formed prostaglandins to cortical nerve-endings is
inevitably made difficult by the abundance of cortical
prostaglandin dehydrogenase. Evidence of a postjunctional
site of action is indicated by De la Lande et al. (1975).
They found that arachidonate depressed vasoconstrictor
responses of the isolated rabbit ear artery to both NS and
NA, and, that this depression was abolished in the presence
of indomethacin (3 Mg/ml). Ryan and Zimmerman (1973, 1974)
report a depression by arachidonic acid (1-2 pg/nil) of vaso¬
constrictor responses to NA in the dog paw, again a post¬
junctional effect.
Contrary to the evidence discussed in favour of a post¬
junctional action, or a combination of pre- and postjunctional
actions of arachidonate, Malik and McGiff (1975) provide
challenging results in support of a primary prejunctional
action. A concentration of lu ng/ml arachidonic acid was
sufficient to significantly reduce vascular responses to NS
without altering equiconstrictor responses to NA, in their
experiments on the isolated rabbit kidney. The capacity of
172
arachidonic acid to affect transmitter release in such low
concentrations in these experiments, when 300 ng/ml had no
effect in present experiments, is indeed inexplicable.
(iii) Influence of arachidonate on adrenergic transmitter
overflow in response to RNS
Experiments in this section furnish conclusive
evidence that arachidonate is capable of reducing the over~
flow of adrenergic transmitter resulting from RNS, without
affecting resting transmitter overflow. Furthermore, this
effect is almost completely suppressed by indomethacin,
indicating that it results from de novo synthesis of




In the first section of this thesis experiments are
described which were designed in the hope of answering the
first of the questions posed in the General Introduction:
do prostaglandins which are released from the kidney on
nerve stimulation originate presynaptically from adrenergic
nerve endings or postsynaptically? It was proposed that
if both NA and RNS could stimulate prostaglandin release,
the site of prostaglandin release was most probably post¬
synaptic. Davis and Norton (1972) have demonstrated that
RNS increases prostaglandin output in renal venous blood of
rabbits. In Section 1, it was shown by two methods of
prostaglandin analysis that noradrenaline also increases the
release of prostaglandins into renal venous blood of rabbits.
These results, in conjunction with additional evidence cited
in the discussion of Section 1, are indicative of a post¬
junctional site of release of prostaglandins in the kidney,
although a prejunctional site of release cannot be excluded
at this stage. The recent finding that the a-adrenoceptor
blocker, phenoxybenzamine, can selectively block either
postjunctional or both prejunctional and postjunctional
a-receptors, according to the dose-level employed
(Dubocovich and Langer, 1974), will hopefully lead to more
definitive studies on the site of release of prostaglandins.
The ability of the kidney to maintain constant blood
flow in face of changing perfusion pressure i.e. to auto-
regulate, is thought to be partly explicable in terms of a
redistribution of cortical blood flow. Thus a reduced
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outer cortical blood flow and an augmented flow to the
inner cortex have been observed during haeraorrhagic
hypotension in dogs (Carriere, Thorburn, O'Morchoe and
Barger, 1966; Truninger, Rosen, Grandchamp, Strebel and
Kriek, 1971; Hardaker, Graham and Wechsler, 1975).
Similarly, graded aortic constriction (McNay and Abe, 1970)
and splanchnic nerve stimulation (Pomeranz, Birtch and
Barger, 1968) have been shown to decrease outer cortical
and increase inner cortical blood flow. Several pieces of
evidence favour PGE as a possible mediator of renal auto-
regulation. Firstly, Itskovitz et al. (1974) observed that
redistribution of renal blood flow to the inner cortex was
associated with a rise in efflux of a PGE-like substance
from the isolated perfused kidney. When indomethacin was
added to the perfusate to block prostaglandin synthesis, a
decrease in total renal blood flow and, in particular,
inner cortical blood flow was observed.
Increased synthesis of endogenous prostaglandin in
the kidney resulting from infusion of the major renal
prostaglandin precursor, arachidonic acid, also affects
renal blood flow distribution. Arachidonate infusion into
the aorta of the rabbit (Larsson and Snggard, 1974) and into
the renal artery of the dog (Chang et al.« 1975) both
increased perfusion of the inner relative to the outer renal
cortex. Thus prostaglandins seem to influence intrarenal
blood flow distribution.
The role of renal nerves and circulating catecholamines
in the control of renal blood flow and its distribution is
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unclear. Although both NA and RNS induce a redistribution
of renal blood flow, they are apparently not essential to
the redistribution occurring during haemorrhagic hypotension.
Hardaker et al. (1975) have shown that redistribution under
these circumstances occurs even in denervated kidneys or
when dogs are reserpinised. In experiments on the isolated
(and hence denervated) canine kidney, Itskovitz et al. (1974)
also observed redistribution of renal blood flow. However,
it has been reported that autoregulation is less efficient
in the absence of renal nerves (see Wesson, 1969 for
references). Since both the outer and inner cortices of
the kidney appear to be innervated, a mechanism must exist
whereby blood flow can be maintained through the inner
cortex during periods of intense sympathetic stimulation. If,
as is suggested, prostaglandins are responsible for
maintenance of inner cortical blood flow, the questions arise
as to whether they act by (1) producing a direct vasodilatation
in this region (2) influencing vascular responsiveness to
catecholamines (circulating or released by RNS) or
(3) decreasing the effectiveness of RNS by reducing trans¬
mitter output. These questions encompass questions (ii)
and (iii) posed in the General Introduction. The results
obtained in Section 2 indicate that PGE2 is the most likely
mediator of blood flow maintenance in the kidney. The
concentration of PGE2 required to produce an effect on
perfusion pressure and/or vascular responsiveness to adrener¬
gic stimuli was similar to the highest concentration observed
in renal venous blood following noradrenaline infusion
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(Section 1) - about 50 ng/ml (ca. 3 x 10~^M). The
requirement of doses at least as high and higher than the
maximum output concentration to produce effects when
infused intra-arterially to the isolated kidney is probably
the consequence of partial metabolism of PGE2 in the renal
cortex before it has an opportunity to reach its site of
action. From the results obtained in Section 2, it was
concluded that PGE2 produced an effectively greater
inhibition of vascular responses to RNS than of those to NA.
Consequently, it was proposed that PGE2 might produce this
differential effect by acting prejunctionally as well as
postjunctionally, at the adrenergic synapse. The results
presented in Section 3 provide evidence that PGE2 does act
prejunctionally to reduce adrenergic transmitter release.
The regional!sation of prostaglandin synthesis
(mainly in the medulla) and metabolism (mainly in the cortex)
suggests a functional separation of the two systems. If
prostaglandins of the E series are involved in the control
of adrenergic transmission in the kidney, they must be able
to gain access to the cortical nerve terminals. Such
access is feasible in view of the findings that PGE2 is
synthesised in the cortex although to a lesser extent (one
tenth) than in the medulla. In order to study effects of
endogenous prostaglandin (and thus its ability to gain access
to adrenergic terminals) on adrenergic transmission
(question (iv), General Introduction), experiments were
conducted in which endogenous prostaglandin synthesis was
either decreased (with indomethacin) or increased (with
arachidonate). The results obtained from these experiments
177
(Sections 4a and 4b) showed that a decrease in prosta¬
glandin synthesis could enhance transmitter release whilst
an increase in prostaglandin synthesis reduced transmitter
release. These results are entirely compatible with the
view that endogenous prostaglandins (mainly PGE2) control
adrenergic transmitter release in the kidney and also
indicate that cortical nerve endings are accessible to
endogenously-produced prostaglandin. It seems probable
that the prostaglandin acting on adrenergic transmission
is synthesised locally to (or perhaps within) the adrenergic
nerve endings, in the renal vasculature itself. Prosta¬
glandin synthesis by vascular smooth muscle has been demon¬
strated using various blood vessel types. Terragno,
Crowshaw, Terragno and McGiff (1975) have demonstrated that
bovine mesenteric arteries and veins share, with equal
capacity, the ability to synthesise prostaglandins. Prosta¬
glandins were assayed in these experiments by the super-
fusion technique. Separation by thin layer chromatography
indicated that, under control conditions, synthesis of PGE2
was twice that of PGF2rr. Kalsner (1975) investigated the
prostaglandin synthetic capacity of bovine coronary arteries
and found that, on incubation in Krebs solution, they
synthesised large amounts of a PGE-like substance. Inhibition
of prostaglandin synthesis with aspirin, indomethacin or
ETA led to a sustained contraction of the arteries suggesting
that endogenous PGE production determines the degree of
relaxation of these arteries. These observations on
isolated preparations clearly provide evidence that prosta¬
glandins can alter vascular smooth muscle tone in the absence
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of sympathetic nervous activity, presumably by a direct
myogenic action.
An interesting observation was made by Rioux and
Regoli (1975) who were studying the release of prosta¬
glandins from thoracic aortae of hypertensive and normal
rats. These authors found that aortae from hypertensive
rats released higher amounts of prostaglandin than those
from normal rats. The results led them to the conclusion
that the absence of relaxation of aortic strips from hyper¬
tensive rats might be due to increased intramural
synthesis and release of prostaglandins. This is an
interesting finding in view of the species differences
previously described in Section 2, namely that PGE2 causes
vasoconstriction in the rat kidney but vasodilatation in
the rabbit kidney. Thus in the rat, PGE may promote
.hypertension.
Possible mechanisms by which prostaglandins might alter
adrenergic transmitter release
It is now well-known that a-adrenoceptor blocking
drugs increase the release of adrenergic transmitter
as shown in early experiments by Brown and Gillespie (1957).
Considerable evidence has since accumulated showing that
NA release is controlled by a negative feedback of noradre¬
naline itself on adrenergic nerve endings to prevent or
reduce further transmitter release. Thus, by blocking the
a-receptors which exert this control (thought to be pre-
junctionally located), the braking effect is lost and trans-
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raitter release increases (for references, see Usdin and
Snyder, 1973; Burnstock and Costa, 1975)• Bearing in
mind the r*-mediated control of noradrenaline release,
some workers have explored the role of endogenous prosta¬
glandins in the control of transmitter release and have
attempted to find out whether they act within the a-mediated
system or exert an independent control.
Hedqvist demonstrated that the nt-blocking drugs
phentolamine and phenoxybenzamine increase adrenergic
transmitter release (gauged using ^H-NA) from the trans-
murally-stimulated guinea pig vas deferens. Following
inhibition of prostaglandin synthesis with ETA, these
compounds still caused an increase in transmitter overflow.
This effect was abolished by PGE2. Noradrenaline also
inhibited H-NA overflow in the presence of ETA. Thus
it may be concluded that the nt-mediated control system can
be triggered in the absence of endogenous prostaglandin,
suggesting that the two control mechanisms operate
independently of each other (Hedqvist, 1974c). In another
set of experiments, Hedqvist found, conversely, that a~
blockade did not significantly affect the inhibitory action
of prostaglandin (Hedqvist 1974a).
Stjarne has further demonstrated that the effect of
noradrenaline on %-NA overflow (to decrease it) from the
field-stimulated guinea pig vas deferens was not signifi¬
cantly altered by incubation of the tissue with ETA, although
■5
the enhancing effect of ETA on "n-NA overflow was dose-
dependently depressed by the a-blocker, phentolamine. These
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results suggest that the two control mechanisms, a-mediated
and PG-mediated, might act independently but that the
release of endogenous prostaglandin is itself a-mediated.
Thus a-receptors trigger two feedback control mechanisms,
one operated by NA and one by PGE (Stjarne, 1973b, 1973d).
Two independent mechanisms of control of adrenergic trans¬
mitter release, one PG-mediated and one a-mediated, have
also been proposed to exist in the rabbit heart (btarke
and hontel, 1973), although in these experiments there was
no indication that the PG-mechanism operated via stimulation
of a-receptors. A role for prostaglandins in the control
of NA release has also recently been extended to humans.
StjEtrne and Gripe (1973) have shown that the dual ot/PG
control mechanisms which appear to control transmitter release
in the vas deferens, also operate in human peripheral
arteries and veins. Studies were carried out on isolated
segments of these vessels, obtained by biopsy from
normotensive individuals.
The release of adrenergic transmitter is critically
calcium-dependent (see Hubbard, 1970). It is interesting,
therefore, that a relationship between calcium and the
inhibitory effect of PGE2 in adrenergic neurotransmission
has been established. Hedqvist (1970c) demonstrated that
when the calcium concentration of the medium used to perfuse
the isolated cat spleen was raised from 2.5 mM to 5.0 mM,
the outflow of NA in response to splenic nerve stimulation
(NS) was increased. Furthermore the increased calcium
concentration strongly counteracted the inhibitory effect of
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PGE2. A similar reversal of the inhibitory action of PGE2
was observed by raising the external calcium concentration
from 1.8 raM to 5.4 mil in the superfusion fluid of the
isolated field-stimulated guinea pig vas deferens (Hedqvist,
1974b). PGE2 was still inhibitory in these experiments
but its effect was less marked, with a shift to the right
of the dose-inhibition curve. EtjSrne also demonstrated,
using the vas deferens preparation, that the inhibitory
effect of PGE2 varies inversely with the external calcium
concentration. He suggested that PGE might facilitate
efflux of intraaxonal calcium (StjSrne, 1973a) since other
workers have shown that PGE may act as a calcium ionophore,
facilitating calcium movement across biological membranes
(Kirtland and Baum, 1972). An alternative suggestion made
by StjSrne, in a kinetic study of the calcium dependence of
the NA secretory process, was that PGE2 might depress the
affinity for calcium of the secretory mechanism (StjSrne,
1973c). It must be concluded, however, that the exact
mechanism whereby PGE inhibits adrenergic transmitter
release is not, as yet, fully understood.
Despite the present lack of understanding of the
mechanism of action of PGE, its effect on renal adrenergic
neurotransmission has considerable implications in the
field of renal hypertensive disorders. If the normo-
tensive state is dependent upon the continued production of
PGE2 to control renal vascular tone, it is conceivable
that some hypertensive states might result from a lack of,
or reduction, in renal prostaglandin production. PGE2,
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itself, would be rather unsuitable as a drug for treatment
of hypertension for reasons of its rapid metabolism by the
lungs. Various prostaglandin analogues have been
synthesised recently, however, which show greater biological
activity and greater stability in the circulation than PGE2
e.g. l6,16'-dimethyl-~PGE2. The development of such
substances will hopefully lead to their eventual application
in the treatment of renal vascular disorders.
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Summary
The effect of prostaglandin E^ on vascular responses of
the rabbit kidney to renal nerve stimulation and noradrenaline
was examined in vitro and in situ as a test of the hypthesis
that prostaglandins of the E series may be involved in the re¬
gulation of adrenergic neuroeffector transmission. Intraarte¬
rial administration of prostaglandin E^ to the in vitro kidney
caused marked inhibition of vascular responses to nerve sti¬
mulation whereas the responses to noradrenaline were not
significantly altered. In the in situ preparation, vascular re¬
sponses to both nerve stimulation and noradrenaline were in¬
hibited by prostaglandin E^ infusion, although its effect on
responses to nerve stimulation was approximately twice that
observed on responses to noradrenaline.
It is concluded that prostaglandin acts primarily at
a prejunctional level of adrenergic neuroeffector transmission
in the kidney, although a postjunctional effect has also been
observed.
I ntroduction
The purpose of the present study was to examine the hypothesis that
prostaglandins of the E series may be involved in the regulation of trans¬
mitter release from sympathetic nerve endings (4). The isolated rabbit kid¬
ney with renal nerve dissected free was used as a model in most experi¬
ments although some iri situ experiments were included in the study as a
check on the validity of the in vitro situation. It has already been shown that
large amounts of prostaglandin E^ (PGE^) are present in renal venous blood
of rabbits, and that this output is increased on renal nerve stimulation (2).
It seems likely, therefore, that this increased output of PGE2 during nerve
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stimulation may serve some regulatory function by affecting further trans¬
mitter release from renal sympathetic nerve endings.
The present experiments consisted of administration of PGE^ to the kid¬
ney intraarterially, and observation of its effects on renal vascular re -
sponses to nerve stimulation (NS), and exogenous noradrenaline (NA).
Methods
a) In vitro experiments
20 rabbits weighing 2-2. 5 kg were anaesthetized with 25 % urethane, 7
ml/kg. The abdomen was opened along its midline and the left kidney, with
its nervous and vascular supply, was dissected free from the surrounding
tissue. The nerve was then carefully freed from the artery. After heparini-
sation (ll.U./g. body weight) the vessels and ureter were cannulated, the
nerve was cut and the kidney was flushed with warm 0. 9 % saline containing
50 I.U, heparin/ml. The preparation was then transferred immediately to a
perfusion chamber maintained at 37°C and was perfused with Tyrode solution
(concentrations in mM: NaCl 136.7, KC1 2. 7, CaCl^l. 8, MgC^l. 0, NaHCO^
11.9, NaH^PO^ 0.4, glucose 5.5) also at 37°C, containing 2% dextran and
gassed with 5 % in
Perfusion flow was kept constant at a rate of 10 ml/min and pressure
was recorded close-arterially to the kidney on a Grass Model 5 Polygraph
using a Statham (P 23 AC) pressure transducer.
The nerve was placed on platinum electrodes and stimulated with a
Grass S5 stimulator delivering 15-30 sec trains of pulses (6-10 Hz, 2 msec,
5-15 V) at 10 min intervals.
NA and PGE^ were infused intraarterially in Tyrode solution.
b) In situ experiments
4 rabbits were anaesthetized as before and the left renal nerve was
freed from the artery. Heparinisation of the animal was maintained by ad¬
ministration of 1 I. U. /g. body weight every two hours. The left kidney was
perfused with blood looped from the carotid artery through a constant rate
pump, adjusted so that the renal arterial pressure approximated normal
systemic pressure (90-110 mm Hg). This procedure required flow rates
ranging from 5-7 ml hlood/min and facilitated the administration of drugs at
constant concentration, as in the in vitro studies.
The renal vascular pressure was measured as before and drugs were
administered in Tyrode solution of minimal volume.
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Results
a) In vitro experiments
It was consistently observed that doses of PGE ranging from 3. 8 x
7 6
10 M to 1. 5 x 10" M, which did not alter the basal renal arterial pressure
on infusion, caused significant inhibition of vascular responses to nerve sti¬
mulation (NS, Fig 1). There was partial or complete recovery from this in¬
hibition 10 - 20 min after ending the infusion of PGE.. At dose-levels below
7 ^
1. 5 x 10 M, PGE2 showed no significant effect on responses to NS in most
cases, although weak inhibition or even slight enhancement of responses was
occasionally observed.
At higher dose-levels, (3. 8 x 10"7 - 1. 5 x 10"^M) the inhibitory effect
of PGE^ was found to be statistically significant at the 2 - 0.1 % level,
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FIG 1
Isolated, perfused rabbit kidneys. Effect of different doses of PGE- on pres¬
sor responses to renal nerve stimulation, NS (200 pulses, 10 Hz, 2'^msec, 7-
10 V) and to noradrenaline, NA (0. 26 - 0. 52 pg/ml, 20 sec infusions). All
values presented as per cent of a preceding control stimulation. Vertical bars
= mean values ± SEM. Figures within brackets = no of expts. x p<. 05, xx p
<. 01, xxx p<. 001 according to Student's t-test for paired variates.
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In contrast to its effect on responses to NS, PGE£ in the same concen¬
trations did not produce well-defined, dose-dependent effects on vascular
responses to NA. The most commonly observed effect was that of enhance¬
ment of responses although in some experiments either no effect or moderate
inhibition was observed.
Although the mean values (responses as % control level) were all at or
above control level, a statistical analysis showed that the mean responses to
NA were not significantly altered from the control level by PGE^ (Fig 1).
b) In situ_experiments
As observed in vitro, PGE^ consistently inhibited vascular responses
of the kidney to NS, with complete recovery from inhibition occurring about
10 min after ending the PGE£ infusion. The in situ kidney proved more sen¬
sitive to the inhibitory effect of PGE- than that in vitro, marked inhibition of
_7
NS responses being produced even in the lower dose-range, 1. 5 x 10 M -







Blood perfused rabbit kidney in situ. Effect of PGE„ on pressor responses to
renal nerve stimulation (A) and to noradrenaline (Bf in one and the same ex¬
periment.
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Within the same dose-range, vascular responses to NA were also in¬
hibited by PGE^, although the inhibition was much less marked than that
observed on responses to NS.
Di scus sion
The present study has shown that PGE2 inhibits responses of the rabbit
kidney to NS both in vitro and in situ. The quantitative difference in effecti¬
veness of PGE2 in the two preparations may be attributable to the fact that a
higher stimulation frequency (10 Hz) was required to produce suitable pres¬
sor responses in the in vitro preparation than was required m situ (5-8 Hz).
It has been demonstrated that the inhibitory effect of PGE^ on responses (of
the vas deferens) to field stimulation diminishes as the frequency of stimula¬
tion is increased (5). The present results are in agreement with those re¬
ported by Lonigro jst al_. (8) on the in vivo dog kidney.
The discrepancy between effects of PGE^ on renal vascular responses
to NA in vitro and m situ is not entirely surprising in view of the many con¬
flicting results which have been reported by other workers. Davies and With-
rington (1) found no effect of PGE2 on vascular responses of the isolated dog
spleen to NA whilst in the isolated cat spleen, the vascular responses to NA
- 8 - 7
were found to be inhibited by low doses of PGE^ 6x10 -3x10 M and
potentiated by high doses, 6 x 10 (3).
The in situ dog kidney was studied by Kadowitz et al. (6), who found
that PGE^ caused inhibition of vascular responses to NA. It is difficult to
extrapolate from such results since PGE^ was used instead of PGE2, al¬
though the two prostaglandins commonly show qualitatively similar effects.
The present in situ studies are, however, in complete agreement with those
of Lonigro ^t al. (8), who have shown that PGE2 inhibits responses of the m_
vivo dog kidney to NA but that this inhibition is weaker than that produced on
similar responses evoked by NS.
McGiff and Itskovitz (10) suggest that use of dose-levels of PGE2 ex¬
ceeding 100 ng/ml blood is questionable. In view of the location of sympathe¬
tic nerve endings being presumably confined to the cortex, it seems justifi¬
able to have used even higher doses of PGE2, since PGE2 is rapidly meta¬
bolized by prostaglandin dehydrogenase in the rabbit renal cortex (7).
Furthermore, the output of PGE2/ml renal venous blood is considerably
higher in the rabbit than in the dog ( 2, 9).
Results of the present studies in vitro would seem to suggest that PGE2
is producing its inhibitory effect on vascular responses to NS mainly at the
pre-junctional level, since its post-junctional effects on NA responses are
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apparently negligible. The in situ studies, however, point to some post-junc-
tional inhibitory action of PGE^. It is unlikely that such an action can ac¬
count for the total inhibitory action of PGE^ on NS, since inhibition of NA re¬
sponses approximates only 50 % of that observed at the same PGE^ dose-
level on NS.
In conclusion, it is suggested that PGE^ has some pre-junctional
effect on the sympathetic nerve endings in the present system. Further
studies on transmitter release from renal nerve endings are required to con¬
firm this suggestion.
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EXCERPTUM
Acta physiol. scand. 1974. 91. 25 A
C 1
ifects of Prostaglandin E2 on the Sympathetic Neuroeffector System of the Rabbit
Lidney in Vitro and in Situ
By Madeline H. Frame and Per Hedqvist. From the Department of Physiolo¬
gy, Karolinska Institute, Stockholm, Sweden
t has already been shown that large amounts of prostaglandin E2 (PGE2) are
resent in the renal venous blood of rabbits and that this output is increased on renal
erve stimulation (Davis and Horton 1972). The present study was carried out to
xamine the hypothesis that PGs of the E series may be involved in the regulation
f transmitter release from sympathetic nerve endings (Hedqvist 1973). The isolated
abbit kidny with renal nerve dissected free was used as a model in most exped¬
ients although some in situ experiments were included in the study as a check on
he validity of the in vitro situation.
Experiments were carried out to observe the effect of intra-arterially infused
'GE2 on (a) vascular response of the kidney to nerve stimulation and exogenous
oradrenaline, and (b) overflow of tritium-labelled noradrenaline during nervi
timulation.
In the (a) experiments, infusion of PGE2 (63—520 ng/ml) into the in vitro
idney caused marked inhibition of vascular responses to nerve stimulation, whereas
he responses to noradrenaline were not significantly altered. In the in situ prepara-
ion, however, vascular responses to both nerve stimulation and noradrenaline were
lhibited by PGE2 infusion, although its effect on responses to noradrenaline was
pproximately half of that observed on responses to nerve stimulation.
In the (b) experiments, infusion of PGE2 (63—320 ng/ml) into the in vitro
idney caused consistent reduction in overflow of labelled transmitter during nerve
timulation. In addition, it was found that this inhibitory effect of PGE2 varied in-
ersely with the stimulation frequency, total number of pulses being kept constant
l every stimulation.
In both series of experiments, the inhibitory effect of PGEo was dose-dependent
nd partial or complete recovery from this effect occurred within 10 to 20 min.
"he necessity for use of relatively high doses of PGE2 seemed permissible in view of
le rapid metabolism of PGs by prostaglandin dehydrogenase in the rabbit renal
ortex (Larsson and Anggard 1973).
It is concluded that PGE2 acts at both prejunctional and postjunctional levels of
drenergic neurotransmission in the rabbit kidney.
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EVIDENCE FOR PROSTAGLANDIN
MEDIATED PREJUNCTIONAL
CONTROL OF RENAL SYMPATHETIC
TRANSMITTER RELEASE AND VASCULAR TONE
MADELINE H. FRAME1 & P. HEDQVIST
Department of Physiology I, Karolinska Institute, S-10401 Stockholm, Sweden
1 Prostaglandin E2 dose-dependently and reversibly inhibited the noradrenaline overflow
resulting from nerve stimulation of the rabbit kidney.
2 The magnitude of this inhibition varied inversely with the frequency of stimulation
employed.
3 The prostaglandin synthesis inhibitors, indomethacin and meclofenamic acid, both
increased the transmitter overflow resulting from renal nerve stimulation, suggesting that
endogenous prostaglandin has a role in the regulation of transmitter release.
4 In the presence of indomethacin, the inhibitory effect of exogenous prostaglandin E2 was
enhanced.
5 The prostaglandin precursor, arachidonic acid, also caused a significant, dose-dependent and
reversible inhibition of transmitter overflow. This inhibition became insignificant when
arachidonic acid was applied in the presence of indomethacin, suggesting that the inhibition was
mediated by newly formed prostaglandin rather than by arachidonic acid itself.
6 It is proposed that newly formed prostaglandin controls noradrenaline release primarily
from inner cortical nerve endings, thereby maintaining juxtamedullary blood flow under
periods of increased sympathetic nerve activity.
Introduction
The rabbit kidney has a high capacity for both
synthesis (predominantly in the medulla) and
degradation (in the renal cortex) of prostaglandins
(Hamberg, 1969; Crowshaw, 1971; Larsson &
Anggard, 1973). Prostaglandin E2 is the most
abundant renal prostaglandin and is a potent
vasodilator (Lee, Crowshaw, Takman, Attrep &
Gougoutas, 1967; Daniels, Hinman, Leach &
Muirhead, 1967). Consequently, it has been
postulated that this prostaglandin has a physio¬
logical role in blood flow regulation in the kidney
(McGiff, Crowshaw, Terragno & Lonigro, 1970;
Lonigro, Terragno, Malik & McGiff, 1973; McGiff
& Itskovitz, 1973; Herbaczynska-Cedro & Vane,
1973, 1974; Larsson & Anggard, 1974;
Needleman, Douglas, Jalsetik, Stoecklein &
Johnson, 1974). It has in addition been shown
that both renal nerve stimulation (RNS) and
catecholamine administration increase the output
of prostaglandins in the renal venous effluent of
rabbits, prostaglandin E2 being most abundant
(Davis & Horton, 1972; Needleman ef al., 1974).
1 Present address: Department of Pharmacology, Univer¬
sity of Edinburgh, Scotland.
In the light of previous evidence which suggests a
role for prostaglandin E2 in regulation of trans¬
mitter release from sympathetic nerve endings
(Hedqvist, 1970, 1973, 1974a, b), it was decided
to examine the possibility of such an interaction in
the rabbit kidney. Previous experiments have
shown that prostaglandin E2 has an inhibitory
effect on vascular responses of the rabbit kidney
to RNS in vitro and in situ and that this inhibition
is probably, in part, prejunctional (Frame,
Hedqvist & Astrom, 1974; Frame & Hedqvist,
1974).
The aim of the present study was to assess the
capacity of prostaglandin E2, prostaglandin
precursor (arachidonic acid) and prostaglandin
synthesis inhibitors (indomethacin, meclofenamic
acid) to affect transmitter overflow resulting from
RNS.
Methods
Forty rabbits weighing 2 to 3 kg were anaes¬
thetized with 25% urethane, 7 ml/kg. The
abdomen was opened along its midline and the left
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kidney, with its nervous and vascular supply, was
dissected free from the surrounding tissue. The
nerve was then carefully freed from the artery.
After heparinization (1000 i.u./kg, i.v.) the vessels
and ureter were cannulated, the nerve was cut and
the kidney was flushed with 0.9% w/v NaCl
solution (saline) containing 50 i.u. of heparin per
ml. The preparation was then transferred to a
perfusion chamber maintained at 37 C and was
perfused with Tyrode solution (mm: NaCl 136.7,
KC1 2.7, CaCl2 1.8, MgClj 1.0, NaHC03 11.9,
NaH2P04 0.4, glucose 5.5, ascorbic acid 0.1) also
at 37 C, containing 2% dextran and gassed with
5% C02 in 02.
The renal perfusion rate was kept constant at
10 ml/min and pressure was recorded on a Grass
Model 5 polygraph using a Statham P 23 AC
pressure transducer.
Noradrenaline (NA) stores were labelled by
infusion of 25-50 pCi of tritiated NA in Tyrode
solution over a period of about 20 minutes. The
kidney was then perfused with isotope-free Tyrode
solution for 30 min to remove surplus tritiated
NA.
The nerve was placed on platinum electrodes
and stimulated with a Grass S5 stimulator
delivering 15 to 75 s trains of pulses (2-10 Hz,
2 ms, supramaximal voltage) at 10 min intervals.
The total number of pulses applied per stimulation
period was kept constant regardless of frequency.
The perfusate was collected in 1 min fractions for
2 min prior to nerve stimulation, during stimu¬
lation and for 2 min post-stimulation. The tritium
content of the perfusate was determined by
counting 0.5 ml aliquots in a Packard liquid
scintillation spectrometer with quenching
monitored by internal standards. Twenty ml of a
3 : 7 ethanol-toluene mixture containing 4 g of
2-5 diphenyloxazole (PPO) and 0.1 g of 1-4 di (2-
(4-methyl-5-phenyloxazo!yl))benzene (POPOP)
per litre of toluene was used as a counting medium
for each sample.
The radioactivity of the perfusate samples was
separated into that of intact NA and that of its
metabolites by cation exchange column
chromatography (Fredholm & Hedqvist, 1973).
The recovery of authentic NA added to the
samples and carried through the entirely
chromatographic procedure was 73.3 ± 2.3%
(mean ± s.e. mean, n = 4).
The following drugs were used: arachidonic
acid, Sigma Chemicals, St. Louis, U.S.A.;
[3 H] -(— (-noradrenaline, 7.2 Ci/mmol, The Radio¬
chemical Centre, Amersham; indomethacin was a
gift from Merck, Sharpe & Dohme, Rahway, N.J.,
U.S.A.; meclofenamic acid from Parke Davies,
Pontypool, Wales, and prostaglandin E2 from Dr
J. Pike, Upjohn Co., Kalamazoo, Mich., U.S.A.
Arachidonic acid (99%, porcine liver) was
further purified by silicic acid column chromato¬
graphy shortly before use. All drugs were
administered close-arterially to the kidney in
Tyrode or saline solution.
Results
Stimulation of the renal nerves (2-10 Hz, 2 ms
duration, supramaximal voltage) caused a marked
increase in overflow of radioactivity from the
kidney, which was accompanied by an increase in
the perfusion pressure. During RNS, intact
[3H]-NA accounted for 81.3% of the radio¬
activity, compared to 14.4% during resting
periods. In contrast, material not adsorbed to the
column (mainly deaminated products) accounted
for only 16.8% during RNS but 74.4% during
resting periods. The content of [3H]-normetane-
phrine, which made up 10% of the radioactivity
during rest decreased to less than 2% during
stimulation (Table 1).
Effect of exogenous prostaglandin E2
It was consistently found that infusions of
prostaglandin E2 (1.8-9.1 x 1 0~7m) 2 min prior to
and during RNS, which did not alter the basal
renal arterial pressure, decreased the overflow of
transmitter in response to RNS in a dose-
dependent manner (Figure 1). The degree of
inhibition of [3H]-NA overflow varied inversely
Table 1 Cation exchange column chromatography of radioactivity appearing in venous effluent of rabbit
kidney previously loaded with [3 H] -noradrenaline.
Sample No. of expts. 'Acid metabolites' Noradrenaline Normetanephrine
Stimulated 7 16.8 ±2.3 81.3 ±2.2 1.3 ±0.4
Resting 5 74.4 ± 2.3 14.4 ±1.1 10.0 ±1.5
Perfusate samples withdrawn before and during nerve stimulation. Chromatographic values presented as relative
distribution (per cent) of recovered 'acid metabolites' (mainly deaminated products), intact noradrenaline and
normetanephrine, and given as means ± s.e. mean.
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Figure 1 Isolated, perfused kidney of the rabbit, preloaded with [3 H]-noradrenaline. Effect of prostaglandin
E2 (PGE2) on overflow of tracer resulting from renal nerve stimulation (NS), 150 pulses at 5 Hz. Time in min =
fraction numbers. Dotted lines represent uncollected fractions.
Figure 2 Inhibitory effect of prostaglandin E2 (PGE2) on transmitter overflow resulting from renal nerve
stimulation (RNS), 150 pulses, 2-10 Hz. Vertical bars show s.e. mean. Figures at the points = number of
observations.
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Figure 3 Effect of cumulative doses of arachidonic acid on transmitter overflow resulting from renal nerve
stimulation (NS), 150 pulses at 5 Hz.
with the stimulation frequency employed
(Figure 2). The vascular responses to RNS were
similarly inhibited and there was partial or
complete recovery from both [3H]-NA overflow
and vascular-inhibition lOmin after ending the
infusion of prostaglandin E2.
Effect of arachidonic acid
When arachidonic acid (2.6 x 10~5m) was infused
5 min prior to and during RNS, transmitter over¬
flow was inhibited by 35.3% (see Table 2). On the
addition of cumulative doses of arachidonic acid, a
dose-dependent inhibition was observed
(Figure 3). Concomitantly there was a corres¬
ponding reduction of the vascular response to
RNS. In most of the experiments, a slight
reduction in perfusion pressure was observed
throughout the duration of the infusion. Partial or
complete recovery from the inhibition usually
occurred within 10-20 min of ending the arachi¬
donic acid infusion, although in some experiments
the transmitter overflow remained depressed.
Effect of prostaglandin synthesis inhibitors
Indomethacin was used to block the synthesis of
endogenous prostaglandins (Vane, 1971) and thus
to evaluate the possible role of the latter in
adrenergic transmission in the kidney.
At a stimulation frequency of 5 Hz (150
pulses), infusion of indomethacin (4.4 x 10~sm)
sometimes caused a slight increase in the resting
perfusion pressure (up to 5 mmHg) and either no
effect or a slight decrease in the effector responses
to RNS. The effect on transmitter overflow,
however, was much more marked. The overflow of
[3H]-NA during RNS increased significantly 8 min
after the start of an infusion of indomethacin and
plateaued after about 15 min of infusion. The
maximal increase of [3H]-NA overflow in
response to RNS was 41.5 ± 7.0% (mean ± s.e.
mean, n = 13). This value was significant at the
P< 0.001 level according to Student's f-test for
paired varieties. After ending the infusion, the
transmitter overflow fell off approaching the
preinfusion level within 10 to 20 min. However, in
some experiments the transmitter overflow
remained at an elevated level throughout post-
infusion controls (Figure 4).
In three additional experiments, meclofenamic
acid, (5 x 10~sm) which is also a potent inhibitor
of prostaglandin synthesis (Gryglewski & Vane,
1972), was used instead of indomethacin. The
increase in [3H]-NA overflow in response to RNS
produced by infusion of meclofenamic acid was
23.3 ± 3.5% (P < 0.05). The drug caused qualita¬
tively the same effects as indomethacin, although
it was less potent on an equimolar basis.
Effect of prostaglandin E2 and arachidonic acid
application during indomethacin treatment
During indomethacin treatment, prostaglandin E2
was still effective in producing an inhibition of
[3H]-NA overflow in response to RNS. The
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Figure 4 Effect of indomethacin on transmitter overflow resulting from renal nerve stimulation (NS), 150
pulses at 5 Hz.
inhibition produced was, in fact, significantly
greater (P< 0.02) than that produced by prosta¬
glandin E2 alone, the values being 61.3% for
indomethacin plus prostaglandin E2 and 39.6% for
prostaglandin E2 alone (Table 2).
The inhibitory effect of arachidonic acid,
unlike that of prostaglandin E2, was significantly
reduced (P < 0.001) from 35.3% for arachidonic
acid alone to 10.6% for arachidonic acid in the
presence of indomethacin. This would suggest that
the inhibitory effect was primarily that of newly
formed prostaglandin rather than that of the
arachidonic acid itself (Figure 5, Table 2).
Discussion
It was previously shown that prostaglandin E2
inhibits renal vascular responses to RNS and, to a
lesser extent, exogenous NA in the dog and rabbit
kidney (Lonigro et al., 1973; Frame et al., 1974).
Those results merited the suggestion of a primary
prejunctional action of prostaglandin E2, as
observed in other tissues (cf. Hedqvist, 1973).
The overflow of NA from an adrenergically
innervated organ can be monitored by determining
the efflux of [3H]-NA previously taken up by the
nerves (Hertting & Axelrod, 1961). Since in the
Table 2 Percentage change of transmitter overflow to RNS (5 Hz, 150 pulses) by prostaglandin E2 (PGE2)
(4.5 x 10~7m), arachidonic acid (2.6 x 10"SM) and indomethacin (4.4 x 10~5M), and by prostaglandin E2 and
arachidonic acid in the presence of indomethacin.
Administered Pretreatment Difference
compound None Indomethacin None — indomethacin
PGE2 -39.6 ±4.5(5) -61.3 + 4.6(3) 21.7 + 6.4
P < 0.001 P < 0.01 P < 0.02
Arachidonic acid —35.3 ± 4.0(5) —10.6 ±4.4(5) 24.7 ± 5.9
P < 0.001 P < 0.1 (NS) P< 0.001
Indomethacin +41.5 ± 7.0(13) — —
P < 0.001
Mean values ± s.e. mean, figures within brackets = number of experiments. Statistical analysis according to
Student's f-test.
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Figure 5 Effect of arachidonic acid (AA) alone and of arachidonic acid in the presence of indomethacin on
transmitter overflow resulting from renal nerve stimulation (NS, 150 pulses at 5 Hz).
present study the majority of the radioactivity
overflowing in response to RNS was represented
by intact [3H]-NA, total radioactivity was
considered an appropriate indicator of endogenous
NA overflow.
It is apparent from this study that transmitter
overflow resulting from RNS is dose-dependently
and reversibly inhibited by exogenous prosta¬
glandin E2 and can also be modified by altering
endogenous prostaglandin levels. Judging from
experiments on the cat spleen and the guinea-pig
vas deferens and heart (Hedqvist, 1970, 1974a;
Bhagat, Dhalla, Ginn, LaMontagne & Montier,
1972), where prostaglandin E2 does not alter the
disposition of released NA, it is likely that the
observed inhibition of transmitter overflow
represents an action directly on the process of
excitation-secretion coupling in the nerve
terminals.
In examining the inhibitory or 'braking' effect
of exogenous prostaglandin E2 on transmitter
release, the control transmitter overflow to RNS
acted as a guide to the effect of prostaglandin E2.
However, it could not be regarded as a true control
since, at least in the dog and rabbit kidney, RNS
causes release of prostaglandin E2 which should
also provide some braking action (Dunham &
Zimmermann, 1970; Davis & Horton, 1972;
McGiff, Crowshaw, Terragno, Malik & Lonigro,
1972). In an attempt to reduce the interference of
endogenous prostaglandins, experiments were
carried out in which prostaglandin synthesis
inhibitors were administered to the kidney. The
primary effect of the synthesis inhibitors, indo¬
methacin and meclofenamic acid (Vane, 1971;
1973), was to elevate transmitter overflow, which
is to be expected if an endogenous braking-
mechanism has been partially or wholly removed.
Moreover, in harmony with previous observations
on the guinea-pig vas deferens (Hedqvist, 1974a), a
given dose of prostaglandin E2 showed an
increased ability to inhibit transmitter overflow
during indomethacin infusion. This increased
potency may also be attributable to removal of a
local braking mechanism, assuming that
administered prostaglandin E2 normally has to
compete with endogenous prostaglandin for active
sites in the nerve terminals.
In a series of experiments the inhibitory effect
of prostaglandin E2 on transmitter release was
studied at different stimulation frequencies.
Generally the inhibition produced by a given dose
varied inversely with the stimulation frequency
employed. This would seemingly suggest an
endogenous prostaglandin-mediated braking
mechanism which operates more readily at a low
impulse activity than at a high. This is in good
agreement with results obtained in the rabbit heart
(Junstad & Wennmalm, 1973) where the sympa¬
thetic transmitter-release-mechanism became less
sensitive to exogenous prostaglandin E2 as the
frequency of stimulation was increased from
2-10 Hz. The release of endogenous prostaglandin
during sympathetic nerve stimulation of the dog
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kidney and the rabbit heart shows no apparent
linear correlation with either the frequency or the
transmitter overflow (Dunham & Zimmerman,
1970; Junstad & Wennmalm, 1973). Thus an
increase in stimulation frequency from 2-10 Hz
only approximately doubled the efflux of prosta¬
glandin E2-like material per unit time whilst the
transmitter overflow increased tenfold. It would
seem, therefore, that the endogenous transmitter
braking-mechanism is capable of compensating for
changes in impulse activity but that its effective¬
ness is limited both by the amount of
prostaglandin releasable and by the sensitivity of
the NA-release process to prostaglandin.
The series of experiments in which the prosta¬
glandin precursor arachidonic acid was used, was
carried out in an attempt to show that newly
synthesized prostaglandins have access to
sympathetic junctions. Infusion of arachidonic
acid produced a marked inhibitory effect on both
transmitter overflow and vascular responses to
RNS. This effect was mainly due to the formation
of prostaglandins since the effect was very much
reduced or abolished when arachidonic acid was
infused in the presence of indomethacin. A small
residual effect of the arachidonic acid is not
unexpected, since indomethacin in doses similar to
that used in the present study has been shown to
inhibit markedly but not abolish the conversion of
arachidonic acid to prostaglandin E2 in rabbit
kidney and in rat kidney homogenates (Larsson &
Anggard, 1974; Fredholm, Hedqvist & Larsson,
unpublished observations).
In discussing a role for prostaglandins as
regulators of transmitter release at renal
sympathetic nerve endings, the assumption is made
that there is a ready source of prostaglandins in
the vicinity of the cortical nerve endings. The
biosynthesis of prostaglandins, however, has been
shown to be ten times greater in the medulla than
in the cortex (Larsson & Anggard, 1973). It has,
nevertheless, been emphasized by these authors
that cortical synthesis is large enough to be of
significance. The renal cortex, in addition to its
biosynthetic capacity, possesses an abundant
amount of prostaglandin degrading enzyme,
prostaglandin dehydrogenase (Anggard, Larsson &
Samuelsson, 1971). It is probable, however, that
endogenous cortical prostaglandin which escapes
degradation may have access to the cortical nerve
endings. This possibility is inhanced by the fact
that prostaglandin E2 infused into the present
system, although going directly to the cortex,
produced an effect on RNS. An alternative
suggestion is that medullary prostaglandins may
reach the juxtamedullary arterioles via the vasa
recta (Larsson & Anggard, 1973).
Although both the juxtamedullary and outer
cortical arterioles have adrenergic innervation, it is
interesting that during RNS or induction of stress
in rabbits, the outer cortex becomes ischaemic
whilst juxtamedullary cortical blood flow persists
(Trueta, Barclay, Daniel, Franklin & Pritchard,
1947). Moreover, the prostaglandin synthesis
capacity of the cortex increases towards the
medulla and stimulation of prostaglandin synthesis
using arachidonic acid increases juxtamedullary
blood flow in the rabbit (Larsson & Anggard,
1973; 1974). It seems, therefore, that prosta¬
glandins are primarily available in the juxta¬
medullary zone to inhibit sympathetic arteriolar
tone. It is apparent from the present study that
this dilatation or prevention of vasoconstriction is,
at least in part, attributable to inhibition of
transmitter release, i.e. a prejunctional action on
adrenergic neuro-effector transmission. However,
part of the effect may be post-junctionally located
at the effector cell level since prostaglandin E2 to
some extent inhibits vascular responses to NA in
the dog and rabbit kidney (McGiff et al. 1972;
Frame et al., 1974) and newly formed prosta¬
glandin increases juxtamedullary blood flow in the
dog kidney under in vitro conditions (Itskovitz,
Terragno & McGiff, 1974).
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